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Abstract 
Infectious diseases are currently, one of the greatest global challenges in medicine. 
Rapid and precise diagnosis and identification of pathogen is important for timely 
initiation of appropriate antimicrobial therapy. However, many patients with infectious 
diseases receive empirical treatment rather than appropriate pathogen-directed 
therapy. As a result antimicrobials have been overused and/or misused, which has 
ultimately led to antimicrobial resistance (AMR). AMR is broadly considered as the 
most significant public health threat facing the world today. Policy makers from all over 
the world have recognised the urgent need for rapid point-of-care (POC) diagnostics 
that would not only identify pathogens but also provide antimicrobial susceptibility 
profiles in meaningful timeframe to initiate appropriate antimicrobial therapy and 
thereby, prevent AMR. Traditional culture-dependent diagnostic methods are still 
considered as gold standard methods. But they are very slow and generally require 18 
to 48 hours with further 8 to 48 hours to perform antibiotic susceptibility test. Among 
culture-independent methods, PCR and ELISA are label-based, costly, laborious and 
require specialised equipment and trained personnel to operate them. Lateral flow 
assays (LFAs) that are low-cost, simple, rapid and paper-based portable detection 
platforms are very popular, as they can be applied at the POC. However, it is difficult to 
integrate them with electronics and they also suffer from higher false-positive rates 
than PCR and ELISA. Optical, electrochemical and acoustic biosensor-based methods 
allow label-free, whole-cell bacterial detection. Among them, a relatively new technique 
called Anharmonic acoustic Detection Technique (ADT) is integrable and can be 
applied at the POC for rapid, label-free, low-cost, detection. ADT also allows detection 
with high specificity, which is lacking in most of the other methods; therefore, it was 
selected to explore its use for whole-cell bacterial detection. For the first time, ADT was 
integrated with specific multivalent DNA aptamers that bind whole bacterial cell for 
direct detection and quantification of viable E. coli (KCTC 2571) bacteria. This aptamer-
based assay coupled with ADT constituted the anharmonic acoustic aptasensor. DNA 
aptamers were immobilised through biotin and streptavidin conjugation, onto the gold 
surface of quartz crystal resonator (QCR) to capture the target bacteria and the 
detection was accomplished by measuring the shift in the maximum value of magnitude 
of the transduced 3f signal (3 times the drive frequency) i.e. ΔI3fmax upon binding, when 
driven at fundamental resonance frequency. This aptasensor provides a practical 
method for rapid, sensitive and quantitative on-site detection of bacteria confidently up 
to 2.5 x 104 (corresponding to 106 E.coli/mL) in 5 min, as compared to standard 
frequency shift (Δf0) and dissipation shift (ΔD) measurements. Anharmonic acoustic 
aptasensor also demonstrated specificity by distinguishing between specific (E.coli) 
and non-specific (S.typhi) interactions. Linear quantitative correlation could be reliably 
achieved with 3f signal (R2 = 0.984) for four concentrations of E.coli bacteria (105-108 
cells/mL), than with Δf0 and ΔD. Comparative performance of other bio-receptors of 
different size (anti-E.coli antibody) and different length (shorter linker with thiolated 
aptamer) was assessed against longer linker with biotinylated aptamer which gave the 
highest sensitivity and specificity than these two different receptors. To further enhance 
the sensitivity and specificity of this system, the same E.coli-binding aptamers were 
modified by introducing smart chemical moieties into their structure such that the newly 
configured aptamer sequences not only quantitatively detected bacteria but also gave 
characteristic signal, highly specific for that interaction. Thus, this anharmonic acoustic 
aptasensor can be applied for rapid, sensitive, specific and quantitative detection of 
whole-cell bacteria and thereby, can reduce diagnostic cycle and improve the 
appropriate prescribing of antimicrobial therapy and thus can be used to combat AMR.  
 
Keywords: antimicrobial resistance, anharmonic detection, acoustic sensor, 
aptasensor, rapid point-of-care diagnostics. 
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Chapter 1 Introduction 
1.1 General Introduction 
Infectious diseases continue to be a global public health problem, despite the 
advancement in knowledge of infectious diseases, improved sanitation, 
effective vaccines and antimicrobial drugs.[1] Rapid and accurate identification of 
microbial cause is vital while caring for an individual patient with an infectious 
disease or even while responding to a worldwide pandemic. This improves 
clinical outcome, reduces recovery time and healthcare costs. Many patients 
with infectious diseases receive empirical treatment rather than appropriate 
therapy dictated by the rapid identification of the infectious agent. As a result 
antimicrobials have been overused and/or misused, which has ultimately led to 
antimicrobial resistance (AMR).[2] AMR is a serious and ever-increasing threat 
to global public health that requires intensive and collective action across all 
government sectors and society.[3] This chapter begins with description of the 
AMR problem and how it is endangering the global health, its emergence and 
also the factors driving AMR. This section is described in detail in order to give 
background information and motives for this research. Following this, the 
approach of policy makers from all over the world to this emerging problem of 
AMR is specified, recognising the urgent need for rapid point-of-care (POC) 
diagnostics to combat AMR. The role of rapid diagnostics in fighting AMR and 
their unmet needs are also listed, guiding the course of this research. 
Subsequently, the specific aim and objectives of this research are highlighted in 
the order in which the thesis chapters are presented. Finally, the chapter ends 
with the description of the thesis structure. 
1.2 What is antimicrobial resistance? 
The WHO defines AMR as a microorganism's (such as bacteria, fungi, viruses, 
and parasites) resistance to antimicrobial drugs (such as antibiotics, antifungals, 
antivirals, antimalarials, and anthelmintics) that were once able to treat an 
infection by that microorganism. AMR is a broader term and includes the more 
specific "antibiotic resistance", which applies only to bacteria becoming resistant 
to antibiotics.[3] 
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1.2.1 The global problem of antimicrobial resistance 
AMR is widely recognised as the most significant public health threat facing the 
world today. Many experts around the world have used appalling language in 
describing the range of challenges posed by AMR. But such a description is 
pertinent as AMR is a worldwide challenge associated with high morbidity and 
mortality, threatening the ability of modern medicine to treat common infectious 
diseases.[4] In the words of England’s Chief Medical Officer, Prof Dame Sally 
Davies: “The world is facing an antibiotic apocalypse.” At the recent Solutions to 
Drug-Resistant Infections (SDRI 2017) conference, she warned that if 
antibiotics lose their effectiveness it will spell “the end of modern medicine” and 
urged world leaders to address the growing threat of AMR.[5] Prior to this, in July 
2014, a review on AMR was commissioned by the then Prime Minister of the 
United Kingdom (UK), who had asked economist Lord Jim O’Neill to analyse the 
global problem of rising drug resistance. This review estimated that if nothing is 
done to control AMR, there will be 10 million deaths a year and up to $100 
trillion lost to the global economy by 2050 (Fig. 1.1).[6] 
 
Fig. 1.1 - Deaths attributable to AMR every year compared to other major causes 
of death. Adapted and modified from [6,7]. 
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It also predicted that if the current resistance rates increased by 40%, the region 
with the highest number of deaths attributable to AMR by 2050 would be Asia 
with 4.7 million followed by Africa with 4.1 million, while there would be 390,000 
deaths in Europe and 317,000 in the United States (US) (Fig. 1.2).[6,7] Although, 
the results from these burden reports were ridiculed as “broad brush estimates”, 
they highlighted the gravity of the incipient problem and the need for more 
comprehensive population-based AMR surveillance data.[8] Nonetheless, 
another analogous report published by Centers for Disease Control and 
Prevention (CDC) estimated that in the US more than 2 million people acquire 
serious infections with antibiotic resistant microbes and at least 23,000 people 
die per year due to these infections. Even though, the total economic cost of 
AMR to the US economy has been difficult to calculate, CDC estimated direct 
costs of AMR to be $20 billion, with a further $35 billion in productivity costs.[9] In 
Europe as well, AMR is estimated to be responsible for 25,000 deaths per year 
and about 700,000 deaths per year globally. In Europe alone, historical 
estimates from 2009 suggest a direct and indirect cost of €1·5 billion annually in 
healthcare costs and productivity losses.[10]  
 
 
Fig. 1.2 – Estimated deaths attributable to AMR every year by 2050. Adapted and 
modified from [7]. 
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According to a recent report by the World Bank Group, by 2050 AMR could 
cause global economic damage as large as the losses caused by the 2008 
financial crisis. This report also projected that a high AMR-impact scenario 
could cause low-income countries to lose more than 5% of their Gross 
Domestic Product (GDP) and push up to 28 million people, mostly in developing 
countries, into poverty by 2050 (as shown in Fig. 1.3). Moreover, unlike the 
financial crisis of 2008, there would be no prospects for a cyclical recovery in 
the medium term, as the costly impact of AMR would persist.[11] Also, the costs 
of some of the methods to contain AMR differ widely across countries, 
especially for infectious diseases like Tuberculosis (TB) which can become 
multidrug-resistant (MDR) or extensively drug-resistant (XDR) strains. MDR-TB 
and XDR-TB infections are far more expensive to treat than drug-susceptible 
TB. Figure 1.4 shows the cost variances in treating TB, with and without AMR. 
Because of the costs of medical personnel and supplies are much higher, it is 
much more expensive to cure infectious diseases in high-income countries 
(HICs) than in low- and middle-income countries (LMICs). Consequently, it 
costs 80 times more to treat one TB patient in the US than in India (Fig. 1.4).[11] 
 
Fig. 1.3 – AMR-impact scenarios on GDP by 2050 (as projected by World Bank 
Group). Adapted and modified from [11]. 
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TB = Tuberculosis (infectious disease caused by bacteria) 
MDR = Multidrug-resistant 
XDR = Extensively drug-resistant  
 
Fig. 1.4 – AMR makes TB far costlier to treat. TB treatments costs are much 
higher in HICs than in LMICs (e.g., 80x higher for TB – and 20x higher for               
MDR-TB – in the US than in India. Adapted and modified from [11]. 
Recently, there has been an upsurge in global connectivity due to increasing 
global trade, growing human and animal populations, and technological 
developments. Consequently, there has been upward trend in rapid transport of 
antimicrobial resistant microbes and their resistant genes, thereby spreading 
AMR at an alarming rate. There is also impending danger of rapid rise in cases 
over a short timescale, if AMR may act as a compounding factor in a pandemic 
infection (e.g., influenza), it would then contribute to overall death and disability 
on a sudden and large scale.[12] AMR phenomenon has thus become a global 
concern, as its impact on a pandemic infection may have catastrophic results. 
Moreover, microbes do not respect geographic borders, the rapidity with which 
new types of AMR can disseminate globally following their initial emergence or 
recognition is demonstrated by the novel carbapenemase New Delhi metallo-
beta-lactamase 1 (NDM-1). The spread of NDM-1 (as presented in Fig. 1.5) 
demonstrates that AMR is a public health problem that surpasses national 
borders and will require international cooperation between health authorities if it 
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is to be controlled.[7,13] Also, the emergence and spread of mobilised colistin 
resistance-1 (mcr-1) gene (Fig. 1.6) is a matter of concern as it confers 
resistance to colistin, a last-resort antibiotic used for treating Gram-negative 
infections.[14] Also, the report issued by CDC on the case of a 70-year-old 
Nevada woman who died of an incurable infection in 2016, resistant to all 26 
different antibiotics in the US, highlights the severity and magnitude of AMR 
problem.[15] 
 
Fig. 1.5 - The spread of NDM-1 resistance across the world. Adapted and 
modified from [13]. 
 
Fig. 1.6 - Countries reporting plasmid-mediated colistin resistance conferred 
by mcr-1. Adapted and modified from [14]. 
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1.2.2 Emergence of antimicrobial resistance 
Lately, AMR problem has been highly publicised with panic headlines using 
media-coined term “superbug” for the drug-resistant bacteria, but this problem 
itself is nothing new.[16] AMR has a longer history than the modern use of 
antibiotics. It is a perception that exposure to antibiotics occurred in the modern 
“antibiotic era,” but research has revealed that the presence of antibiotic 
resistance genes dates back to between 10,000 and 2 billion years ago, as a 
response to the naturally occurring antibiotics in the environment.[17] However, 
the beginning of so-called “antibiotic era” can be attributed to the period when 
the first antibiotic, “penicillin”, was serendipitously discovered by Sir Alexander 
Fleming in 1928.[18,19]   
Fleming was recognised for his achievements and he received the Nobel Prize 
for Physiology in 1945 along with his co-laureates, Sir Howard Florey and Dr. 
Ernst Chain, two Oxford based researchers who later devised a method of 
mass-production of this drug for commercial use. This discovery revolutionised 
the field of medicine and mankind believed that it had overcome the problem of 
bacterial infections. But Fleming had already predicted that penicillin would be 
used carelessly and over time become less effective at killing bacteria.  At the 
end of his Nobel lecture he said, “There is the danger that the ignorant man 
may easily underdose himself and by exposing his microbes to non-lethal 
quantities of the drug make them resistant”.[18] 
Penicillin was successfully used in controlling bacterial infections among World 
War II soldiers.[20] But true to Fleming’s prophecy, by the mid-1940s, after its 
introduction into clinical practice, penicillin resistance began to emerge because 
of its wide-scale use.[21] This fostered development of new and better drugs in 
response to the inchoate AMR problem. The following period between 1950 and 
1960 is often referred to as the golden era of antimicrobial discovery, and 
sometimes also as the halcyon years, when most of the antimicrobials used 
today were discovered.[22]  
But nearly all antimicrobial drugs developed so far were followed by the 
detection of resistance.[23] Also, the triumphs in the golden era were soon 
followed by a considerable hiatus as there have been no successful discoveries 
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of novel agents after 1987, but only variations in existing drugs.[24] This problem 
of “innovation gap” is further escalated by a discovery void in terms of 
antimicrobials with novel mechanisms of action that could primarily overcome 
resistance.[24] Due to this imminent AMR problem, simple treatable infections 
pose a serious challenge for modern medicine, as they can soon be converted 
into untreatable deadly infections.[25] 
1.2.3 Factors driving AMR 
To battle antimicrobial resistance, which is the biggest threat to human health, 
an understanding of its drivers is needed. There are several factors causing 
antimicrobial resistance, as outlined and described below:[19,26,27]  
a. Lack of availability of new antimicrobial drugs 
b. Antimicrobial misuse or overuse 
c. Inappropriate prescription 
d. Sub-optimal diagnostics  
e. Patient perception and behaviour 
f. Poor-quality medicines 
g. Other factors 
 
a. Lack of availability of new antimicrobial drugs 
The number of new antimicrobial drugs developed and approved has 
decreased steadily over the past 30 years due to economic and regulatory 
barriers (Fig. 1.7), leaving fewer options to treat resistant bacteria.[19] Many 
big pharmaceutical companies have given up antimicrobial research 
because of these obstacles, adversely affecting antimicrobial drugs 
pipeline.[28] Antimicrobial resistance occurs as part of a natural evolution 
process in which microbe evolves, so the resultant AMR crisis can only be 
slowed but not stopped. Therefore, there is exigent need for new 
antimicrobial drugs as well as well as, new diagnostic tests to track the 
development of resistance.[29] 
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*Antibacterial drugs are limited to systemic agents.  
Fig. 1.7 - Number of Antibacterial New Drug Application (NDA) Approvals versus 
Year Intervals. Adapted and modified from [19]. 
 
b. Antimicrobial misuse or overuse 
Livestock animals are frequently given antimicrobial drugs for disease 
prevention and growth promotion, which are ultimately transferred to the 
humans through meat, and even via their manure which is used as crop 
fertiliser. Antibiotic use in animals, agriculture and aquaculture, actually, 
account for about 80% of all in the US, so it's indisputably a main source of 
human antibiotic consumption (as shown in Fig. 1.8).[30] Due to poor 
surveillance data in many other countries, the estimate of total global 
antibiotic consumption in agriculture vary, ranging from around 63,000 to 
over 240,000 tonnes, and is anticipated to increase by 67% from 2010 to 
2030, with 99% increase amongst the BRICS countries (Brazil, Russia, 
India, China and South Africa) in that same time period.[31] More than 70% of 
the antibiotics considered medically important for human health by the FDA 
and sold in the US (and >50% in most countries) are used in livestock. 
Antibiotics doses used in aquaculture are often higher than those in livestock 
and mostly remain in fish products as residues and also aquatic 
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environment. Amount of antibiotics used for crops is relatively lower than 
used in livestock, and does not require immediate attention, but the quantity 
of antibiotic use in the larger food chain needs close monitoring with 
mounting AMR concern. Also, a direct correlation between higher antibiotic 
consumption and prevalence of AMR has been seen in many studies 
conducted in industrialised countries.[32,33] 
 
Fig. 1.8 - Estimated Annual Antibiotic Use in the United States. Adapted and 
modified from [30]. 
c. Inappropriate prescription 
Antimicrobial drugs are among the most commonly prescribed drugs and 
almost half of them are not optimally prescribed.[9] A review of patient data 
by CDC found that 30% of the prescriptions are unnecessary and huge 
amount of antimicrobial drugs are wasted globally.[29] There are several 
factors that influence prescribing, including sociocultural, socio-economic 
factors, and cultural beliefs of both the physician and the patient.[34] 
Inappropriate prescribing has been ascribed to a number of causes, 
including patient’s demand for antibiotics;[35] unjustified prescription 
especially, for upper respiratory tract infections (URTIs) even though 
antibiotics are useless against viruses;[36] under-prescription, for example, in 
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urinary tract infections; under-dosing, and short duration.[37] Sub-inhibitory 
and sub-therapeutic antibiotic concentrations contribute to AMR by 
supporting genetic alterations in bacteria such as Pseudomonas 
aeruginosa and Bacteroides fragilis.[19] The timing of initiation of antibiotic 
therapy is also important. Many times antibiotic therapy is initiated 
prematurely by physicians, in clinically stable patients. Also, in critically ill 
patients, antibiotic therapy is initiated by physicians mostly based on 
empirical diagnosis, due to lack of rapid diagnostic tools required for quickly 
arriving at definitive diagnosis. Moreover, broad-spectrum antibiotics are 
often prescribed by physicians as initial therapy, to cover a number of 
possible causative pathogens of that clinical presentation. Thus, in order to 
reduce AMR, it is important that physicians understand the difference 
between empiric and definitive therapy; identify opportunities to switch to 
narrow-spectrum antibiotics and diagnose accurately with the help of rapid 
diagnostic tools.[38] 
d. Sub-optimal diagnostics  
Many experts consider sub-optimal diagnostics as the high driver of AMR. In 
spite of this, innovation in the field of diagnostics has been very slow, and 
many pharmaceutical companies have no interest in the advent of rapid 
diagnostics, that would decrease inappropriate prescription of antibiotics. As 
there is growing demand for diagnostic precision that can modify the 
widespread empiric antimicrobial use; there is need for development of 
rapid, reliable diagnostic methods for identifying the presence of infection, 
the specific infecting organism, and the susceptibility of the microbe to 
various therapeutic agents. It is well established that rapid diagnostic tests 
have a critical role to play, as they improve the efficiency of health care 
spending by guiding physician decision-making. They are also the 
foundation of disease surveillance and elimination. But, paucity of optimal 
diagnostics together with lack of interconnected diagnostic networks further 
augments the AMR problem.[39,40] 
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e. Patient perception and behaviour 
Knowledge about appropriate antibiotic prescription is lacking in most of the 
patients especially, for infections like URTIs.[41] It is a common perception of 
patients that an antibiotic is a quick and effective antidote to most of their 
ailments. Consequently, physicians repeatedly experience pressure from 
patients to prescribe them.[42,43] But treatment non-adherence to the 
prescribed antibiotic course is a shared trait of most of the patients and often 
the remaining unused pills of the course are “hoarded” by them for future 
use; thereby increasing the chances of misusing them later against                 
non-susceptible organisms and consequent treatment failures.[44] In many 
countries, multiple sources are sought by patients for the same illness and 
this problem is further escalated by the availability of wide variety of 
unregulated antibiotics without prescription, promoting overuse.[44,45] The 
ability to purchase such antibiotics online has also made them available in 
countries where antibiotics are regulated.[42] Also, there are many            
self-medicating patients that buy antibiotics over-the-counter (OTC) directly 
from pharmacists. Availability of new rapid diagnostics can facilitate 
pharmacists to provide a full and confident diagnosis at point of sale, without 
the need for a prescription from a physician. 
f. Poor-quality medicines 
Dissemination of poor-quality medicines including, falsified (i.e., intentional 
fraudulent manufacturing) or substandard (i.e., unintentional errors in 
manufacturing or degradation because of poor storage/handling) products 
pose a major obstacle to the treatment of many diseases.[46,47] The 
inadvertent use of poor-quality medicines is likely to be one of the key 
factors contributing to AMR. By delivering sub-therapeutic drug 
concentrations, poor-quality medicines may promote the selection of drug 
resistance. Antimicrobials, particularly anti-malarial drugs, are susceptible 
targets and among the most common classes of drugs associated with 
quality concerns.[48] Over 120,000 deaths among children younger than 
5 years were reported, in 39 countries in sub-Saharan Africa, due to 
consumption of poor-quality anti-malarial medicines.[49] 
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g. Other factors 
Antimicrobial resistance selection process has been driven by antimicrobial 
exposure in health care setting and also the environment. Ongoing 
transmission of AMR is affected by many other factors such as, travel, 
migration, and standards of infection control, sanitation, and access to clean 
water, etc.  
In a nutshell, of all the factors fuelling antimicrobial resistance, inappropriate 
use of antimicrobials is driving the emergence of AMR globally, and is also 
decreasing the usefulness of the few treatment options left to treat microbial 
illnesses. But lack of rapid POC diagnostic tests is the crux of the AMR 
problem, as unnecessary use of antibiotics is largely fostered by diagnostic 
uncertainty. Therefore, AMR problem can be controlled to great extent, if rapid 
diagnostic tests are made available for pathogen identification and also 
determination of their susceptibility to antimicrobials; as this will facilitate 
appropriate prescription and reduce the chances of development of                      
drug-resistant or multidrug-resistant infectious diseases. 
1.3 Global policy response to AMR 
In April 2014, the WHO issued its first global report on AMR, in which they 
highlighted AMR as a “serious, global threat”.[23] In July 2014, the UK Prime 
Minister commissioned an internationally renowned economist Lord Jim O’Neil 
to lead an independent review on AMR. This was co-founded and hosted by 
Wellcome Trust.[6,7] Same year, in the month of September, US President 
signed an Executive Order and also declared 5 year plans to combat the AMR 
problem, both at national and international level.[50] In October 2014, Europe’s 
Innovative Medicines Initiative (IMI) under its ‘New Drugs for Bad Bugs’ 
programme, a major public-private partnership effort, launched the DRIVE-AB 
project to promote responsible use of antibiotics and development of new 
economic models of antibiotic research and development.[51]  
The following year in Mar 2015, the White House in US published the “National 
Action Plan for Combating Antibiotic-Resistant Bacteria” and defined its number 
one goal as: “to slow the emergence of resistant bacteria through the judicious 
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use of antibiotics”.[50] In May 2015, the World Health Assembly (WHA) of WHO 
endorsed a Global Action Plan (GAP) to tackle antimicrobial resistance, 
including antibiotic resistance, which is the most urgent drug resistance trend.[52] 
A year later, in May 2016, Lord Jim O’Neil presented ten key elements to tackle 
AMR in a global way.[6] In September 2016, global leaders met at the United 
Nations General Assembly in New York to commit to fighting antimicrobial 
resistance together; this boosted the worldwide action to control AMR. 
Meanwhile, the WHO continued to facilitate execution of the GAP through 
numerous meetings across the world in 2017.[53] Also in May 2017, the US 
Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria 
(PACCARB) held a two-day meeting discussing how labelling changes can be 
used to narrow the use of medically important antimicrobial drugs in            
food-producing animals.[54] The National Action Plan that was initiated in 2015 
released a report, emphasizing that strategies should ensure patients receive 
the “right antibiotic at the right time at the right dose for the right duration”. 
Based on this report, in 2017, Congress appropriated $163 million for CDC to 
continue to fight AMR via the Antibiotic Resistance Solutions Initiative, which 
speaks to the seriousness of the problem.[55] One of the main goals of the 
National Action Plan included development of Antimicrobial Stewardship 
Programs (ASPs) to primarily address inappropriate antimicrobial use and 
decrease drug resistance. The WHO has also developed the Global 
Antimicrobial Resistance Surveillance System (GLASS) to support the 
implementation of the GAP, which promotes and facilitates standardised AMR 
surveillance worldwide. The WHO GLASS Manual for Early Implementation 
provides details of the proposed approach and defines targets for the 
surveillance of resistance in common bacterial pathogens. As an 
accompaniment to the manual, a guide also has been developed to support the 
practice of robust microbiological diagnosis, including Antimicrobial 
Susceptibility Testing (AST), in patients presenting with clinical symptoms 
compatible with infectious diseases; a concept known as “diagnostic 
stewardship”. As part of a broader antimicrobial stewardship programs, 
diagnostic stewardship is aimed at reducing false-positive testing results, which 
can lead to overuse of antibiotics, and enhancing the detection of true-positive 
cases of infection for appropriate treatment. Effective ASP is closely related with 
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the ability to make correct and rapid diagnoses. Through careful diagnostic and 
antimicrobial stewardships, rapid diagnostics can be implemented successfully, 
revolutionizing the clinical care of patients.[56,57] 
1.4 Tackling AMR through rapid diagnostics 
Antimicrobial de-escalation (ADE) has been widely accepted and recommended 
as an important strategy for addressing the global AMR crisis.[58] ADE has been 
defined in numerous ways across studies, but in general it refers to the 
reduction in the use of broad-spectrum antibiotics through discontinuation of 
antibiotics or switching to a narrower spectrum agent when clinically possible, 
based on the sensitivity profile obtained from the antibiogram, thereby 
decreasing the risk of bacterial resistance.[58] Although ADE is profoundly 
considered as key factor of controlling AMR, it is very challenging due to various 
reasons, including problem of comparability and reproducibility due to its 
inconsistent definition, overt reliability on clinical judgement, and lack of 
evidence supporting it.[58,59] But above all, one of the main problems in creating 
reliable systems for ADE is due to the limitations with our current diagnostic 
testing. However, emerging technologies in the field of rapid diagnostics may 
augment ADE strategies and provide new prospects for stewardship 
programmes. Conventional pathogen identification can take up to 48 to 96 
hours, followed by an additional 48 to 72 hours for AST from sample collection 
but with rapid diagnostics, it can be shortened to less than 24 hours, thereby 
supporting patient welfare.[60,61] Main goals of stewardship programmes can be 
accomplished through rapid diagnostics - decreasing time to appropriate 
antibiotics, reducing unnecessary use of antibiotics, and facilitating decisions 
regarding ADE or discontinuation.[62-64] 
One of the ten points proposed in Jim O’Neill’s Review on Antimicrobial 
Resistance is to transform antibiotic use through better use of 
rapid diagnostics.[6] Global Action Plan of WHO on AMR also emphasised the 
need for “effective, rapid, low-cost diagnostic tools...for guiding optimal use of 
antibiotics in human and animal medicine”.[52] One of the main goals of US 
National Action Plan for Combating Antibiotic-Resistant Bacteria is also to 
advance the development and use of rapid and innovative diagnostic tests for 
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identifying and characterising resistant bacteria. Thus, the need for rapid 
diagnostics is not only the key component of ADE strategy but also the central 
theme of most of the recent policy initiatives taken to combat AMR.  
1.5 Unmet diagnostic needs 
Rapid diagnostics have the potential to change the drug paradigm and 
transform the fight against the superbugs. But in order to achieve that, 
diagnostics need to fulfil a variety of different roles in clinical practice and 
research. A number of professional groups like Infectious Diseases Society of 
America (IDSA, US), Jim O’Neill’s AMR review group (UK) and Presidential 
Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB, US) 
and have reviewed the established diagnostic methodologies and highlighted 
the following key unmet needs regarding diagnostic testing:[2,64,65] 
 Provide faster turnaround time compared with established culture 
methods,  
 Diagnostic tests that rapidly identify pathogens with high sensitivity and 
high specificity and guide selection of appropriate antimicrobial agents 
and avoid unnecessary antibiotic use, 
 Provide phenotypic drug-susceptibility results directly from clinical 
samples, thus guiding targeted antibiotic escalation or de-escalation from 
broad-spectrum to narrow-spectrum agents, and/or discontinuation of 
antimicrobial treatment, 
 Diagnostic tests that distinguish between bacterial and viral infections to 
avoid or discontinue antibiotics for nonbacterial (viral, fungal, or parasitic) 
infections, 
 Enable point-of-care testing for use in a variety of healthcare settings, 
 Improve capabilities for AMR surveillance and outbreak investigation of 
drug-resistant pathogens. 
Thus, rapid diagnostic test that meets the above criteria would ensure that 
patients receive effective treatment more quickly and also prevent infection 
“outbreaks”, as an infected patient can be rapidly isolated and infection control 
measures can be initiated promptly. This would also avoid wasting resources in 
unnecessary isolation. Patients, who are isolated as a precautionary measure 
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and waiting for their pending confirmatory diagnosis, could be quickly diagnosed 
and the use of costly resources could be averted. Thus, the rapid diagnostics 
can streamline and accelerate the initiation of the treatment regimens, improve 
patient outcomes and shorten duration of hospitalisation, thus freeing up 
hospital beds.[66] 
Traditional culture-dependent diagnostic methods identifying pathogens and 
also providing antimicrobial susceptibility profiles in microbial culture are still 
considered as gold standard methods. But these methods are very slow and 
also fail to fulfil most of the above mentioned criteria. Other culture-independent 
rapid diagnostic methods are reviewed in the light of the above mentioned 
unmet needs and discussed in chapter 2. Of all the culture-independent 
methods discussed in next chapter, label-free biosensors have the potential to 
combat AMR effectively through rapid pathogen identification at the                
point-of-care.  
A biosensor is an analytical device comprised of 2 elements: a biological 
recognition element (e.g., nucleic acid, antibodies or aptamers) able to interact 
specifically with a target pathogen and a transducer that is able to convert the 
recognition of the pathogen into a measurable signal. Different transduction 
methods were reviewed (e.g. optical, electrochemical and acoustic) and among 
them Anharmonic acoustic Detection Technique (ADT) transduction method 
was selected for further investigation.  
A transduction method however, requires means to enhance the capture of the 
target pathogen with sufficient efficiency for direct detection. This can be 
achieved through integration of an appropriate biological recognition element (or 
bio-receptor) with the tranducer.  
In chapters 4, 5 and 6, bio-receptors of different sizes and lengths are explored 
for direct, sensitive and specific detection of target E.coli bacteria.  
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1.6 Problem statement 
1.6.1 Aim 
The aim of research is to investigate the bio-affinity based platform for rapid 
point-of-care detection of bacteria by integrating a ‘multivalent aptamer’, binding 
whole bacterial cell as bio-receptor with the Anharmonic acoustic Detection 
Technique (ADT)* transduction method, that can be applied for rapid 
identification of the pathogen and subsequent determination of antimicrobial 
susceptibility. 
(*ADT is applied for bacterial detection for the first time using multivalent 
aptamers in this work) 
1.6.2 Objectives 
The objectives of this research are: 
O.1. To investigate the feasibility of detection of the target E.coli bacteria 
rapidly, sensitively and specifically using multivalent aptamer-based bioassay 
after integrating with ADT  
O.1.1 To address the experimental challenges and develop a solution around 
the integrated biosensor assay and microfluidic flow-cell 
O.2. To explore the comparative performance of different bio-receptors for 
whole-cell detection of E.coli bacteria coupled with ADT: 
O.2.1 Compare multivalent aptamer with polyclonal antibody (a different 
receptor, one that is more common) 
O.2.2 Compare aptamers with different linker lengths (long vs short) 
O.3. To study the influence of structurally modified aptamers with designed 
nonlinearity in enhancing sensitivity and specificity of the anharmonic acoustic 
detection of E.coli bacteria; this includes introducing novel designs in the 
aptamers’ molecular structures, two configurations were designed. 
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1.7 Dissertation Organization  
The thesis incorporates seven chapters, summary of which is as follows: 
Chapter 1 describes the problems related to infectious disease diagnosis, 
factors causing AMR and how rapid diagnostics can address these problems, 
unmet diagnostic needs and the aim and objectives of the research. 
Chapter 2 deals with the literature review of various currently used rapid 
culture-independent diagnostic methodologies used at present. It highlights the 
potential advantages of Anharmonic acoustic Detection Technique (ADT) over 
other methods used for detection of whole-cell bacteria. In this chapter, the 
rationale to select E.coli bacteria as target microorganism is also discussed. 
Chapter 3 describes materials and methods that were used and also deals with 
the experimental challenges that were addressed in relation to the biosensor 
assay to meet the research objective (O1.1): (a) increasing the sensitivity of the 
sensor through energy trapping; (b) identification of optimal method of 
measurement of 3f signal; (c) validation of surface cleaning method of gold 
electrodes of quartz crystal resonators (QCRs); (d) selection of suitable 
biosensor assay format; (e) addressing the problem of bubble formation with the 
microfluidic flow-cell; and (f) achievement of baseline stability. 
Chapter 4 investigates the behaviour of the anharmonic acoustic response of a 
QCR for the rapid, sensitive and specific detection and quantification of E.coli 
bacteria through aptamer-based biosensor assay, for the first time. It describes 
the steps taken to meet the research object O.1. The developed anharmonic 
acoustic aptasensor response was observed for the different bacterial 
concentrations. Quantitative correlation was achieved with this new method and 
it was also compared with standard frequency and dissipation shift 
measurements. 
Chapter 5 presents the experiments that explored the comparative 
performance of different bio-receptors (type and length) for whole-cell detection 
of E.coli bacteria using ADT transduction method. To meet the objectives O.2.1 
and O.2.2, the multivalent E.coli-binding aptamer was first compared with 
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polyclonal anti-E.coli antibody and then with the same aptamer but of different 
linker length, respectively. The sensitivity and specificity of different assays 
were compared. 
Chapter 6 is devoted for the experiments conducted to study the influence of 
novel structurally modified aptamers with designed nonlinearity in enhancing 
sensitivity and specificity of the anharmonic acoustic detection of E.coli bacteria. 
The E.coli-binding aptamer was further modified by introducing novel designs in 
the aptamers’ molecular structures. Two different configurations were designed 
and explored to achieve the objective O.3.  
Chapter 7 summarises the important contributions of this work and outlines the 
potential future directions. 
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Chapter 2 Literature review 
2.1 Introduction 
The aim of this chapter is to provide an overview of the rapid diagnostic 
methods that can be applied as point-of-care tests (POCTs) for detection and 
identification of pathogens. In this chapter, the limitations of the                          
culture-dependent methods are discussed. Also, currently available various 
culture-independent diagnostic methods are reviewed that can quickly identify 
pathogens and reduce the length of the diagnostic cycle. Among the              
biosensor-based culture-independent diagnostic methods, the focus of this 
review was only on those methods that can be used for whole-cell bacterial 
detection. The rationale behind choosing E.coli bacteria as the target analyte is 
also discussed.  
2.2 Background 
Point-of-care testing is one of the most powerful tools available today in the fight 
against AMR. Lord O’Neil’s report is the first report that highlights the 
importance of rapid POC diagnosis in deterring the dissemination of AMR, this 
ground-breaking report also appeals the governments and regulators of HICs to 
promote the use of rapid POCTs among healthcare professionals.[6,7,64] There 
are several definitions of POCT but no universally accepted definition.[67] As per 
one textbook, POCT can be defined as the “provision of a test when the result 
will be used to make a decision and to take appropriate action, which will lead to 
an improved health outcome”.[68]  Regardless of the exact definition, the most 
important elements of POCT are rapid turn-around time that enables shortening 
of the diagnostic cycle; better decision-making at the point-of-prescription and 
preventing the unnecessary use of antimicrobials.[69-71] POCTs play an 
important role in filling the gap between the centralised laboratory diagnostics 
and peripheral healthcare professionals.[72] The important attributes of POCTs 
that distinguish them from conventional laboratory tests are: they do not require 
specialised laboratory infrastructure or trained personnel to use them; they 
deliver a rapid (i.e. within 1 hour) diagnosis and they are more cost-effective 
than conventional tests.[73] 
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Presently, bacterial identification (ID) and antibiotic susceptibility testing (AST) 
are the well-established diagnostic methodologies. Pathogen isolation and 
identification from pure culture generally requires 18 to 48 hours with further 8 
to 48 hours to perform AST and report the results. In case of infections with 
MDR organisms, AST results take almost 48 to 96 hours to reach the clinician 
and have very little effect on the ensuing therapy.[60,61,64,74] For these kinds of 
serious infections, it is essential to get right drug in the first 24 hours of disease 
presentation so that there is a desired outcome.[75-77] Phenotypic culture-based 
AST methods can be highly sensitive and more absolute, but suffer from a long 
turnaround time. Although, faster molecular AST methods are available[78-80], 
but in addition to cost they have many limitations, like unable to detect unknown 
resistance mechanisms; unwarranted susceptibility, as they report only about 
the lack of resistance mechanism; cover narrow range of detectable resistance 
mechanisms; and limited information in comparison to phenotypic AST.[81,82] 
Because of these limitations, molecular methods are better suited as an 
expensive add-on to current diagnostic cycle and cannot replace the 
conventional antibiogram.[81] Since, it is unlikely to reduce the time required for 
phenotypic AST; if the initial pathogen identification step is shortened it will 
ultimately reduce the overall time of diagnostic cycle, and thus help clinicians to 
start appropriate antimicrobials at the same time as the clinical encounter. 
2.3 Culture-dependent diagnostic methods 
The conventional bacterial pathogen detection and identification methods are 
based on culturing the microbes on a selective medium followed by standard 
biochemical identification tests to confirm the presence of the target bacteria.[83] 
These conventional methods are generally simple and economical but the major 
drawback of these methods is that they are time-consuming, as the microbes 
are required to be grown in different culture media such as pre-enrichment 
media, selective enrichment media and selective plating media. Typically 
conventional methods are laborious as they require the preparation of culture 
media, inoculation of plates and colony counting and may require several days 
for preliminary identification depending on the growth of the bacteria and more 
than a week for confirmation of the species of the pathogens.[83,84] Additionally, 
 35 
 
the sensitivity of conventional methods is low and sometimes they give                  
false-negative results due to viable but non-culturable (VBNC) pathogens.[85,86] 
Despite the fact that these conventional culture-dependent methods are still 
essential, recently different rapid culture-independent methods have been 
developed that overcome the limitations of culture-dependent methods for 
identification of pathogens. Figure 2.1 provides a comparison of                        
culture-dependent and culture-independent detection methods.[87] 
Novel culture-independent methods are been developed with advances in terms 
of rapidity, sensitivity, specificity and distinction of the viable cells.[84] However, 
each of these rapid culture-independent methods has its own advantages and 
limitations. Based on their main principle, these methods can be broadly 
classified into the following categories: nucleic-acid-based methods, 
immunological methods, mass spectrometry-based methods and                  
biosensor-based methods.[84] This review examines these rapid                      
culture-independent diagnostic methods and their applications in combating 
AMR along with their advantages and limitations. 
 
Fig. 2.1 - Culture-dependent methods vs Culture-independent methods. Adapted 
and modified from [87]. 
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2.4 Culture-independent diagnostic methods 
2.4.1 Nucleic acid-based methods 
Nucleic acid-based detection methods comprise of two key techniques: nucleic 
acid hybridisation with probes or primers and nucleic acid amplification 
technique for pathogen identification.[84] These methods include detection of 
species, strain, or serotype-specific DNA (deoxyribonucleic acid) or RNA 
(ribonucleic acid) sequences present in the target pathogen, by hybridising the 
target nucleic acid sequence to a synthetic oligonucleotide (probes or primers) 
which is complementary to the target sequence.[84,87] The current nucleic             
acid-based methods are simple polymerase chain reaction (PCR), multiplex 
polymerase chain reaction (mPCR), real-time/quantitative polymerase chain 
reaction (qPCR), nucleic acid sequence-based amplification (NASBA),                  
loop-mediated isothermal amplification (LAMP) and microarray technology.[84]  
 
1. Denaturation at 94-96°C 
2. Annealing at ~68°C 
3. Extension at 72°C 
 
Fig. 2.2 – Schematic presentation of polymerase chain reaction (PCR). Adapted 
and modified from [88]. 
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PCR was invented about 30 years ago and is one of the most commonly used 
nucleic acid-based methods for pathogen detection.[89] The working principle of 
PCR is amplifying a specific target DNA sequence in a sample during a cyclic   
3-step process (as shown in Fig. 2.2).[83] Multiplex PCR also operates on a 
working principle similar to conventional PCR but comparatively, offers a more 
rapid detection. There are several commercial PCR-based systems for 
detection of antimicrobial resistance, already available in the market[90], but they 
mostly focus on detecting Gram-positive bacteria and not Gram-negative 
bacteria due to the high intricacy of their resistance patterns.[90,91] However, few 
PCR-based systems capable of detecting Gram-negative bacteria are in 
developmental stage, near to market.[92-96] The PCR products are visualised on 
electrophoresis gel as bands by staining with ethidium bromide in simple             
PCR-based methods whereas in real-time PCR or quantitative PCR (qPCR) 
method, they are monitored by measuring the fluorescent signal produced by 
labelled probes or dyes.[84] Thus, unlike simple PCR and multiplex PCR tests 
which are arduous and costly, qPCR allows high-throughput analysis and 
automation.[97] Because of these advantages, various commercial qPCR kits for 
the detection of pathogens such as Listeria monocytogenes, Escherichia coli, 
Salmonella, and Campylobacter, etc. has been developed.[98] NASBA also 
operates by amplifying nucleic acids but under isothermal conditions without 
thermocycling system needed for PCR.[99] But, post-NASBA products are also 
detected using agarose gel electrophoresis or enzyme-linked gel assay, making 
it labour-intensive and costly.[100] LAMP is a nucleic acid amplification method 
which is based on auto-cycling strand displacement DNA synthesis under 
isothermal conditions. Post-LAMP amplicons are also detected by agarose gel 
electrophoresis or SYBR Green I dye, making it expensive and laborious.[84,100] 
However, different types of LAMP methods have been developed that use 
fluorescence assays to monitor amplicons, allowing high-throughput analysis 
but adding to the cost because of fluorescent labelling.[100]  
In general, all these nucleic acid-based methods do not allow isolating 
pathogens for further characterisation.[2,61,78,101]  In addition to the cost, the major 
limitation of nucleic acid-based methods is the incongruity between phenotype 
and genotype.[90] Also, these genotypic tests for the detection of antimicrobial 
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resistance may generate false-negative results due to their inability to detect 
new resistance mechanisms or false-positive results, because they may detect 
inactive or incomplete resistance genes in a sample, which have not inferred 
resistance to the antimicrobial drug under test. A general disadvantage of PCR 
assays used for detection of bacterial pathogens is that the PCR amplification 
process will target DNA from both live and dead cells. Thus, PCR cannot 
distinguish between live and dead cells and hence providing more                      
false-negative results.[102] Therefore, though the nucleic-acid based tests are 
rapid, traditional culture-dependent methods are still considered as gold 
standard for pathogen identification.  
2.4.2 Immunological-based methods 
The detection of bacterial pathogens by immunological-based methods is based 
on antibody-antigen binding interactions, where a particular antibody will bind to 
a specific antigen. The sensitivity and specificity of these methods thus, 
depends on the binding strength of particular antibody to its antigen. The two 
major categories of immunological-based methods reported for the                   
culture-independent detection of bacterial pathogens are enzyme-linked 
immunosorbent assay (ELISA) and lateral flow immunoassay (LFI).[84]  
ELISA is one of the most widely used immunological assays for pathogen 
detection, and is very precise and sensitive method for detecting antigens.[103] 
Conventional ELISA normally includes chromogenic reporters and substrates 
that produce some kind of apparent colour change indicating the presence of 
antigen or analyte. Sandwich ELISA is the most effective form of ELISA 
whereby, the antigen to be measured is bound between two primary antibodies: 
the capture antibody and the detection antibody.[84] In this method, the capture 
antibody is typically immobilised onto the walls of the microtiter plate wells. The 
target antigen binds to this primary antibody and the remaining unbound 
antigens are removed by washing step. After that, an enzyme-conjugated 
secondary detection antibody is introduced which binds to the antigen, thereby 
forming a complex. This complex can be detected by adding colourless 
substrate which changes colour in the presence of the conjugated enzyme (Fig. 
2.3).[100,104,109] Different types of enzymes are used in ELISA, for e.g., 
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horseradish peroxidase (HRP), alkaline phosphatase and beta-
galactosidase.[105] Because it is sensitive and robust, many studies have used 
sandwich ELISA for rapid detection of pathogens like Vibrio 
parahaemolyticus,[106] Salmonella, etc.[107]  Lately, high-throughput and 
automated ELISA systems that use enzyme-linked fluorescent assay (ELFA) 
such as VIDAS® (BioMerieux) and Assurance® EIA  (BioControl) are available 
for the detection of pathogens.[100,108] These systems are more sensitive and 
take about 45 mins to 2 h to complete an assay. However, ELISA is costly and 
requires specialised equipment and trained personnel to operate the system 
and use of fluorescent labelling in ELFA, makes it even more costly.[84] 
Therefore, rapid, reliable and inexpensive, methods that can be conducted and 
interpreted at the point-of-care are still needed. 
 
Fig. 2.3 - Principle of ELISA test: This test combines the specificity of antibodies with 
the sensitivity of simple enzyme assays, using antibodies or antigens coupled to an 
easily-assayed enzyme. Adapted and modified from [109]. 
 
Lateral flow immunoassays such as dipstick and immunochromatographic strips 
have been developed for rapid on-site detection of pathogens. This is a            
paper-based platform that is based on biochemical interaction of                      
antigen-antibody. A lateral flow immunoassay is composed of four parts: a 
sample pad starting at the bottom, on which liquid sample is dropped; conjugate 
pad; reaction membrane containing test line and control line for target              
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antigen-antibody interaction; and absorbent pad, which reserves waste. The 
principle of LFI is very simple: a liquid sample (or its extract) containing the 
analyte of interest moves via capillary action through various zones of the strips. 
It travels through the conjugate release pad, which contains antibodies that are 
specific to the target analyte and are conjugated to coloured or fluorescent 
particles. Then the sample, together with the conjugated antibody bound to the 
target analyte, migrates along the strip to the nitrocellulose membrane, 
immobilised with antibody or antigen (as depicted in Fig. 2.4). The coloured or 
fluorescent particle can bind to the antibody or antigen immobilised at test line 
depending on the analytes present in the sample. The result can be visualised 
approximately 5 to 30 mins after the addition of sample.[110] LFI employs 
different labels such as monodisperse latex, colloidal gold, carbon and 
fluorescent tags for pathogen detection.[84]  LFIs are designed for individual tests 
rather than high-throughput screening.[110,111]  Limitations of LFIs include: it is 
one-step assay so can be used only one time; obstruction of pores due to 
matrix components and restriction on total volume in a test gives a limit of 
sensitivity; test-to-test reproducibility is challenging; and also integration with 
on-board electronics and built-in quality control functions is challenging.[110]  
LFIs have advantages of low cost, long-term stability, minimum skill required 
and can be applied at the POC,[110,111]  but they have higher false-positive rates 
than ELISA and PCR.[112] Also, growing demand for higher sensitivity is 
challenging the existing formats of this method. [113] This is because most lateral 
flow assays employ antibodies to capture the analytes and there is an 
increasing concern about the specificity, sensitivity, and stability of these 
antibodies. This can be improved by using high-affinity aptamers instead of 
expensive antibodies in lateral flow assays.[113]  
Most lateral flow assays require a controlled temperature for storage which is 
largely a function of the stability of antibodies used in the system. Since 
aptamer have very high stability at high temperatures, it should be feasible to 
apply aptamer-based lateral flow tests to very low resource settings and highly 
sub-optimal field conditions with minimum performance loss. Also, protein-
based antibodies show high sensitivity to denaturing agents, which limit their 
applications or require complicated sample pre-treatment. While, nucleic acid 
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aptamers show more resistance to different chemical buffers such as large 
ranges of pH, ion strength, and organic reagents. An additional advantage of 
using aptamers is the regeneration by heating or other methods. These 
advantages make aptamers appealing in the development of low-cost, reusable 
lateral flow assays.[113] 
 
Fig. 2.4 – Pictorial representation of lateral flow immunoassay format. Adapted 
and modified from [114]. 
2.4.3 Mass spectrometry-based methods 
Mass spectrometry-based method, such as matrix-assisted laser 
desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) utilizes 
lasers to ionise and accelerate bacterial and fungal molecules, which separate 
according to the mass-to-charge ratio, yielding a distinct signal. Its working 
principle is shown in Fig. 2.5.[78,115]  MALDI-TOF allows direct identification of 
organisms from positive blood-cultures and thus has reduced turnaround times 
by at least one working day. In two studies, it has been found that MALDI-TOF 
reduced the time to optimal antimicrobial therapy, hospital length of stay and 
hospitals costs by directly identifying pathogens from positive blood-cultures. 
But, in both the studies, direct MALDI-TOF identification was only one part of an 
intervention package, which also included rapid susceptibility testing from 
positive blood cultures and intensified antimicrobial stewardship measurements. 
Hence, it was difficult to assess the exact contribution of rapid pathogen 
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identification by MALDI-TOF in reducing the time to diagnosis.[116,117]  Moreover, 
MALDI-TOF-based identification of bacterial pathogens directly from positive 
blood-culture bottles is laborious, requires trained personnel to operate and is 
confined to the laboratory, difficult to use at the point-of-care.[78] 
 
Fig. 2.5 - Principle of MALDI-TOF-MS: Target is embedded in surplus matrix molecules 
and the samples are prepared on a microtiter plate. The matrix and the analyte are evaporated 
into gas phase using a pulsed UV-laser. The matrix ionises the analyte molecules by proton 
transfer and also gives desorption support. The ions are then accelerated by an electrical field 
and enter the field-free flight tube of the mass spectrometer. By simple measurement of the 
TOF of the analyte ions, their mass to charge ratio can be determined. Adapted and modified 
from 
[118]
. 
2.4.4 Biosensor-based methods 
Biosensors have fomented a revolutionary breakthrough in the field of science 
and technology and are currently influencing all the areas of our life. Biosensors 
offer various advantages including small fluid volume manipulation, low energy 
consumption, portability, specificity, simplicity, high sensitivity, potential ability 
for real-time and on-site analysis coupled with the speed and low cost, etc. 
Therefore, they have been projected to have applications in controlling AMR.  
Biosensors have been developed for many different analytes, which range in 
size from individual ions and small molecules to nucleic acids and proteins up to 
whole viruses and bacteria.[119] Broadly, two types of biosensors have been 
developed: (i) those which involve sample processing steps for bacterial lysis in 
order to release the target bacterial component and (ii) processing-free methods 
which target whole bacterial cells. The main shortcoming of the first type of 
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biosensors that detect bacterial components (e.g., DNA, RNA, enzymes, 
exotoxins, etc.), is the requirement of extra reagents for sample processing, 
thus increasing both time and cost of these tests. Therefore, biosensors for the 
direct, reagent-less detection of whole bacterial cells are much more desirable 
for fast, cost-effective testing at the POC.[120] 
According to IUPAC definition, a biosensor is ‘a device that uses specific 
biochemical reactions mediated by isolated enzymes, immune-systems, tissues, 
organelles or whole cells to detect chemical compounds usually by electrical, 
thermal or optical signals’.[121] A biosensor is different from a bio-analytical 
system, which requires additional processing steps, such as reagent addition 
and also from bio-probe which is disposable after one measurement, i.e. single 
use, and unable to continuously monitor the analyte concentration. Biosensor is 
a self-contained integrated device which is capable of providing specific 
quantitative or semi-quantitative analytical information using a biological 
recognition element (bio-receptor) which is in direct spatial contact with a 
transducer element.[122]  Thus, biosensor is an analytical device that consists of 
two main elements: a transducer and a bio-receptor (as shown in Fig. 2.6). 
 
  
Fig. 2.6 - Principle of biosensor and main components: Biosensor is composed of two 
main elements viz. biological recognition element (or bio-receptor) and signal transducer. A               
bio-receptor is an immobilised sensitive biological element recognising the analyte. The 
biological response resulting from the interaction of the analyte with the bio-receptor is 
transformed to an electrical, optical or electrochemical signal by the transducer and then further 
processed, providing the information. Adapted and modified from 
[123]
. 
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2.4.4.1 Transduction methods 
A transducer is used to convert (bio)chemical signal resulting from the 
interaction of the analyte with the bio-receptor into an electronic one. The 
intensity of generated signal is directly or inversely proportional to the 
analyte concentration. According to the transducing elements, biosensors 
can be classified as optical, electrochemical, acoustic, thermometric, 
micromechanical or magnetic sensors.[84,89,100]   
The focus of this review is only on the biosensors that are commonly used 
for the rapid detection of whole bacterial cells - optical, electrochemical and 
acoustic biosensors. 
a. Optical transduction methods 
Optical biosensors are the most commonly reported class of biosensors. 
The optical transduction method exploits the interaction of the optical field 
with a bio-receptor. There are two detection protocols that can be 
implemented in optical bio-sensing: label-based and label-free detection. In 
label-based sensing, the optical signal is detected through multiple methods 
like colorimetric, fluorescent or luminescent methods.[124,125] In    
fluorescence-based detection, either target molecules or bio-receptors are 
labelled with fluorescent tags, such as dyes; the intensity of the fluorescence 
indicates the presence of the target molecules and the interaction strength 
between target and bio-receptors. In fiber-optic biosensors, optical fibers are 
employed for whole-cell bacterial detection. In this method, a source of light 
passes through the fibers that are immobilised with bio-receptors to a photon 
detector. After analyte binding event, appropriate labelling reagent is added 
which indicates change in signal at the detector. The label-based methods 
are very sensitive, for instance, fluorescent dye-loaded micelle approach 
could detect 15 bacteria/mL of E.coli bacteria,[126] but these methods suffer 
from laborious labelling processes that may even interfere with the function 
of a bio-receptor. Also, there is signal bias as the number of fluorophores on 
each molecule cannot be accurately controlled making quantitative analysis 
difficult.[127] 
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Most of the label-free detection mechanisms measure refractive index (RI) 
change induced by molecular interactions, which is related to the sample 
concentration or surface density, instead of total sample mass. Various 
optical structures have been investigated for sensitive label-free detection 
based on Surface Plasmon Resonance (SPR), interferometer, optical 
waveguide, optical ring resonator, optical fiber and photonic crystal 
biosensors. Most of these optical structures such as ring resonator and 
photonic crystal are in their infancy while others like SPR and waveguides 
are mature and have even been commercialised.[124] SPR biosensors use 
surface plasmon waves (electromagnetic wave) to detect changes when the 
target analyte interacts with a bio-receptor immobilised on the sensor.[124] 
The working principle of SPR is shown in Fig. 2.7. Different bio-receptors 
have been used along with these transduction methods for whole-cell 
bacterial detection, for e.g., antibodies, bacteriophages, and lectins. But 
there are two potential problems that limit their applications in whole-cell 
bacterial detection. First, the evanescent field in those basic SPR structures 
only penetrates into the surrounding medium for about 100 nm, and thus it is 
very difficult to detect the large target molecules like cells and bacteria. 
Second, there is similarity in RI between the bacterial cytoplasm and the 
aqueous medium.[128]  Thus, the performance of the SPR is weakened when 
detecting the target molecules in a complex solution, such as blood 
samples. Lately, nanoparticles have been used to enhance the sensitivity of 
the system through a process called Localised Surface Plasmon Resonance 
(LSPR), but this too have been reported to be less sensitive for detection of 
whole-cell bacteria. Additionally, there are other problems with optical 
biosensors like, lack of specificity,[129] not suitable for studying small 
analytes, bulky size, high cost of instrumentation, technical difficulties for 
fabrication, etc. This emphasises that more research efforts are needed for 
developing optical biosensors that can be used as POCT for combating 
AMR. 
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Fig. 2.7 - The principle of surface plasmon resonance (SPR): Polarized light is 
applied to the surface of the sensor chip and is reflected. The intensity of the reflected light is 
reduced at a certain incident angle, the SPR angle. Interacting substances near the surface of 
the sensor chip increase the refractive index, which alters the SPR angle. The optical detection 
unit detects position changes of the intensity dips in the wedge of the reflected light 
corresponding to the SPR angle. The signals produced are measured in resonance units (RU). 
Adapted and modified from 
[130]. 
b. Electrochemical transduction methods 
The basic transduction principle for this class of biosensors is that chemical 
reactions between immobilised bio-receptor and target analyte produce or 
consume ions or electrons, which affects measurable electrical properties of 
the solution, such as electric current, potential, capacitance and electron 
transfer resistance across the working electrode.[131] Based on this principle 
the electrochemical biosensors can be divided into three groups: 
potentiometric, amperometric, and impedimetric biosensors. 
Potentiometric transduction method uses ion-selective electrodes to 
measure the change in potential that occurs upon recognition of analyte at 
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the working electrode. Though this method is widely used, but examples of 
its application for detection of whole bacterial cells are very few as 
potentiometric biosensors cannot provide specific and sensitive signals for 
larger analytes like bacteria. However, a chrono-potentiometric method 
called as Potential Stripping Analysis (PSA) was used to detect marine 
pathogenic bacteria. The detection range of PSA method was found to be 
good but it involved pre-incubation steps of bacterial processing, making it 
unsuitable for rapid and on-site detection methods.[132] 
Amperometric transduction methods involve direct measurement of the 
current generated by the oxidation or reduction of species produced in 
response to analyte and bio-receptor interaction. The measured current is 
directly proportional to the analyte concentration.[133] These methods are 
very sensitive and easy but their limitations include low specificity as the 
signal depends on the applied potential. Also, its application in biological 
media is difficult as the other redox-active species may interfere with the 
signal at high potential and generate inaccurate results. The bio-receptor 
commonly employed for amperometric biosensors are enzymes, thus 
conferring it another limitation as the analyte of interest needs to be an 
enzymatic substrate. Because of these reasons, although amperometric 
biosensors are widely used their application for whole-cell bacterial detection 
is limited.[134] An attempt was made to detect E.coli K-12 bacteria through 
bacteriophages which are viruses with the ability to infect and lyse specific 
bacterial strains. Bacteriophage-mediated cell lysis increased specificity and 
sensitivity but this bio-sensing system had the disadvantage of the need for 
pre-incubation of bacterial cells with enzyme enhancer and phage, thus 
increasing the duration of the test.[135] Few other label-based amperometric 
methods have been tried for bacterial detection, but the system requiring 
labels again repudiates its POC utility.  
Impedimetric transduction methods involve measurement of the change in 
capacitance and electron transfer resistance across a working electrode 
surface after analyte and bio-receptor interaction. They have advantage over 
amperometric biosensors as there is no need for the analyte to be an 
enzymatic substrate. Recently, many reports detailing the impedimetric 
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detection of whole bacterial cells have emerged. Most of these impedimetric 
biosensors have focused upon detection of the model organism Escherichia 
coli, although other bacteria have also been detected, including Salmonella 
Typhimurium, Campylobacter jejuni, and Staphylococcus aureus.[120] 
Different amperometric methods are being employed to detect whole-cell 
bacteria, like bio-imprinting technique in which, bacterial cells can be 
deposited on a surface and then washed off, leaving their imprint on the 
surface.[136]  In another new method antibody-tagged bio-functional magnetic 
beads that were used to facilitate the migration of target bacteria to the 
sensor surface.[137] Although, these methods are innovative but their set-up 
method is complicated and difficult to be translated at POCT. Additionally, 
the key disadvantages of amperometric transduction methods are variable 
reproducibility, high limits of detection, and problems with nonspecific 
binding which might raise false alarms, negating its application as POCT for 
fighting AMR. 
c. Acoustic transduction methods 
The application of acoustic transduction methods in the field of bacterial 
detection is generally lesser than electrochemical and optical 
biosensors.[89,100] Acoustic transduction methods are so named because 
they apply an acoustic wave, as the sensing mechanism. Almost all acoustic 
biosensors use a piezo-electric quartz resonator (PQR) to generate acoustic 
waves.  If the acoustic waves propagate on the surface of the material, the 
biosensors are classified as Surface Acoustic Wave (SAW)-based sensors 
and if they propagate through the bulk of the material then they are called as 
Bulk Acoustic Wave (BAW)-based sensors.[138] SAW-based biosensors are 
mostly useful for chemicals sensing application and monitoring purposes 
rather than for physical measure and quantity determination with high 
absolute accuracy. Also, the performance of SAW-based biosensors, suffer 
from damping problems in the liquid phase. On the other hand, BAW-based 
biosensors were found to be suitable for measurement in liquid medium, as 
damping of oscillation is less than in SAW-based biosensors.[139] 
PQR are largely described as BAW devices. Other terms used for reference 
(i.e. name) or to describe these PQR or BAW crystals are: quartz crystal 
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microbalance (QCM) and thickness shear mode (TSM). The QCM term is 
often used because it describes the mass sensitivity of the crystal. TSM is 
used because it describes the motion of the crystal’s vibration. In 1959, 
Sauerbrey demonstrated the dependence of quartz oscillation frequency on 
the change in surface mass.[140] In fact, he coined the term quartz crystal 
microbalance in late 1950’s and it was his work that led to the use of PQR 
as sensitive microbalances for thin films. He also developed an empirical 
equation showing that the frequency change of a quartz crystal TSM 
resonator was a linear function of absolute mass.[141,142] 
Thus, QCM sensors detect the resonance frequency change that results 
from increased mass on the sensor surface due to analyte binding (as 
depicted in Fig. 2.9). QCM sensors have been developed for the detection of 
whole bacterial cells, including Escherichia coli, Salmonella enterica serovar 
Typhimurium, Campylobacter jejuni and Bacillus anthracis.[120]                            
Micro-cantilever sensors also work on the same principle as of QCM. A 
change in resonant frequency of the cantilever is observed due to induced 
mechanical bending upon an increase in mass on the sensor surface.       
Micro-cantilever sensors have been developed for the detection of various 
whole-cell bacteria, including E.coli O157:H7, Salmonella Typhimurium etc. 
But the major disadvantage of micro-cantilever based method is that it 
needs to be operated in air as opposed to physiological media. Also, there 
are some other drawbacks that need to be overcome such as lack of 
specificity and sensitivity as well as excessive interference.[120] 
As per the equation given by Sauerbrey, the relationship between the mass 
and the frequency is linear but only, if the sensitive layer coated on the 
oscillator is rigid and the adsorbed analyte oscillates synchronously with 
PQR. But if the interaction between the sensitive layer and analyte is not 
rigid (flexibly/loosely bound analyte) it leads to free movement of the 
particles which then causes a positive frequency shift – anti-Sauerbrey 
behaviour. Also, if large sized analyte is bound to surface through weak 
bond then too positive frequency shift can be observed. Thus, positive and 
negative frequency shifts of QCM and micro-cantilever sensors depend on 
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the interaction strategies of the sensitive material with corresponding 
analyte, making them unreliable and imprecise.[142] 
 
Fig. 2.9 – Principle of QCM: (a) Pressure exerted on a quartz crystal results in an 
electric field (E) between deformed surfaces. This is called piezoelectric effect. (b) 
Experimental setup of the quartz crystal microbalance (QCM). (c) Schematic representation 
of a QCR oscillating in the fundamental thickness shear mode. (d) Both, the frequency shift 
and the damping (dissipation) of the oscillation are captured with QCM. Adapted and 
modified from 
[143]. 
 
The positive frequency shift with increasing mass was also pointed by 
Dybwad. He postulated that positive frequency shift occurs if the PQR is put 
in contact with a very large sphere (representing analyte). He explained this 
phenomenon through a model termed as, “coupled-resonance model” (Fig. 
2.10).  In this model, the sphere is connected to the sensor via small bridge 
(or “point contact”) and it together with this contact forms a second resonator 
system of their own. Thus, the crystal and the sphere (analyte) form a 
coupled-resonator system with two different resonant frequencies ω and ωs, 
respectively. The frequency shift of the coupled resonator relative to the 
unloaded crystal depends on whether ωs is higher or lower than ω. In case 
of small mass tightly attached to the crystal, ωs is much larger than the 
resonance frequency of the crystal, ω. So, this leads to negative frequency 
shift as the force exerted by the crystal does not move the sphere in space. 
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This is also called as “inertial loading”. But if large (micrometer-sized) 
spheres are attached to the crystal via weak bridges, ωs, may be smaller 
than ω. In this case, positive frequency shift is observed that is proportional 
to the stiffness of the contact and independent of the sphere’s mass. This 
situation is termed as “elastic loading”. However, this model is applicable for 
spheres in dry state. The liquid leads to a strong coupling between the 
sphere and the crystal. In such situations, the frequency shift depends on 
the stiffness of the contact, rather than the size of the adsorbed object.[144] 
 
Fig. 2.10 Dybwad model: A sphere is shown adsorbed to the surface of a QCM. The sphere 
and the contact between the sphere and the surface constitute a resonating system of their 
own. Mechanical representation is shown on the right side. The crystal and the sphere form a 
system of coupled resonators with two resonance frequencies ω (crystal) and ωs (sphere). The 
frequency shift of the composite resonator relative to the unloaded crystal depends on whether 
ωs is higher or lower than ω. ωs is high for small particles tightly attached to the crystal, which 
leads to Sauerbrey-type behavior (“inertial loading”). In the opposite limit, the sphere remains 
immobile in space due to inertia, but exerts a restoring force onto the crystal, thereby increasing 
the stiffness of the composite resonator (“elastic loading”). Adapted and modified from 
[144]. 
Another method that attempted to detect the affinity of interaction includes the 
bond rupture immunosensors, such as the rupture event scanning (REVS). In 
this technique, the sensor attached with the biological particles is driven close to 
its fundamental resonant frequency (f) by a pure sinusoidal oscillation at 
increasing amplitude. As the amplitude of oscillation increases, there is 
increasing acceleration of analytes adhered to the surface; which causes 
increase in force exerted by the surface on the analytes. This ultimately causes 
rupture of the bonds attaching the analytes to the surface. This rupture event is 
detected by measuring changes in the transduced electric signal recorded at 
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the third harmonic (3f). The signal indicated not only the presence of the 
analytes but also the number of analytes present and their affinity for a surface-
bound receptor. However, this concept was not supported by theoretical 
explanation of the physical mechanism responsible for generation of the so 
called “rupture” signals, claimed to differentiate specific and non-specific 
interactions. It was also notified that it is challenging to reliably reproduce the 
rupture signal, especially when the concentration of adsorbents is low. Since 
the analyte detaches away from surface after a single measurement, the 
measurements are not repeatable with the same specimen.[145] 
Another acoustic transduction method, known as “Anharmonic ascoustic 
Detection Technique (ADT)” employs a concept similar to that of Dybwad’s 
“coupled-resonance model”.  ADT also explores the interaction between the 
surface of resonator and particle bound to the surface through a tether (or 
linker). Ghosh et al. postulated that anharmonic interaction forces could be 
responsible for the generation of the nonlinear signal.  They developed a model 
to explain this phenomenon using a spring-mass model, where the particle was 
modelled as sphere and tether (or linker) as a spring (as shown in Fig. 2.11). In 
case of inertial loading, the sphere remains stationary but the resonator 
oscillates, this stretches the tether and this is transduced as nonlinear signal. 
The nonlinear signal thus depends upon the stiffness of the tether and also the 
angle it makes with the surface of resonator. This concept was validated by 
quantitative modelling of the interactions of a surface-bound particle with the 
oscillating surface for both physisorbed and specifically-bound cases, and the 
resulting nonlinear acoustic modulation of the oscillator was analysed. This 
technique demonstrated the ability to differentiate between specific (target) and 
non-specific (non-target) interactions, which is lacking in most of the sensing 
techniques. It also allows the measurement of activation energy or mechanical 
force-extension characteristics of a molecule. ADT has been previously 
established to selectively detect Bacillus subtilis spores and distinguished them 
from physisorbed SCPM (streptavidin-coated polystyrene microbeads), and can 
be further employed for detecting pathogens. ADT is ideal for application as 
rapid POC of diagnostic method, as it is entirely electronic; it is integrable and 
scalable and enables cost-effective, rapid and easy-to-use detection with 
minimal sample preparation.[146-149] 
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Fig. 2.11 - Concept of Anharmonic acoustic Detection Technique (ADT):           
Spring-mass model of a particle bound to an oscillating sensor surface via bio-molecular linker 
in liquid. The particle is modelled as a sphere, and the bio-molecular linker as an equivalent 
nonlinear spring of length (l). The force along the bio-molecular linker is given by Fl and the 
force perpendicular to the linker due to its angular stiffness is given by Fa and the horizontal 
component of the interaction force is given by Ftx. Adapted and modified from 
[146,147]. 
2.4.4.2 Bio-receptors  
The bio-receptor responsible for recognising the target analyte can either be a:  
 biological material: enzymes, antibodies, nucleic acids and cell 
receptors, or;  
 biologically derived material: aptamers and recombinant antibodies, 
or;  
 biomimic: imprinted polymers and synthetic catalysts.[84,89,100] 
Bio-receptors of different sizes and lengths have been explored that 
could be then integrated with ADT transducer for detection of target 
bacteria and are discussed in chapters 4, 5 and 6. 
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2.5 Target bacteria  
ADT have been earlier used to sensitively detect Bacillus subtilis spores but not 
used for detecting pathogen as a whole. Hence, ADT technique has been used 
here for on-site detection of the Escherichia coli (E.coli) bacteria as a “model 
organism” because of the following reasons: 
a) E.coli bacteria are typically commensal bacteria of warm-blooded 
animals. They are often used as indicators for the presence of AMR in 
monitoring and surveillance programs, given the availability of simple and 
efficient isolation procedures.[150,151] 
b) Easy handling in laboratory: E.coli has been widely studied for it is easy 
to maintain and breed in a laboratory setting owing to its particular 
experimental advantages.[152] 
c) Indicator of water and food safety: It gets transmitted by the consumption 
of contaminated water and food. Even though most of the E.coli strains 
found in water or food are not virulent, the detection of E.coli is still 
crucial to the monitoring of water and food safety because the existence 
of E.coli indicates that microbial contamination is high.[152] 
2.6 Summary 
Both pathogen identification and phenotypic AST should be fast to reduce the 
length of diagnostic cycle. As it is unlikely to shorten the time required to 
conduct phenotypic AST, the initial pathogen detection and identification step 
needs to be reduced, to abridge the overall time of the diagnostic cycle. This will 
help clinicians to initiate appropriate treatments quickly. Culture-dependent 
methods are very time-consuming and are currently considered obsolete. 
Therefore, in this chapter the most commonly used culture-independent rapid 
diagnostic methods were reviewed including, nucleic acid-based methods 
(PCR, mPCR, qPCR, NASBA, LAMP), immunological methods (ELISA, LFI), 
mass spectrometry-based method (MALDI-TOF-MS) and biosensor-based 
methods (optical, electrochemical and acoustic biosensors).  
Detection of whole-cell bacteria is important so that they can be further utilised 
for subsequent determination of antibiogram. However, nucleic acid-based 
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methods are genotypic tests and do not permit isolating pathogens for further 
use. Immunological tests can detect whole-cell bacteria but in these methods 
also, bacteria cannot be recovered for AST. New method has been tried to 
identify lipid A directly on intact bacteria with MALDI-TOF mass spectrometry, 
but it is laborious. Optical and acoustic biosensors allow detection of whole-cell 
bacteria, but there are very few examples of application of electrochemical 
biosensors for detection of whole-cell bacteria. Furthermore, biosensor-based 
methods allow label-free detection of bacteria, except for optical label-based 
biosensors. Nucleic acid-based methods and immunological methods are also 
label-based and require laborious labelling processes, making them costly and 
this may also interfere with the function of the bio-receptor. Methods like PCR, 
ELISA or MALDI-TOF-MS also require specialised equipment and trained 
personnel to operate the system. Optical biosensors are bulky in size and the 
set-up method of electrochemical biosensors is very complicated, making them 
both difficult to be translated as POCT. Although, portable SPR biosensors 
have been fabricated the cost of instrumentation is very high. LFIs are cheap 
and can be employed at the point-of-care but it is difficult to integrate them with 
electronics. While, ADT is an easy-to-use, integrable, low-cost technology that 
can be miniaturised and applied as POCT. LFIs suffer from higher false-positive 
rates than PCR and ELISA. On the other hand, ADT could potentially address 
this problem because of its intrinsic ability to differentiate specific and                   
non-specific interactions, making diagnosis more reliable and reproducible. 
Moreover, it is also possible to maintain suitable temperature and grow bacteria 
within the microfluidic device integrated with ADT, to investigate antibiotic action 
on slow growing pathogens. Therefore, as ADT is integrable and can be applied 
at the point-of-care for rapid, label-free, low-cost, detection with high specificity 
which is lacking in most of the other methods, this technology was selected to 
explore its use for whole-cell bacterial detection.     
Also, for the first time, different bio-receptors of different sizes and lengths are 
integrated with ADT transduction method for sensitive and specific detection of 
whole-cell E.coli bacteria, which are covered in chapters 4, 5 and 6. E.coli 
bacteria were selected as target analyte, owing to its applicability in AMR 
surveillance program and easy handling procedure in laboratory.  
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Chapter 3 Experimental considerations and methodology 
3.1 Introduction 
In this chapter, experimental methodology and materials used are described. 
The principle and theoretical concept of ADT technique is also discussed. 
ADT together with the TSM AT-cut quartz crystal resonator constitute the 
‘transducer element’ of the biosensor. This technique can detect the           
surface-bound particles and also has the ability to differentiate between 
specific (target) and non-specific (non-target) interactions, which is lacking in 
most of the sensing techniques. But, to achieve high sensitivity and specificity 
with this transduction technique, in this chapter several experimental 
considerations were addressed: exploration of different electrode geometry; 
choice of mode of scan for measurements; selection of suitable bioassay 
format; validation of gold electrode surface cleaning method and achievement 
of stable baseline, before performing experiments with the target E.coli 
bacteria. 
3.2 Transduction system: Concept and Experimental apparatus 
3.2.1 Anharmonic acoustic Detection Technique (ADT) 
ADT is based on the anharmonic acoustic modulation of the oscillator caused 
by the nonlinear interactions between the attached particles and the surface. 
Ghosh et al. have hitherto, investigated the bio-molecular linker interaction 
forces in a biosensor through experimentation and also have validated the 
results by means of numerical modelling. They have used this technique and 
studied the nonlinear acoustic response from a TSM AT-cut quartz crystal 
resonator with specific antibodies functionalised on its surface, to selectively 
detect Bacillus subtilis spores and distinguish them from physically adsorbed 
SCPM (streptavidin-coated polystyrene microbeads). Their work unveiled the 
prospective benefits of ADT like, sensitive, quantitative and selective detection 
of surface-bound particles.[146-149] Because of these advantages, this 
technique has potential to be further employed for detecting pathogens and/or 
biomarkers, which can be used for controlling AMR in due course. 
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Concept of ADT: 
The concept of anharmonic acoustic detection technique has been explained 
through quantitative modelling; where a surface-bound particle attached to the 
sensor surface via bio-molecular linker (or tether), is modelled as a                 
spring-mass system.[146,147]  Figure 3.1 shows this model along with the factors 
involved.  
The sensor used here is thickness shear mode (TSM) AT-cut quartz crystal 
resonator which transduces charge by piezoelectric effect. When the sensor is 
driven by a harmonic force with a pure sinusoidal signal of frequency f0, which 
is typically its fundamental resonant frequency, the sensor surface oscillates 
in-plane. At higher frequencies, the particles bound to the surface through 
linkers are apparently static due to inertia effects or partially follow the 
displacement of the sensor surface. As a result, the oscillation stretches the 
bio-molecular linker and opposing forces act along the linker, which are then 
passed onto the sensor. These forces due to surface-particle interaction alter 
the acoustic response of the sensor to an anharmonic one, which is then 
transduced into an electrical signal.  
These forces acting on the sensor surface were investigated and a 
mathematical function was derived for the amplitude of the forces. Fourier 
analysis was applied to analyse this function and expressed as a Fourier 
series which contains harmonics with n times the excitation frequency, where 
n is an odd and non-zero number. The relative deviation in first harmonic (1f) 
is negligible.  
Also, the amplitude of the harmonics decreases with increase in harmonic 
number [as shown in Fig. 3.1 (B)]. Therefore, among the higher odd 
harmonics, the shift in amplitude of the third harmonic (3f) was selected as a 
parameter for measurement of the anharmonicity of the consequent response.  
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Fig. 3.1 – Concept of ADT: (A) Anharmonic output current comprised of current due to 
bulk shear force and surface-particle shear force and (B) Fourier analysis of current due to 
surface-particle shear force. Adapted and modified from [146,147]. 
3.2.2 Quartz crystal resonator (QCR) with gold electrodes 
QCRs have been extensively used as TSM acoustic wave devices for 
detecting changes occurring on the surfaces of the quartz crystal. For many 
years, QCRs were used for mass measurement in vacuum[140,141] and in                    
gas-phase experiments and were called as quartz crystal microbalance 
(QCM), however; recently scientists realised that they can be used in contact 
with liquids and viscoelastic deposits. When the QCR comes in contact with a 
solution, there is a decrease in frequency that is dependent upon the viscosity 
and the density of the solution. For proper analysis and elucidation of 
experimental results, it is important to understand the behaviour of the QCR 
operating under total liquid immersion. This problem was first treated by 
Glassford, and later by Kanazawa and Gordon.[153] They demonstrated that 
QCR measurements can be performed in liquid, in which case a viscosity 
related decrease in the resonant frequency will be observed as: 
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∆𝑓 = −𝑓𝑢3 2⁄ [(𝜌𝐿 × 𝑛𝐿)/(𝜋 × 𝜌𝑞 × 𝜇𝑞)]1 2⁄                                              Eqn. (1) 
Where, 
fu - frequency of oscillation of unloaded crystal,  
ρq - density of quartz – 2.648 g . cm-3,  
µq - shear modulus of quartz- 2.947.1011 g.cm-1.s-2,  
ρL - density of the liquid in contact with the electrode, and  
ηL - viscosity of the liquid in contact with the electrode. 
 
There is decrease in resonant frequency as a result of damping of the 
resonant oscillation due to viscous coupling of the liquid medium onto the 
oscillating crystal surface. Thus, since the resonant frequency is affected by 
both mass and liquid loading, measurement of the resonant frequency alone 
cannot distinguish changes in surface mass from changes in solution 
properties. The viscous loss results in increase in resonance resistance, R, of 
the QCR. Thus, both ∆f and ∆R measurements are typically used as 
independent indicators of mass loading and viscosity at the crystal-liquid 
interface of the QCR.[153]  
 
Fig. 3.2 - Butterworth Van-Dyke Model for a Piezoelectric Resonator: Equivalent 
circuit for a QCM under mass loading including parasitic capacitance (C0). Adapted and 
modified from 
[154]
. 
 
The electrical behaviour of the QCR is often described using an equivalent 
equivalent circuit model. The Butterworth-Van Dyke (BVD) equivalent circuit 
routinely used to describe the unperturbed (without mass or liquid loading) 
QCR as shown in Fig. 3.2. The BVD electrical model consists of two arms. 
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The “motional arm” has three series components modified by the mass and 
viscous loading of the crystal: (1) Rm (resistor) represents energy dissipated 
during oscillation, (2) Cm (capacitor) represents energy stored during 
oscillation (3) Lm (inductor) corresponds to the inertial component of the 
oscillation, which is related to the mass displaced during the vibration. Making 
electrical contact to a quartz crystal is done through electrodes on each face 
of the crystal. These electrodes introduce additional “static arm” capacitance 
(C0) in parallel with the series RLC, as shown in the Fig. 3.2. It has not been 
meticulously demonstrated that the BVD circuit model is an appropriate 
description for the loaded QCR, but it has been used extensively by many 
researchers, as the impedance measurements made on liquid-loaded QCRs 
could be fitted well with this model. 
The mechanical interactions between the QCR and the contacting liquid 
influence the electrical characteristics of QCR, especially near its resonance, 
where the amplitude of the oscillation is maximum. To evaluate the electrical 
characteristics of QCR, the electrical admittance is used, which is defined as 
the ratio of current flow to applied voltage. For analyses purposes, the 
measured admittance data was fitted to the BVD model to extract the values 
of three equivalent circuit parameters Q (quality factor), Rm (motional 
resistance), and f0 (resonance frequency). 
Martin et al. have also applied BVD circuit model, to derive a linear 
relationship between the change in series resonance resistance, ∆R, of the 
quartz oscillator and (ρL. ηL)1/2 under liquid loading, which is given by 
following equation:[154] 
∆𝑅 = [𝑛.𝜔𝑠.
𝐿𝑢
𝜋
] . [
2.𝜔𝑠.𝜌𝐿.𝑛𝐿
𝜌𝑞.𝜇𝑞
]
1 2⁄
                                                                 (Eqn. 2) 
Where, 
∆R - change in series resonance resistance, in Ω,  
n - Number of sides in contact with liquid,  
ωs - angular frequency at series resonance(=2.Π.fs, where fs is the oscillation 
frequency in solution in Hz), and  
Lu - Inductance for the unperturbed (i.e. dry) resonator, usually in mH. 
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Dimensions of QCR with gold electrodes 
TSM quartz crystal resonators used were 8.3 mm in diameter and 112 µm in 
thickness with fundamental resonant frequency range of 14.275 -14.325 MHz 
(Lap-Tech Inc., Bowmanville, Ontario, Canada). They were made from 
optically polished AT-cut quartz, cut at an angle of 35° 15.0±1’ to the crystal 
optical axis. The crystals had excellent frequency stability with operating 
temperature range between 20°C to 40°C. The quartz substrate was 
sandwiched between evaporated layers of gold keyhole-styled electrodes of 
165 nm uniform thickness, with 5 mm and 4 mm diameters, respectively, as 
shown in Fig. 3.3.  
 
Fig. 3.3 – Schematic of Quartz Crystal Resonator with gold electrodes obtained 
from Lap-Tech Inc., Canada. 
 
For all applications that require use of QCR, it is important to reduce or 
eliminate the unwanted spurious responses; this can be achieved by 
improving the electrode geometry, thereby, improving the performance of 
QCR. Shockley et al. had postulated that to obtain a strong resonance and to 
suppress these unwanted spurious responses, energy trapping by partial 
loading (deposition of extra mass) is vital.[155] Energy trapping has been 
known and used for a long time in TSM quartz crystal resonators and its basic 
theory is discussed in next section.  
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3.3.2.1 Energy trapping concept 
The concept of energy trapping was first introduced by Mortley in 1946,[156-158] 
but it remained relatively unknown and its significance was not recognised, 
until his results were rediscovered independently by Shockley et al. in 
1967.[154] They applied the energy trapping theory to a simplified model of a 
TSM AT-cut quartz crystal (or wafer), by partially loading it with extra mass. 
They also gave an approximate mathematical theory to explain the 
phenomenon of energy trapping in rectangular crystals, where the            
thickness-shear vibrations in a partially electroded quartz crystal can be 
confined to the area under and close to the electroded region of the 
crystal.[155]  
This concept was also applied to the circular AT-cut quartz crystals by Efimov 
et al., where they even investigated the variation in sensitivity of QCR in 
response to energy trapping effect. They reiterated that “energy trapping” 
means the total inner reflection of the acoustic wave generated in the 
electroded area from the boundary with the non-electroded part of the crystal. 
Moreover, they further focussed the oscillation energy by partially loading the 
gold electrode of QCR with extra copper deposits in the centre as well as, at 
controlled locations.[159] They observed that the central copper deposit (as 
shown in Fig. 3.4) not only shifted the resonant frequency of the QCR but also 
changed the shape and magnitude of the sensitivity curve. The sensitivity 
decreased near the boundary of the electrode and the quartz, but increased 
close to the copper deposit, to a peak at the centre that is higher than the 
value for the unloaded gold electrode.[159] Thus, it was observed that the 
energy trapping effect not only suppresses the spurious modes but also 
increases the sensitivity of the QCR by confining the oscillations to the region 
of additional loading. Hence, this effect was further explored in terms of 
anharmonic acoustic detection technique and the electrode geometry was 
modified to stepped (non-uniform) crystals, by loading the gold electrodes of 
QCR with central gold deposits. 
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Fig. 3.4 – Schematic representation of spatial distribution of oscillation at a 
QCR with thickness (lq) in case of: (a) uniform crystal (b) stepped (non-uniform) crystal. 
The distance δ represents exponential decay of the oscillation from the edge of: (a) the 
electrode area and (b) the localised metal deposit. Adapted and modified from 
[159]
. 
 
3.2.2.2 Preparing the stepped (non-uniform) crystals 
The QCRs with stepped electrodes were prepared by following three steps:             
(1) Preparing the substrates for gold sputtering, (2) Gold sputtering, and               
(3) Thickness measurements. 
Preparing the substrates for gold sputtering:  
The area of the gold electrode of QCR that was not supposed to be coated 
with gold was masked. But, the central circular area with diameter of 2.5 mm 
(to be coated with gold) was left unmasked (as depicted in Fig. 3.5). The 
substrates thus prepared, were then sputtered with gold using Q150T ES 
System. 
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Fig. 3.5 – Preparation of stepped (non-uniform) crystals: (a) Top view of gold 
electrode of quartz crystal (b) Central circular area of gold electrode (diameter 2.5 mm) left 
unmasked (c) Top view and (d) Side view of stepped (non-uniform) crystals after gold 
sputtering. 
 
Gold sputtering: 
Q150T ES System was used for sputtering the gold electrodes with another 
layer of gold in centre.  The coating thickness is proportional to the square of 
the distance between the stage height and the rods (loaded with small 
quantity of gold to be evaporated). Also, the thickness of the gold to be 
deposited can be controlled by changing the property of current and the time 
for which it is passed. With a current of 20 mA, a deposition rate 20 nm/min is 
typically achieved. So after setting material to gold and passing 20 mA current 
for ~180 milliseconds, gold deposition of thickness ranging from 60 nm to           
70 nm was achieved on the substrates. 
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Thickness measurement: 
The thickness of the sputtered crystals was measured using Zygo NewView 
5000. The Zygo NewView 5000 is a non-contact 3D surface profiler that uses 
scanning white light interferometry to image and measure the microstructure 
and topography of surfaces. It provides graphic images and high-resolution 
numerical analysis to accurately characterise the surface structure of test 
parts. Figure 3.6 shows vertical step height measured of typical stepped (non-
uniform) crystal using Zygo NewView 5000. 
   
Fig. 3.6 - Vertical step height measured of stepped crystal using Zygo NewView 
5000. 
 
3.2.2.3 Demonstration of energy trapping with ADT 
To demonstrate the energy trapping effect on the ADT signal, pilot 
experiments were performed, where QCRs with the uniform and stepped 
electrodes were used to detect the streptavidin-coupled beads. The 
anharmonic acoustic response from both the sensors was compared. 
Experimental procedure:  
QCRs with the uniform and stepped (~ 65 nm height) electrodes were cleaned 
as per procedure given in section 3.3.5 (c). Then, both the cleaned quartz 
crystals were immersed in about 250 µl of 1mM ethanolic solution of mixture 
of thiols [biotin terminal group (10%), and methoxy terminal group (90%)] and 
left overnight for formation of a self-assembled monolayer (SAM). Next day, 
the crystals were then washed with ethanol in a well 3 times, followed by 
flowing de-ionised (DI) water. Phosphate buffer saline (PBS) solution was 
then flowed over the surface of each crystal at the flow rate 10 µL/min and 
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then baseline measurements were taken over 20 mins. Streptavidin-coupled 
Dynabeads® (Thermo Fisher Scientific, UK) with 2.8 µm diameter were used 
as analyte, at concentration 107 beads per mL of PBS. 100 µL of beads were 
flowed over the surface at 10 µL/min flow rate for further 15 mins. 
Resonant frequency (f0) was determined with frequency sweep and the 
sensor was then driven by a pure sinusoidal oscillation at f0 in amplitude mode 
scan. Three successive 1s AMS scans were taken every 5 mins after stopping 
the flow for baseline measurement and similarly after flowing streptavidin-
coupled beads. The maximum (terminal) values of the 3f current were plotted 
as seen in the Fig. 3.7, for both the crystals with uniform and stepped 
electrodes.  
 
Fig. 3.7 – Last values of 3f current plotted for detecting streptavidin-coupled 
beads  using QCR with uniform and stepped (non-uniform) electrodes (Surface 
– 10% Biotin thiol and 90% OCH3 thiol / AMS scan 0.5 amp /1s scan). 
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Results and discussion:  
The terminal values of modulus of 3f current for all the scans are plotted in 
Fig. 3.7. The baselines were recorded for both QCRs with uniform and 
stepped electrodes over 20 mins, with %CoV as -4.1% and -1.0%, 
respectively. A shift of 7.6% was seen in 3f signal after passing streptavidin-
coupled beads over QCR with uniform electrode. However, almost three times 
shift of 24.8% was recorded after passing the beads over stepped (non-
uniform) crystal. Thus, it was observed that the sensitivity of the QCR 
increased dramatically by loading it with central gold deposit (~ 65 nm height) 
and concentrating the oscillations to loaded area through energy trapping 
effect. Thus, QCRs with central gold deposits i.e. stepped crystals were used 
for all further experiments.  
3.2.3 Transduction system check-up  
It is a good practise to test the sensor parameters, in order to optimize 
equipment performance or to detect faults at an early stage; because an 
erroneous parameter characterisation can lead to misinterpretation of the data 
measured during the experiment. Operation at increasing glycerol 
concentrations is an excellent test of a QCR experimental setup, and should 
provide predictable results up to more than 70% glycerol. Therefore, the effect 
of the variation of the density of the glycerol and water mixture (% w/w) in 
contact with the surface of the QCRs with stepped (non-uniform) electrode 
was compared to that with uniform electrode. A comparison was made against 
the theoretical predictions of equations 1 and 2. Thus, both frequency shift in 
Hz (Fig. 3.8 and 3.9) and resistance shift in ohms (Fig. 3.10 and 3.11) were 
measured and compared with the values calculated from the equations.  
In both the crystals (uniform and stepped), an agreement between measured 
and expected values was within +/- 25% which is generally considered 
acceptable for glycerol concentrations up to 70%. Although, slight deviation 
from the equations was observed after introducing 70% glycerol/water mixture 
(% w/w) over the surfaces, as glycerol becomes inhomogeneous after 70% in 
water.[160] Thus, the QCRs with stepped electrodes were validated for 
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experimental use with ADT technique, as their behaviour in liquid medium is 
similar to that with uniform electrodes. 
  
Fig. 3.8 - Frequency shift (Hz) after loading the Uniform crystal                                
(fu = 14.280696 MHz) with titrations of glycerol/water (%w/w). 
 
Fig. 3.9 - Frequency shift (Hz) after loading the Stepped (non-uniform) crystal 
(fu = 14.235522 MHz) with titrations of glycerol/water (%w/w). 
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Fig. 3.10 - Resistance shift in ohms (Ω) after loading the Uniform crystal                                
(fu = 14.280696 MHz) with titrations of glycerol/water (%w/w). 
 
Fig. 3.11 - Resistance shift in ohms (Ω) after loading the Stepped (non-uniform) 
crystal (fu = 14.235522 MHz) with titrations of glycerol/water (%w/w). 
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3.2.4 Selection of mode of scan for experiments 
ADT allows measurements of response on fundamental resonance and higher 
harmonics to the signal of varied amplitude applied to fundamental resonance 
only. There are generally two modes of scans used for measurements:              
(1) Frequency mode scan (FMS scan): In this mode, the sensor is driven at a 
fixed frequency (the resonant frequency) and amplitude, for specified time 
span. The frequency span could be varied between 0 and 200 kHz.  
(2) Amplitude mode scan (AMS scan): In this mode, the sensor is driven at a 
fixed frequency (which is equal to the fundamental resonant frequency 
obtained from preceding FMS scan), for specified amplitude ramp (start and 
finish value, amplitude linearly increasing with time) and for specified time 
span. The highest amplitude applied is 0.5 Standard Units (SU), which equals 
an excitation voltage of 15 Volts (1 SU equals 30 Volts). 
In both the modes, shift in the peak (or maximum) values of 3f current (I3f) is 
measured, as an anharmonic response for quantitative detection of analytes 
(at different concentrations) after binding with corresponding bio-receptor. 
Both FMS and AMS scans are preceded by FMS scans at 0.02 SU to 
determine resonant frequency (f0). However, for AMS scans it is imperative to 
determine f0 values before each scan to get maximum response. 
Consequently, real-time measurements are difficult to obtain with AMS mode 
scan, as the driving frequency needs to be reset to resonant frequency before 
each scan. Thus, both the scan modes were tested to determine whether the 
relative shift in I3f values are affected or not, if the driving frequency is not 
reset to f0. Titrations of glycerol and water were flowed over the surface of 
QCR and corresponding I3f values were obtained in both AMS and FMS mode 
scan. 
 In AMS mode scan, the driving frequencies were selected at f0 and varied 
around it: from f0–3 kHz to f0+3 kHz with amplitude ramp of 0.5 SU, as shown 
in Figure 12. The corresponding maximum values of I3f after passing titrations 
of glycerol/water (% w/w), are plotted in Fig. 3.13. Similarly, FMS scans were 
taken at fixed f0 (with span 200 kHz) and amplitude of 0.5 SU; and the 
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corresponding peak values of I3f curves are plotted in Fig. 3.14. The resonant 
frequency (f0) shifted by ~0.5 kHz and ~1 kHz with 20% and 30% 
Glycerol/water mixtures, respectively. In Fig. 3.13, the I3fmax on 20% 
Glycerol/water curve (b’) corresponds with the resonant frequency after 
resetting the driving frequency to f0 (-0.5 kHz). While the I3fmax corresponding 
to 0 kHz which is initial driving frequency f0 for 10% Glycerol/water mixture, is 
less than that observed at -0.5 kHz i.e. b’>b. Same is the case, with 30% 
Glycerol/water curve, where c’ = I3fmax at -1KHz (after resetting) and c = I3fmax 
at 0 KHz (without resetting) and c’>c.  Thus, with AMS scans if the driving 
frequency is not reset to resonant frequency, the true maximum values are not 
captured, as it does not take into account the lateral (resonant frequency f0) 
and vertical (amplitude of I3f) shift after viscous loading, as shown in Fig. 3.13. 
So, there is need to reset the driving frequency to f0 before each 
measurement, which adds one more step to experiment making real-time 
measurements difficult. However, with FMS scan as depicted in Fig. 3.14, 
both the shifts in amplitude of I3f as well as in resonant frequency f0 are 
accounted for and the peak values give the precise extent of change in signal 
without resetting the driving frequency to f0 after each measurement. 
 
Fig. 3.12 – Graph showing AMS scans (0.5 SU) taken at resonant frequency (f0) 
and from f0–2 kHz to f0+2 kHz after flowing 10% Glycerol/water mixture (% w/w).  
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Fig. 3.13 – Graph showing last (maximum) values of I3f with AMS scans (0.5 SU) 
after flowing titrations of Glycerol/water (% w/w) – (a) I3fmax for 10%; (b) & (c) 
I3fmax for 20% and 30% without resetting the driving frequency to f0; and (b’) & 
(c’) I3fmax for 20% and 30% after resetting the driving frequency to f0. 
 
Fig. 3.14 – Graph showing I3f curves with FMS scans (0.5 SU) after flowing 
titrations of Glycerol/water (% w/w). The arrows point towards the peaks of the 
curves (I3fmax). 
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3.2.5 Surface cleaning of gold electrodes  
Over the last two decades, there has been growing interest in surface science 
to design surfaces with tailored properties; as this has application 
predominantly in biosensor studies. Molecular level of control over surface 
can be achieved through controlled grafting of monolayers. The main route to 
achieve this level of control over surface modification is to use self-assembled 
monolayer (SAM).[161]  It is important that monolayer forming molecules should 
align on the surface with exactly the same orientation and also to avoid 
defects there should be perfect packing of the monolayer. For this, the 
substrate on which the monolayer is formed should be clean and devoid of 
contamination layer. The gold electrodes of QCR were used as substrate for 
all the experiments. 
The properties of an alkanethiolate SAM formed on gold primarily depends on 
the immersion time, the solvent used, and purity of the thiol and on the quality 
of the gold substrate.[162] The roughness and cleanliness of the immersed 
substrate is of crucial importance for the quality of the monolayer. There are a 
variety of techniques for cleaning the surface before depositing the SAM. 
These include exposure to a powerful oxidising mixture of concentrated 
sulphuric acid and hydrogen peroxide (Pirahna solution),[162] and the less 
aggressive solution comprising of hydrogen peroxide, ammonium and 
water,[163] electrochemical potential cycling, UV photo-oxidation,[164] 
ozonolysis,[165] thermal desorption,[166] and dry cleaning methods include 
UV/ozone treatment, and etching in oxygen or argon plasma. The sensitive 
nature of the metal (gold) surfaces requires avoidance of harsh cleaning 
procedures. Therefore lately, there has been growing importance of plasma 
cleaning as surface treatment. Thus for the experiments, the substrates used 
i.e. gold electrodes of QCR were first treated with organic solvents and then 
cleaned with argon plasma. To arrive at optimal cleaning procedure, the 
surfaces were characterised by measuring contact angles and with X-ray 
photoelectron spectroscopy (XPS) measurements. 
Chemicals and materials used: All solvents and chemicals were of reagent 
quality and were used without further purification. For cleaning quartz crystals 
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acetone, isopropyl alcohol (IPA) and ultra-pure 200-proof ethanol                  
(Sigma-Aldrich, USA) were used. 
Substrate preparation: Cleaning procedures were investigated by preparing 
the substrates under different conditions, described as follows: 
a) As received (AR): QCR with gold electrodes, as received from              
Lap-Tech Inc., Bowmansville, Ontario, Canada were used. 
b) Organic solvent treatment (OST): The substrates were cleaned with 
acetone for 5 mins; then with IPA by ultra-sonication process for         5 
mins. After that they were dried with nitrogen gas and then stored in a 
well of clean 24-well tissue culture plate, containing 250 µL of ethanol. 
c) Organic solvent plus Argon plasma treatment (OST+APT): After 
cleaning the substrates with OST, they were further cleaned with argon 
plasma for 1 min in a Harrick Plasma cleaner. They were then stored in 
a well of clean 24-well tissue culture plate covered with plastic film. 
d) Organic solvent, Argon plasma plus Ethanol treatment 
(OST+APT+ET): After cleaning the substrates with OST+APT, they 
were then stored in a well of clean 24-well tissue culture plate, 
containing 250 µL of ethanol. 
Contact angle measurements: 
The substrates were prepared as described above and then carried to the 
LMCC Analysis suite in Chemical Engineering Building to measure surface 
contact angle. Contact angles measurements were determined by sessile 
drop technique at ambient temperature in atmospheric conditions, where a 
droplet of liquid was placed on the solid surface using a syringe or a 
micropipette.  
For each type of surface two drop sizes were used viz. 1 µL and 2.5 µL and 
the apparent contact angles were measured using a microscope equipped 
with an instrument. All reported contact angles are the average of at least 
three measurements taken at different locations on the substrate for three 
different crystals and have a maximum error of ±4°. 
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The static contact angles measured were more or less same for the two drop 
sizes used viz. 1 µL and 2.5 µL (volume). It was observed that substrates with 
AR, were borderline hydrophobic with static contact angles as 90.56° (± 4.23°) 
for 1 µL and 94.02° (± 0.32°) for 2.5 µL drop sizes, indicating that they had 
contamination layer over the surfaces.[167,168]  
Also, the substrates treated with only OST were slightly contaminated as the 
static contact angles measured were 87.72° (± 3.70°) for 1 µL and 88.94° (± 
1.75°) for 2.5 µL drop sizes. The static contact angles for the substrates 
cleaned with OST+AT were <40° viz. 33.07° (± 0.45°) and 39.00° (± 0.41°) for 
1 and 2.5 µL drop sizes, respectively. But when the substrates where further 
immersed in ethanol, the contact angles increased to 62.33° (± 0.75°) and 
71.64° (± 0.83°) for 1 and 2.5 µL drop sizes, respectively. Thus, the crystals 
treated with OST+APT were more hydrophilic and clean than the ones 
immersed in ethanol OST+APT+ET; possibly due to contamination, to a much 
lesser extent, upon exposure of the cleaned surface to ethanol and ambient 
conditions. The results from the static-contact-angle measurements versus 
droplet volume for all the surfaces of the different substrates cleaned with 
different treatments are given in Table 3.1. 
X-ray photoelectron spectroscopy (XPS) measurements 
XPS measurements were carried out with a Thermo Scientific K-Alpha 
spectrometer using a monochromatic Al Kα X-ray source (Ion Gun Operating 
range: 100 eV - 4 keV) with a spot size of 400 μm. The survey spectra were 
collected over a range of −10 to 1350 eV with pass energy of 200 eV. The 
high resolution spectra over the Au 4f, C1s, O1s, S2p, and N1s regions were 
acquired with pass energy of 50 eV.  
The substrates were prepared as described above (AR, OST, OST+APT and 
OST+APT+ET) and then carried to the LMCC Analysis suite in Chemical 
Engineering Building where the Thermo Scientific K-Alpha spectrometer 
equipment is located.  
In XPS, the surfaces of the substrates were irradiated with X-rays. This 
excited photoemission from the core levels of the atoms present on the 
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surface and the resulting photoelectrons emerging from the surface were 
collected and their energy was analysed. The kinetic energy of a 
photoelectron depends on the binding energy of electrons in the core levels 
from which photoemission is excited and each element gives rise to a set of 
peaks at characteristic energies. Thus, the following Figure 3.15 showing 
photoelectron spectrum for the different substrates allows identification of the 
elements present on their surfaces.  
The XPS spectra showing surveys of entire surface for AR and OST+APT are 
almost overlapping each other with high peaks for gold indicating no 
contaminants on the surface. For substrates treated with OST+APT+ET the 
gold peak was comparatively lower, suggesting contamination to lesser 
extent, as confirmed from the high resolution spectra for Au 4f (Fig. 3.16).  
High resolution spectra over Au 4f (Fig. 3.16) demonstrated that the peaks 
were higher for relatively cleaners surfaces – AR and OST+APT. Also, the 
high resolution spectra over C1s and O1s (Fig. 17 and 18) showed that peaks 
were high for substrates treated with OST and OST+APT+ET, but 
comparatively, lower for OST+APT. However, the peak for O1s for OST+APT 
was slightly higher than for AR. For substrate treated with organic solvent, 
there is no peak for gold but high peaks for C1s and O1s as seen in Fig. 17 
and 18 showing high contamination.  
Contact angle measurements provide an easy tool for the routine control of 
surface contamination on metals. Although, they give no direct information on 
the chemical composition of the contaminant, however correlating these 
measurements with XPS survey data provided accurate characterisation of 
the contaminants.  
The substrates treated with organic solvent and then with argon plasma 
(OST+APT) were found to be hydrophilic and cleaner with comparatively less 
contaminants on the surface, as confirmed from XPS measurements. Further 
immersing in ethanol contaminated them to a lesser extent. Therefore, for all 
the experiments the substrates were cleaned with organic solvents first and 
then with Argon plasma for 1 min; and subsequently immersed them into the 
thiol solution directly rather than in ethanol to avoid contamination. 
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Table 3.1 – Static contact angles  
Substrates 
Static contact angles 
1 µL drop 2.5 µL drop 
AR 
  
90.56° (± 4.23°) 
  
94.02° (± 0.32°) 
OST 
 
87.72° (± 3.70°) 
 
88.94° (± 1.75°) 
OST+APT 
 
33.07° (± 0.45°) 
 
39.00° (± 0.41°) 
OST+APT+ ET 
 
62.33° (± 0.75°) 
 
71.64° (± 0.83°) 
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Fig. 3.15 - XPS spectra showing comparison of surveys for different substrates 
– As received (AR), Organic solvent treatment (OST), Organic solvent plus 
Argon plasma treatment (OST+APT) and Organic solvent, Argon plasma plus 
ethanol treatment (OST+APT+ET). 
 
Fig. 3.16 - High resolution spectra over the Au 4f for different substrates – As 
received (AR), Organic solvent treatment (OST), Organic solvent plus Argon 
plasma treatment (OST+APT) and Organic solvent, Argon plasma plus Ethanol 
treatment (OST+APT+ET). 
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Fig. 3.17 - High resolution spectra over the C1s for different substrates – As 
received (AR), Organic solvent treatment (OST), Organic solvent plus Argon 
plasma treatment (OST+APT) and Organic solvent, Argon plasma plus Ethanol 
treatment (OST+APT+ET). 
 
Fig. 3.18 - High resolution spectra over the O1s for different substrates – As 
received (AR), Organic solvent treatment (OST), Organic solvent plus Argon 
plasma treatment (OST+APT) and Organic solvent, Argon plasma plus Ethanol 
treatment (OST+APT+ET). 
 
 80 
 
3.2.6 Experimental apparatus 
3.2.6.1 Instrumental set-up 
ADT instrumental set-up consists of following components: 
(a) Signal generator and amplifier  
(b) SensAND ADT machine (Nonlinear Network Analyzer) 
(c) Printed Circuit Board (PCB) cartridge on which QCR is mounted            
(RAPP-ID project, KTH, Sweden) 
(d) Computer with SensAND control software  
 
Fig. 3.19 – Schematic view of connections. 
A dedicated electronic instrument, which may be described as a “Nonlinear 
Network Analyzer”, has been designed, built and used for ADT 
experiments.[146-149] It is referred to as SensAND ADT machine here, 
consisting of a filtering unit and a signal processing unit, which are connected 
to each other through connections not visible externally. Figure 3.19 gives a 
schematic view at the connections between the components of ADT 
instrumental setup. This instrument is capable of driving a large variety of 
piezoelectric oscillators at a range of amplitude (0 up to 40V) at Radio 
Frequencies (RF 100 kHz to 300MHz), and recording complex (real and 
imaginary) electrical signal (current and voltage) at three frequencies 
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synchronously and sensitively (noise ~1µV/Hz½) using 12 heterodyne 
receivers.  
 
Fig. 3.20 – Schematic circuit of filtering unit. The input signal provided by the 
signal generator, is amplified and conducted to the filtering unit. Power splitter then 
splits the input signal into two signals which are filtered through low pass filters. Due 
to potential difference VQCR, a current IQCR starts flowing. The potential measurement 
points are designated with a φ. The values measured at these points are passed 
over to the signal processing unit.[169] 
In ADT experiments, the complex current and voltage signals were recorded 
at the drive frequency (first Fourier harmonic 1f) and three times the drive 
frequency (third Fourier harmonic 3f). The piezoelectric quartz oscillator acts 
as an actuator and a microphone at the same time. The driving and pickup 
electrodes are the same, i.e. only two electrodes used, as in a QCM. The 
microvolt-level third harmonic signals were separated from the powerful drive 
signal applied at the fundamental resonance by appropriate highly linear 
passive filtering network. Fig. 3.20 shows the schematic circuit of the signals 
within the filtering unit.  
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For convenience, the experimental data is reported in terms of normalised or 
scaled units, where 1 unit on the applied voltage scale corresponds to 30 V. 
SensAND control software is used to display transduced output signal. The 
recorded data was analysed using Wolfram Mathematica software.  
3.2.6.2 Microfluidic set-up 
A sample delivery system must ensure that the sensor is efficiently exposed to 
the sample. Earlier experiments with ADT machine done by                           
Ghosh et al. were done using simple batch method, wherein a droplet of 
sample was placed on the sensor surface.[148,149]  However, in all the 
experiments for this PhD project, a microfluidic flow-cell (Fig. 3.21) was used 
for sample delivery. The microscale features of the microfluidic flow-cell 
ensured laminar flow and very little mixing. This microfluidic flow-cell was 
procured from KTH, Sweden where it was specifically designed for use with 
PCB cartridge (RAPP-ID project, KTH, Sweden) on which QCRs were 
mounted. 
However, the performance of this microfluidic flow-cell was frequently 
challenged with the problem of bubble formation, which apparently affected 
the signal acquired. The problem was identified to be at the entry point of 
tubes into the flow-cell. The tubes had to be cut diagonally to fit in the              
flow-cell. Due to the difference in the diameter of the tubes and inlet/outlet of 
flow-cell bubbles were formed. Potential site of bubble formation is shown in 
Fig. 3.22 (A). This problem was resolved by increasing the diameter of both 
inlet and outlet and inserting small piece of softer tube having internal 
diameter same as the outer diameter of the harder tubes connected to sample 
reservoir (as shown in Fig. 3.22 (B) and (C). Thus, introducing the softer tube 
at the inlet and outlet eliminated the problem of bubble formation as the 
harder tubes could be inserted directly without cutting them diagonally. 
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Fig. 3.21 – Microfluidic flow-cell (A) mounted on PCB holder (B) fixed with clips. 
 
Fig. 3.22 – Microfluidic flow-cell inlet and outlet modified to solve problem of 
bubble formation. Microfluidic flow-cell (3D view) showing: (A) Potential site for 
bubble formation due to insertion of diagonally cut harder tube into the inlet; (B) Inlet 
diameter increased to incorporate softer tube (outer) into which harder tube (inner) is 
inserted, (C) Cut section of inlet showing circumferences of outer softer tube and 
inner darker tube. Inner circumference of softer tube is same as outer circumference 
of harder tube. 
3.3 Linking bio-receptor with the transduction system 
3.3.1 Formation of Self Assembled Monolayer (SAM) on gold electrode 
Self-assembled monolayer is a highly ordered film, exactly one molecule thick 
that forms on a solid support. The experimental conditions more often 
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implemented for preparing SAMs yield organic interfaces having reproducible 
and desired functional behaviours. Molecules that form SAM (Fig. 3.23) 
usually have one group that binds to the substrate, a “chain” in the middle that 
helps them pack tightly by van der Waals forces, and a head group that 
endows the modified surface various desirable properties (e.g., hydrophobicity 
or hydrophilicity, chemical reactivity, bio-specificity or biological resistance). 
Thus, the selection of surface terminal group depends on the preferred 
properties required for immobilising the target analyte. Thiols and disulphides 
form SAMs on various metals including gold which is the mostly widely used 
substrate. Figure 3.24 depicts the steps used for adsorption of alkane thiols 
on the surface of gold electrode.[170]  Since biotin terminal group was chosen 
for experiments, the cleaned gold electrodes of the QCRs were immersed in 
about 250 µl of 1mM ethanolic solution of mixture of thiols [biotin terminal 
group (10%), and methoxy terminal group (90%)] and left overnight for 
formation of a mixed self-assembled monolayer (SAM) with good monolayer 
packing. 
 
Fig. 3.23 – Self-assembled monolayers (SAMs) formed by adsorption of 
alkanethiols, X(CH2)nSH, onto gold substrate. Adapted and modified from [171]. 
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Fig. 3.24 – Adsorption of alkanethiols on the surface of gold electrode. Adapted 
and modified from [172].  
3.3.2 Streptavidin Biotin interaction 
Streptavidin is a basic tetrameric protein isolated from Streptomyces avidinii. It 
binds tightly to biotin, a small vitamin ligand. The association constant 
between biotin and streptavidin is about 1015, highest known in biochemistry. 
A combination of high affinity, binding capacity, reproducibility, and chemical 
resistance makes the biotin streptavidin system ideal for sensor-based 
bioassays.[173] Moreover, biotin-group can be incorporated into 
oligonucleotides sequences and these biotinylated bio-receptors are easily 
available.  
Optimum orientation of the bio-receptor can also be achieved through the 
streptavidin biotin interaction that can enhance biosensor performance, as the 
recognition sites are not sterically hindered.[174] Thus, streptavidin was 
selected as bio-molecule of choice to be linked to the other end of the thiol 
through biotin 
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3.3.3 Immobilisation of bio-receptor on the gold electrode 
The bio-receptor immobilisation step is critical in the development of any kind 
of biosensor. After coating the surfaces with streptavidin, biotinylated              
bio-receptors (antibodies and aptamers) were immobilised on the surfaces of 
gold electrodes. Immobilisation steps of different bio-receptors are described 
in respective chapters.  
3.4 Stability of baseline measurements of transduction system 
Baseline measurements are taken before introducing target analyte on the 
sensor functionalised with corresponding bio-receptor. For the comparability 
purposes, it is imperative that baseline is measured under the same 
conditions as that after passing analyte. Baseline values essentially represent 
the noise in the system. Therefore, baseline stability is important to get better 
signal-to-noise ratio after introduction of the target analyte.  
To achieve baseline stability following measures were taken. Before any 
experiment, the QCR was warmed up for at least 30 mins.  For the QCR to 
warm up, the PCB cartridge had to be plugged into the machine, and the 
crystal had to be mounted on the PCB. After ensuring proper clamping and no 
bubble in the system, the surface was acoustically cleaned by flowing PBS 
buffer at high flow rate (~100 µL/min) and by taking intermittent constant 
amplitude scans at 0.5 SU for 30 seconds. By following the above steps, a 
stable baseline could be achieved.  
Sometimes conducting liquids can provide a short circuit between the QCR 
electrodes; if not prevented, the QCR stability can be severely degraded. 
Hence, simple solution was applied, to dry the bottom surface of the crystal 
before placing the crystal on the PCB shielded from the solution on the top 
surface of the QCR. Changes in hydrostatic pressure due to turbulence while 
withdrawing liquids using syringe can also cause unwanted signal variations 
due to crystal stress and sometimes degrade QCR baseline stability. Hence, a 
syringe pump procured from Harvard Apparatus (UK) was used to withdraw 
fluids at steady flow rate to minimize variances in these effects.  
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3.5 Summary  
Linking suitable bio-receptor to the transduction system of choice is the most 
critical step determining the performance parameters of the biosensor 
assembly. In this chapter, before linking the bio-receptor to the QCR that 
vibrates in thickness shear mode and transduces anharmonic acoustic signal, 
optimal experimental procedures were achieved and objective O.1.1 was 
attained. Energy trapping effect was explored to obtain sensitive ADT signal 
by loading the QCR with central gold deposit. The Kanazawa response of this 
QCR with loaded (stepped) electrode was validated. Different modes scan 
were tested i.e. AMS and FMS, out of which FMS mode scan was selected for 
further measurements. Also, the QCR was integrated with microfluidic set-up 
and the problem related to bubble formation that affected the ADT signal was 
resolved. The interface between the transducer and the bio-receptor plays 
important role, influencing the generation of anharmonic acoustic signal. 
Biotin-streptavidin bioassay format was selected to ensure optimum 
orientation of the bio-receptor, thereby, enhancing the performance of the 
biosensor assay. The surface cleaning method of gold electrodes was 
validated and measures to achieve baseline stability were identified, before 
performing experiments with E.coli bacteria which are described in next 
chapters. 
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Chapter 4 Detection of bacteria using anharmonic acoustic 
aptasensor 
4.1 Introduction 
Rapid and conspicuous detection of specific pathogens is regarded as the 
greatest challenge to combat AMR. Target detection in biosensor-based 
diagnostic methods relies on successful bio-recognitions. Ligands having high 
affinity and specificity make diagnosis exact and efficient.[175] In                 
biosensor-based diagnostic methods, it is vital to identify appropriate            
bio-receptor targeting bacteria, which can be then potentially coupled with the 
transducer. The right combination would then expedite diagnosis and thus 
decreasing the time between culture collections to specific antimicrobial 
treatment. Antibodies have been commonly used as ligands in diagnostics 
due to their target specificities and affinities.[176] However, their intrinsic 
properties as proteins confer a number of shortcomings, such as, production 
via animal immunization, labour-intensive and time-consuming production 
process, expensive, inter-batch variation, sensitivity to temperature, 
irreversible denaturation, and limited shelf-life, etc.[177] Therefore, aptamers 
have been developed that can be used instead of antibodies. Aptamers are 
composed of single-stranded oligonucleotides (ssDNA or ssRNA), and exhibit 
highly selective and specific binding affinities for target molecules.[178] While 
aptamers are analogous to antibodies in their range of target recognition and 
variety of applications, they possess several key advantages over their protein 
counterparts. Therefore, in this chapter for the first time ‘aptamer’ as                     
bio-recognition element, have been coupled with anharmonic acoustic 
transduction technique for detection of target E.coli bacteria. 
4.2 Background 
The biosensor-based diagnostic methods exploit the distinctive properties of a 
biological recognition event on a transducing device. Bio-receptor is the 
distinguishing feature of a biosensor and comprises recognition system of the 
sensor toward target analyte. Antibody-based detection methodologies are still 
considered the standard assays in environmental, food and clinical analysis. 
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But, though very commonly used, antibodies are posed with lot of limitations 
like, batch-to-batch variation in the production of antibody, and difficulty in 
generating even specific monoclonal antibodies, especially against                      
non-immunogenic molecules. These drawbacks has lead several groups to 
consider using other recognition molecules like artificial DNA or RNA 
sequences as the screening ligand. However, these new single-stranded 
oligonucleotides (DNA or RNA molecules) work in an entirely different manner 
compared to earlier DNA or RNA microarrays, in that the ligand binding 
capacity is the result of the oligonucleotides’ three-dimensional conformation, 
not nucleotide base–base complementarity.[179]  
4.3 Aptamers as bio-receptor 
These new synthetic ssDNA or ssRNA ligands, known as aptamers, have 
been defined in the Encyclopaedia of Analytical Chemistry as artificial nucleic 
acid ligands that can be generated against amino acids, drugs, proteins and 
other molecules.[179,180] Aptamers are usually 20–80 nucleotides with 6–30 
kDa molecular weights, that can fold into unique three-dimensional 
conformations characterised by stems, loops, bulges, hairpins, pseudoknots, 
triplexes, or quadruples as shown in below Fig. 4.1.[181] Based on their three-
dimensional structures, aptamers can well-fittingly bind to a wide variety of 
targets from single molecules to complex target mixtures or whole organisms.  
Aptamers are mostly unstructured in solution, but they fold upon associating 
with their target into three-dimensional structures as shown in Fig. 4.2. Similar 
to conformational recognition that mediates antibody–antigen recognition and 
complex formation, aptamers bind to their targets using high-specificity and 
high-affinity through van der Waals forces, hydrogen bonding, electrostatic 
interactions, stacking of flat moieties and shape complementarity. Thus, 
aptamers are also referred to as “chemical antibodies”.[182]  
In 1990, two labs independently identified nucleic acids (aptamers) specifically 
binding to their targets. Gold lab used the term SELEX for their process of 
selecting RNA ligands against T4 DNA polymerase; and the Szostak lab, 
coined the term in-vitro selection, selecting RNA ligands against various 
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organic dyes. The Szostak lab also coined the term aptamer (from the 
Latin, apto, meaning 'to fit') for these nucleic acid-based ligands.[183-185]  Since 
then, a variety of aptamers have been generated against number of targets. 
Aptamers can be used to detect any target ranging from simple small 
molecules such as dyes[186], ATP[187], metal ions[188], to complex protein[189-192] 
to whole organism.[193-195]  
 
Fig. 4.1 – Tertiary structures of aptamers adopted after binding to their target 
molecules. Adapted and modified from [181]. 
 
Fig. 4.2 - Schematic diagram of aptamer conformational recognition of targets 
to form an aptamer-target complex. Adapted and modified from [182]. 
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SELEX method 
Systematic Evolution of Ligands via Exponential Enrichment (SELEX) is the           
gold-standard methodology for developing specific aptamers. In principle, the 
conventional SELEX process includes multiple rounds of exponential 
amplification and enrichment, which allows evolution of aptamers with high 
target-specific affinity from a random oligonucleotide pool.[182]  
The steps involved in SELEX process to successfully generate target-specific 
aptamers are as follows (Fig. 4.3): First a single-stranded DNA or RNA 
oligonucleotide pool or library is carefully designed and chemically 
synthesised. The pool or library is comprised of 1014–1015 random sequences, 
with a centralised random sequence (35–50 nucleotides long) flanked by fixed 
sequences at either end which served as primer binding domain during 
PCR[183-185]; the random sequences prepared in the initial pool fold into 
different secondary and tertiary structures.  
They are then then incubated with targets (immobilised or free) under optimal 
conditions to form aptamer-target complexes; unbound sequences are 
separated from target-bound sequences through different methods, such as 
membrane filtration, affinity columns, magnetic beads, or capillary 
electrophoresis;  target-bound sequences are then amplified by PCR, and 
reaction products are used as a new aptamer sub-pool for the next selection 
round; the enriched aptamer sequences are identified by high-throughput 
sequencing methods.  
Several negative-target selections (counter-selections) are added to the 
process that can eliminate nonspecific sequences generated by their binding 
to non-target moieties. Specific aptamers can be obtained after 8–20 rounds 
of selection, with the entire process taking weeks to months. Thus, aptamers 
can be selected using a relatively rapid in-vitro selection process and can be 
inexpensively synthesized. 
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Fig. 4.3 - Schematic diagram of the SELEX process to generate target-specific 
aptamers. Adapted and modified from [182]. 
Although, both DNA and RNA aptamers can adapt a three dimensional 
structure, and give rise to binding pockets for their respective targets,[196]  RNA 
aptamers are versatile and have generally superior binding affinity and 
specificity than DNA aptamers due to the frequent occurrence of modified 
nucleotides within their structure, their base pairing properties and their 
tendency to form intricate three-dimensional structures.[197,198] But the 
production of RNA aptamers is very expensive as the SELEX process 
requires the synthesis of random oligonucleotide libraries which is costly. 
Therefore, an in-vitro transcription step is introduced in the SELEX procedure 
to obtain the initial RNA pool. As opposed to this, the selection procedure for 
DNA aptamers is simpler and inexpensive pools (libraries) of DNA 
oligonucleotides can be chemically synthesized and contain only                  
single-stranded sequences as opposed to the initial double-stranded pool of 
DNA sequences required for the in-vitro transcription step used for            
RNA-based aptamer selection. Furthermore, reverse transcription is not 
required and an asymmetric PCR step is sufficient to recover the sub-library of 
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ligand-binding aptamers needed to proceed to the next round of selection.[199] 
Also, RNA aptamers are more susceptible to nuclease degradations than 
DNA aptamers. Some researchers have tried to stabilise the RNA aptamers 
by modifying them but it had negative impact on their binding affinities.[200,201] 
For these reasons, ssDNA aptamers were chosen to be used as                   
bio-recognition element to be coupled with ADT for detection of E.coli 
bacteria. 
Advantages over antibodies 
Single-stranded DNA aptamers have high affinity and specificity toward their 
targets that is comparable to antibodies. Additionally, they have several 
advantages over antibodies. Aptamers can be easily generated by chemical 
synthesis, which not only excludes any batch-to-batch variations but also 
reduces the cost and the time needed for production.[202] Aptamers can be 
identified even for non-immunogenic targets, as the SELEX process can be 
performed completely in-vitro and independent of living, contrary to antibodies 
which are limited to physiologic conditions by animal immunisation. Also, 
antibodies undergo irreversible denaturation at room temperature or higher, 
while aptamers are more thermostable can reform to their original 
conformations when optimal temperature is restored.[203] Likewise, aptamers 
have dissociation constants that can reach as low as the picomolar–
femtomolar range.[204-206]  
As they are nucleic acids, different functional groups (e.g., thiol or amino) can 
be easily incorporated onto the 3’ and/or 5’ ends of oligonucleotides during 
synthesis and employed for immobilisation on substrates. In the same way, 
variety of labelling molecules (e.g., biotin, fluorescent tags) can also be 
covalently attached and serve as reporters in bio-sensing applications.[203,207] 
Moreover, aptamers are very specific as they can discriminate even between 
highly similar molecules, such as theophylline and caffeine, which differ by 
only a methyl group.[208,209] Therefore, due these attractive features, aptamers 
are very suitable to be used in bio-sensing applications.  
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Application of aptamers as ‘aptasensors’ 
When aptamers are used as biological recognition element for specific target 
analyte to form a stable complex, the device together with transducer is called 
aptasensor. Thus, the so-called aptasensors (aptamer-based biosensors) are 
expected to be one of the most promising devices in bio-sensing 
applications.[210] Similar to immunoassays, aptamer-based bioassays can 
adopt different assay configurations to produce a clear signal and are suitable 
for nearly all antibody-based designs. Since, aptamers can be generated 
against range of targets, many aptamer-based bioassays have been 
developed for application in medical diagnostics, food and environmental 
analysis, etc.[211-214] Aptasensors have also been developed, in which 
aptamers are immobilised on the substrate and different biosensing 
techniques are used for detecting target-binding, for e.g., electrochemical or 
optical systems such as fluorescence[215], surface plasmon resonance[216], 
quartz crystal microbalance [217], or cantilever.[218,219] Efficient immobilisation at 
high density is also possible due to their small size and versatility, which is 
essential for multiplexing for miniaturized systems.[220] Aptamers are 
chemically stable and confer greater stability which is one of the important 
aspects for biosensor development. However, aptamer technology in 
biosensors remains in an early phase of development. As a result, there 
remains a need to combine aptamers and their potential biosensors to tackle 
the numerous challenges of the currently limited conventional diagnostic 
methods. Therefore, for the first time ‘aptamer’ was coupled with the ADT 
technique (advantages discussed in chapter 2), to harness the benefit of this 
unique combination for detection of target bacteria.  
4.4 Aptamer for E.coli bacteria 
Escherichia coli (E.coli) bacteria is part of large family of gram-negative 
bacteria viz. Enterobacteriaceae and is referred to as entero-bacteria or 
"enteric bacteria", as several members live in the intestines of people and 
animals. It has been reported that gram-negative bacteria possess a 
negatively-charged outer membrane that can repel nucleic-acid molecules 
due to which it is difficult to generate aptamers that bind to the surface 
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molecules of bacterial cells. Moreover, bacteria have short generation times 
leading to rapid changes in protein expression and high surface variation 
between cultures and colonies. Such variation can hinder consistent 
measurement of aptamer binding.[221] 
Nevertheless, some ssDNA aptamers against E.coli bacteria have recently 
been reported. Peng et al. enriched ssDNA library specific for E.coli K88 
bacteria.[222] This group further isolated ssDNA with high affinity and specificity 
against K88 fimbriae protein, selected after 11 rounds.[223] Bruno and                  
co-workers have selected DNA aptamers against the endotoxin 
lipopolysaccharide (LPS) and the outer membrane protein of E.coli 
bacteria.[224,225]  Savory et al. identified ssDNA with high specificity and affinity 
for an  uro-pathogenic strain of E.coli bacteria.[226] Wu et al. reported the 
development of aptamer-based biosensors (aptasensors) based on label-free 
aptamers and AuNPs for the detection of E.coli O157:H7 and S.typhimurium, 
with the aim of establishing a preliminary method to evaluate the utility of 
aptamer-AuNPs assay for enteropathogenic bacteria.[227] 
Single-stranded DNA aptamers targeting bacteria can be classified into two 
general categories, (1) targeting whole cells with known or unknown molecular 
targets and (2) targeting predefined bacteria cell surface targets or bacteria 
spores.[228] Whole-living cell SELEX conserves two major advantages:                  
(1) selection without a prior purification of the targets and (2) conservation of 
membrane proteins in their native conformation similar to the in-vivo 
conditions. It is also well-known that there is difference in the bacterial cell 
membrane because they express different sets of molecules at different 
growth states. This impedes with the consistent measurement of the aptamer 
binding as detection of bacteria based on the single surface molecule or 
protein might omit the positive bacteria which happen to negatively express 
specific molecules or express mutated ones.[229] Consequently, it was decided 
to obtain polyvalent ssDNA aptamers targeting whole cells of E.coli bacteria. 
To obtain ssDNA aptamers targeting whole bacterial cells, whole-cell SELEX 
method is used. It was beyond the scope of this project to perform whole-cell 
SELEX method to get ssDNA aptamers for E.coli bacterial cells. Therefore, 
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alternative option was to use the already reported aptamer sequences in 
literature for capturing E.coli bacteria. 
Kim et al. had isolated four sequences of ssDNA aptamers against E.coli 
bacteria using a whole bacterial cell–SELEX process and characterised their 
affinity and selectivity to other E.coli strains and faecal coliform bacteria 
cells.[220,230] They performed 10 rounds of selection against a faecal strain of 
E.coli along with multiple negative selections against other species of 
bacteria. They identified four candidate sequences with high affinity for the 
target strain.  
All four candidates were highly selective against negative target bacteria. Out 
of them the one with strong fluorescent intensity at the saturation point was 
selected to be coupled with ADT transduction method. The ssDNA aptamer 
consists of a central random region of 45 nucleotides flanked by two different 
constant sequences at the 3′ and 5′ ends: 5′-GCAATGGTACGGTACTTCC-
N45-CAAAAGTGCACGCTACTTTGCTAA-3′ (88-mer) with fluorescein (FITC) 
at 5’ end [5′-fluorescein-GCAATGGTACGGTACTTCC-3′ (19-mer)] and Biotin 
TEG at 3’ end [CAAAAGTGCACGCTACTTTGCTAA-3′- Biotin TEG (24-mer)]. 
4.5 Binding experiment  
Binding of ssDNA sequence to E.coli (KCTC 2571) bacterial strain were 
assessed by measuring fluorescence intensity.  
Bacterial strain and culture conditions: 
E.coli (KCTC 2571) strain reported to bind the selected ssDNA aptamer, was 
procured from Microbial Resource Centre, Korean Collection for Type Culture 
(KCTC), Korea Research Institute of Bioscience and Biotechnology. The 
E.coli (KCTC 2571) strain cultures were supplied by KCTC in lyophilised 
powder form which was further re-activated and cultured at 37°C. E.coli 
(KCTC 2571) strain lyophilised cultures were re-activated by breaking open 
the ampoule containing them by following steps showed in Fig. 4.4. The 
lyophilised powder was added to nutrient broth media and was cultured 
overnight in incubator with mild shaking. Next day, the colonial growth               
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(18 – 24 hours) of pure culture was inoculated with cryopreservative in 
Microbank™ cryovials and stored in freezer at -80°C. 
 
Fig. 4.4 – Procedure for breaking open the ampoule and re-activating 
lyophilized cultures of E.coli (KCTC 2571) bacterial strain. 
Reagents: 
a) Binding buffer was prepared with 0.1 mg/ml salmon sperm DNA, 1% 
bovine serum albumin [BSA], 1× phosphate-buffered saline [PBS], and 
0.05% [v/v] Tween 20. 
b) Washing buffer was prepared with 1× PBS and 0.05% [v/v] Tween 20. 
Method: 
Microplate wells were first washed with 150 µL of 5% BSA in PBS overnight at 
4°C and next day washed with washing buffer. E.coli (KCTC 2571) was 
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cultured in nutrient broth to middle growth phase (OD600 of 0.45) and 
centrifuged at 13,000 rpm for 10 mins to remove the media. Subsequently, 
bacterial cells at concentration 107 E.coli/mL were incubated with different 
amounts of both the fluorescein-labelled ssDNA aptamers (0, 5, 12.5, 25, 500, 
125, and 250 nM as final concentrations) in 1 ml of binding buffer for 45 mins 
at 25 °C with mild shaking. Cells were washed two times to remove unbound 
ssDNA aptamers from cells by centrifugation (13,000 rpm for 10 mins) and 
were re-suspended in 1 ml of washing buffer. Finally, the fluorescence 
intensity of each sample was measured with BMG FLUOstar Omega 
microplate reader (at excitation 485 nm and emission 520 nm wavelengths). 
The fluorescence intensity was compensated by subtraction with the 
fluorescence intensity of blank and then by division with respective gains. 
  
Fig. 4.5 – Binding saturation curve obtained by fluorescence analysis for E.coli 
binding aptamer with Kd value of 11.8 nM obtained by nonlinear regression 
model. 
Results and discussion: 
Fluorescent intensities of each sample of E.coli (KCTC 2571) strain bacteria 
mixed with different concentrations of fluorescein-labelled ssDNA (0, 5, 12.5, 
25, 500, 125, and 250 nM as final concentrations) were measured. Binding of 
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ssDNA sequences to E.coli (KCTC 2571) strain were assessed. To estimate 
the affinity of the selected ssDNA to target cells, the fluorescence intensity 
versus the added ssDNA concentration was plotted. The resultant saturation 
curve was then fitted by nonlinear regression analysis, and the dissociation 
constant was calculated. The dissociation constants (Kd) was estimated to be 
11.8 nM (as shown in Fig. 4.5), which was found to be close to the Kd value of 
12.4 nM, as reported in literature.[230] Thus, binding of the reported ssDNA 
aptamer to the target E.coli (KCTC 2571) bacteria was confirmed by 
measuring fluorescence intensity. 
4.6 Linking the bio-receptor to the QCR 
4.6.1 Cleaning the surface of gold electrode  
AT-cut stepped (non-uniform) quartz crystals were used with fundamental 
resonant frequency range of 14.23 -14.25 MHz (Lap-Tech Inc., Bowmansville, 
Ontario, Canada). The surfaces of gold electrodes of quartz crystals were 
cleaned with acetone for 5 mins and then with isopropanol (IPA) by                       
ultra-sonication process for 5 mins. Then after drying with nitrogen gas, they 
were placed in plasma cleaner to remove impurities and contaminants from 
the surface using inert argon gas for 1 min in a Harrick Plasma cleaner. They 
were then stored in a well of clean 24-well tissue culture plate covered with 
plastic film.  
4.6.2 Formation of self-assembled monolayer (SAM) 
The cleaned quartz crystals were then immersed in about 250 µl of 1mM 
ethanolic solution of mixture of thiols [biotin terminal group (10%), and 
methoxy terminal group (90%)] and left overnight for formation of a             
SAM. Thiols with biotin terminal group HS-C11-(EG)6-Biotin (th004-m11.n6-
0.005) and methoxy terminal group HS-C11-(EG)3-OCH3 (th006-n3) were 
obtained from Prochimia Surfaces, Poland. The following day, the gold 
surfaces of quartz crystals were rinsed three times with ultra-pure ethanol 
(Sigma-Aldrich, UK) for removing the non-adsorbed thiols and then both sides 
of crystal were dried with a stream of nitrogen gas. After making sure that the 
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electrode on bottom side was completely dried, the crystal was mounted on 
PCB cartridge and sealed with “O-ring” of microfluidic flow-cell with only one 
face exposed to the solution. The gold surfaces were then rinsed with                  
de-ionized (DI) water to remove ethanol followed by phosphate buffer saline 
(PBS) with physiological pH 7.4. 
4.6.3 Deposition of Streptavidin  
PBS buffer solution (100 µL) was then flowed over the substrate at the 
continuous flow rate of 10 µL/min and baseline measurements were taken for 
15 mins at 5 min interval (Fig. 4.6 Step-1). This was followed by about 150 µl 
of Streptavidin (10 µg/mL) for 15 mins at the flow rate of 10 µL/min; thus 
forming a strong bond with the biotin terminal group of the alkane thiol. 
Measurements were taken under flow for 15 mins at 5 min interval (Fig. 4.6 
Step-2). 
4.6.4 Immobilisation of bio-receptor on the gold electrode of QCR 
After depositing streptavidin, PBS buffer solution (500 µL) was then flowed 
over the substrate at the continuous flow rate of 100 µL/min for 5 mins, to 
remove the unbound streptavidin. Then the surface was functionalised with 
biotinylated E.coli-binding ssDNA aptamer, by passing over the surface for 15 
mins (Fig. 4.6 Step-3). The excess aptamers were removed by flowing PBS 
solution and then baseline measurements were taken every 5 minutes over 30 
minutes under a continuous flow of PBS at flow rate of 5 µl/min.  
After this, in order to detect E.coli (KCTC 2571) bacteria by direct assay, 
different concentrations of bacteria were spiked into the sample over the 
prepared sensor surface at a flow rate of 5 µl/min for further 60 mins (Fig. 4.6 
Step-4). 
4.7 Step-wise characterisation 
When aptamers i.e. single stranded oligonucleotides are used as biological 
recognition element for specific analytes (antigens) to form a stable complex, 
the device together with transducer is called ‘aptasensor’. Here, for the first 
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time the anharmonic acoustic transducer ADT was coupled with aptamers as 
bio-receptor for detection of E.coli bacteria. The resultant aptasensor was 
characterised step-by-step (as depicted in Fig. 4.6) with the admittance 
analysis. 
To determine the viscoelastic properties of the bound surface mass on QCR 
surface, the measured admittance data points were fitted to the BVD model to 
extract the values of the three equivalent circuit parameters Q (quality factor), 
Rm (motional resistance), and f0 (Resonance frequency). Out of these, 
frequency (Δf) and dissipation (ΔD) spectra of the same quartz crystal were 
monitored that were subjected to different treatments as shown in Fig 4.6. 
 
Fig. 4.6 - Functionalisation steps – (1) Mixed SAM with 10% biotin thiol and 90% 
methoxy thiol, (2) Streptavidin layer, (3) Biotinylated ssDNA aptamer and (4) final step of 
flowing the E.coli (KCTC 2571) bacteria.  
 
The frequency shift is reported in Hz whereas the dissipation shift is plotted in 
terms of arbitrary units (a.u). When streptavidin is injected into the flow-cell, 
frequency shift of Δf (~ 150 Hz) and dissipation (a.u) shifts are observed (Fig. 
4.6 Step-2). Large Δf (~ 275 Hz) and ΔD (a.u) are observed during the 
biotinylated aptamer immobilisation step due to the more mass going on the 
surface. Following aptamer binding, any unbound aptamer was removed from 
the flow-cell by rinsing with PBS. After taking baseline measurements, the  
bio-interface was used for detection of the target bacteria. When                           
E.coli (KCTC 2571) bacteria are spiked and it enters the flow chamber and 
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binds to the immobilised aptamers (Fig. 4.6 Step-4), an increase in the 
resonance frequency and a corresponding increase in the dissipation signal of 
the functionalised sensor crystal are observed. The positive frequency shift is 
conceivably due to flexible binding of bacteria to immobilised ssDNA aptamer. 
It has been reported earlier by Olsen et al. that when attachment is flexible, as 
observed for bacteria, the sensor signals are inversely proportional to 
additional mass, and is probably determined by interfacial viscoelasticity and 
acoustic and electro-magnetic coupling.[231] Pomorska et al. have also 
reported that the QCR most likely probes the contact strength, rather than the 
mass of the particle.[232] The E.coli-binding ssDNA aptamer used here have 
been isolated by whole bacterial cell–SELEX process and its possible binding 
targets on E.coli surface may be the components of outer cellular membrane 
of E.coli such as LPS, outer membrane proteins, and flagella. The flexibility 
can perhaps be attributed to the binding of aptamer to target 'flagella’ on the 
surface of E.coli bacteria. The bacteria thus have a high degree of freedom 
and the displacements of crystal particles may not be in phase with the 
displacements of the bacteria. This causes stretching of the bonds and thus 
causing a positive frequency shift (anti-Sauerbrey effect). 
 
Fig. 4.7 – Resonant frequency (Δf) spectra of the QCR monitored that was 
subjected to the stepwise treatment as shown in fig. 4.6 
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Fig. 4.8 - Dissipation (ΔD) spectra of the QCR monitored that was subjected to 
the stepwise treatment as shown in fig. 4.6 
4.8 Determination of drive amplitude 
The surfaces of the QCR were functionalised with E.coli-binding aptamers, 
and then rinsed with PBS buffer. After taking baseline measurements,            
107 E.coli/mL (as final concentrations) were spiked into the sample and 
passed over the prepared sensor surface at a flow rate of 5 µl/min for 60 
mins. Resonant frequency (f0) was determined with frequency sweep and the 
sensor was then driven by a pure sinusoidal oscillation at f0 in frequency mode 
scan, at different amplitudes ranging from 0.1 to 0.5 SU. The complex values 
(in-phase and quadrature) of current and voltage were recorded at 1f and 3f 
simultaneously using the ADT machine. The percentage shift in the peak 
values of the corresponding 3f signal (I3fmax) from baseline, are plotted over 
time (Fig. 4.9) and at 60 mins (Fig. 4.10). Maximum shift was observed at             
0.1 SU which corresponds to excitation voltage of 3 Volts and 7.5 nm of 
oscillation amplitude at surface.[233,234] But the value of oscillation amplitude 
seems to have inverse relation with corresponding 3f signal. At 0.2 SU (6 
Volts) 3f signal dropped despite increase in oscillation amplitude. Thus, 0.1 
SU was selected for further measurements as it gave maximum 3f signal.  
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Fig. 4.9 - I3fmax shift (%) measured at different amplitudes – 0.1 to 0.5 SU over 60 
mins, after passing 107 E.coli/mL on the surface functionalised with aptamers.  
 
Fig. 4.10 - I3fmax shift (%) measured at different amplitudes – 0.1 to 0.5 SU at 60 
mins, after passing 107 E.coli/mL on the surface functionalised with aptamers. 
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4.9 Detection of E.coli bacteria with anharmonic acoustic aptasensor 
After determining the optimal drive amplitude, triplicate sets of experiments 
were carried out with a range of E.coli bacterial concentrations. In order to 
detect E.coli (KCTC 2571) by direct assay, different concentrations of bacteria 
were spiked into the sample (105 - 108 cells/mL as final concentrations) over 
the prepared sensor surface at a flow rate of 5 µl/min for further 60 mins. A 
total of 3x104, 3x105, 3x106 & 3x107 bacterial cells were therefore injected 
over 60 mins, respectively. To check specificity of the sensor, S.typhi bacterial 
samples were also used at 10 times the concentration of E.coli bacteria. Thus, 
108 cells/mL as final concentrations of S.typhi bacteria were also spiked into 
the sample over the prepared sensor surface at a flow rate of 5 µl/min for 
further 60 mins. As a control, only PBS buffer solution was also flowed and 
baseline measurements were taken. Frequency mode scans were taken at 
0.02 SU and 0.1 SU (0.1s period) and Δf0, ΔD and ΔI3fmax were simultaneously 
monitored in real time during streptavidin and aptamer immobilisation and 
E.coli detection using a quartz crystal nonlinear network analyzer. All the 
measurements were taken in continuous flow mode.  
Relative decrease in peak values of ΔI3fmax (% shift) from baseline are plotted 
over 60 mins for which the E.coli bacteria were flowed over the sensor surface 
after achieving the baselines, as shown in the Fig. 4.13. This relative 
decrease in ΔI3fmax was compared with the increase in resonant frequency 
(Δf0) and the relative increase in dissipation values ΔD. Fig. 4.11 and Fig. 4.12 
depict the frequency shift and dissipation shift over 60 mins after introducing 
the E.coli bacteria over the surface functionalised with E.coli-binding 
aptamers.  
It was observed that the measurements were less noisy with lower coefficient 
of variation for ΔI3fmax compared to Δf0 and ΔD measurements over time. Also, 
the signal-to-noise ratio was comparatively higher for ΔI3fmax compared to Δf0 
and ΔD measurements. 
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Fig. 4.11- Frequency shift (Hz) as a function of time with bacterial suspension 
of different concentrations (cells/mL) over the surface functionalised with 
aptamers.  
 
Fig. 4.12 - Dissipation shift (%) as a function of time with bacterial suspension 
of different concentrations (cells/mL) over the surface functionalised with 
aptamers. 
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Fig. 4.13 – I3fmax shift (%) as a function of time with bacterial suspension of 
different concentrations (cells/mL) over the surface functionalised with 
aptamers. 
For all the three parameters, shift in the respective values are plotted at 5 
mins (please see Fig. 4.14, 4.16 and 4.18) and 30 mins (please see Fig. 4.15, 
4.17 and 4.19). Also, the shifts measured at 60 mins at the end of the 
experiment are given in the table 4.2 for all the three parameters with mean 
values and standard deviations. About 106 E.coli/mL bacteria could be reliably 
and rapidly detected with 3f signal (ΔI3fmax) at 5 mins (i.e. 2.5 x10
4 bacteria) 
than with Δf0 and ΔD; as the 3f signal was much higher (x 250.228) than that 
observed for 100 times the concentration of S.typhi bacteria at 5 mins. Signal 
observed with Δf0 (x 0.315) and ΔD (x 1.029) was comparatively much less at 
5 mins for 106 E.coli/mL bacteria with respect to 108 S.typhi/mL. Quantitative 
correlation could be also achieved with only I3fmax. Thus, ADT technique 
enables reliable and rapid quantitative detection of bacteria as compared to 
standard frequency shift and dissipation shift measurements. 
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Fig. 4.14 - Frequency shift (Hz) at 5 mins with E.coli bacterial suspension of 
different concentrations (cells/mL) over the surface functionalised with 
aptamers. 
 
Fig. 4.15- Frequency shift (Hz) at 30 mins with E.coli bacterial suspension of 
different concentrations (cells/mL) over the surface functionalised with 
aptamers. 
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Fig. 4.16 - Dissipation shift (%) at 5 mins with E.coli bacterial suspension of 
different concentrations (cells/mL) over the surface functionalised with 
aptamers. 
 
Fig. 4.17 - Dissipation shift (%) at 30 mins with E.coli bacterial suspension of 
different concentrations (cells/mL) over the surface functionalised with 
aptamers. 
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Fig. 4.18– I3fmax shift (%) at 5 mins with E.coli bacterial suspension of different 
concentrations (cells/mL) over the surface functionalised with aptamers. 
 
Fig. 4.19 - I3fmax shift (%) at 30 mins with E.coli bacterial suspension of different 
concentrations (cells/mL) over the surface functionalised with aptamers. 
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Table 4.2 – Mean values and standard deviations measured after 60 mins*  
At 60 mins 
Δf0 ΔD ΔI3fmax 
Mean S.D Mean S.D Mean S.D 
 Baseline 1.833 0.907 0.176 0.179 0.158 0.110 
104 Ecoli/mL 2.667 2.307 0.068 0.078 0.204 0.126 
105 Ecoli/mL 2.233 2.155 0.095 0.142 0.761 0.137 
106 Ecoli/mL 24.500 10.221 1.105 0.992 2.444 0.282 
107 Ecoli/mL 40.800 11.012 2.111 0.509 3.836 0.402 
108 Ecoli/mL 33.833 12.154 1.919 0.372 4.927 0.002 
108 Ecoli+Styphi/mL 28.933 10.450 1.736 0.34 4.857 0.126 
108 Styphi/mL 9.500 2.390 0.261 0.276 1.297 0.263 
* Triplicate set of experiments were performed for each concentration of bacteria. 
4.10 Quantitative analysis 
 
Fig. 4.20 – Signal response for different concentrations of E.coli bacteria 
(cells/mL) showing: (a) Frequency shift, Δf (Hz); (b) Dissipation shift,                 
ΔD (% shift); and (c) 3f signal, I3fmax (% shift). 
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A strong linear correlation was observed for four concentrations of E.coli 
bacteria (105-108 cells/mL) with ΔI3fmax (R
2 = 0.984) than for three 
concentrations of E.coli (105- 107 cells/mL) with Δf0 (R
2 = 0.955) and ΔD                
(R2 = 0.826); excluding higher concentration 108 cells/mL. For the highest 
concentration of E.coli of 108 cells/mL, negative frequency and dissipation 
shifts were observed. This could be due to increase in mass going on the 
surface, underlining the need for washing step with these methods. Linear 
quantitative correlation could be achieved for E.coli concentrations with ΔI3fmax, 
from the fit and this does not require washing step, as the 3f signal 
corresponds to the number of bacteria attached to the surface and not their 
mass. 
4.11 Specificity analysis 
 
Fig. 4.19 – Comparison of specificity: ratio of mean values of Δf0, ΔD and ΔI3fmax 
for baseline and different concentrations of E.coli/mL and 108 S.typhi/mL. 
Mean values of the triplicate sets of experiments conducted with each 
concentration of E.coli bacteria (105- 108 cells/mL) and S.typhi bacteria (108 
cells/mL) recorded at 30 mins, were calculated and their ratios were 
compared. These ratios for Δf0, ΔD and ΔI3fmax measurements are plotted in 
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Fig. 4.19. For same concentrations of E.coli and S.typhi bacteria (108 
cells/mL), the ratio values were, 1.01 for Δf0, 8.42 for ΔD and highest 19.02 for 
ΔI3fmax. Thus, the increase in resonant frequency and the relative increase in 
dissipation were found to be lower by 18.83 and 2.26 times than the relative 
decrease in 3f signal (I3fmax). Thus, ADT technique enables reliable specific 
detection of bacteria as compared to standard frequency shift and dissipation 
shift measurements. 
4.10 Summary 
This work investigated the behaviour of the nonlinear acoustic response of a 
QCR in the rapid detection and quantification of E.coli (KCTC 2571) bacteria 
through aptamer-based assay. In this investigation, the fabricated 
‘anharmonic acoustic aptasensor’ on gold surface of QCR electrodes was 
successful in rapid, sensitive, specific and quantitative detection of E.coli 
bacteria and met the first objective O.1 of this thesis. The response of this 
sensor was observed for the bacterial suspensions ranging from                    
105-108 cells/mL and this sensor enabled the following: 
Rapid and sensitive detection of viable whole-cell E.coli bacteria: The results 
show that the 3f signals (I3fmax) allow rapid, sensitive and quantitative 
detection of 2.5 x 104 viable E.coli bacteria in 5 mins, as compared to 
standard frequency shift (Δf0) and dissipation shift (ΔD) measurements.  
Quantitative detection of viable whole-cell E.coli bacteria: Linear quantitative 
correlation could be reliably achieved with 3f signal (I3fmax) (R
2 = 0.984) for 
four concentrations of E.coli bacteria (105-108 cells/mL), than with Δf0 and ΔD.  
Specific detection of viable whole-cell E.coli bacteria: To determine specificity, 
S.typhi bacteria were used as control sample. For the same concentrations of 
E.coli and S.typhi bacteria (108 cells/mL), the ratio values were, 1.01 for Δf0, 
8.42 for ΔD and highest 19.02 for ΔI3fmax. Thus, the increase in resonant 
frequency and the relative increase in dissipation were found to be lower by 
18.83 and 2.26 times than the relative decrease in 3f signal (I3fmax).  
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Reproducible detection of viable whole-cell E.coli bacteria: Triplicate set of 
experiments were performed to validate reproducibility after achieving stable 
baseline each time.  
To sum up, this anharmonic acoustic aptasensor which allows fast, sensitive 
quantitative detection of viable target bacteria with high specificity and 
reproducibility not only saves time but also allows subsequent AST by sparing 
intact bacteria for further characterisation. Thus, this could be applied to 
reduce the diagnostic cycle and prevent AMR. 
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Chapter 5 Detection of bacteria using bio-receptors of 
different size and length integrated with ADT 
5.1 Introduction 
In biosensors, the interaction forces between the ligand and the bio-receptor 
are very important as they determine the characteristics of the output signal. 
In chapter 4, anharmonic acoustic aptasensor detected E.coli bacteria 
sensitively and specifically due to the high affinity of the polyvalent aptamers 
towards the target bacteria and the level of selectivity of the ADT technique. In 
the ADT technique, for a given drive frequency (f), the 3f signal is dependent 
on the force-extension characteristic of the molecular tether, its length, and 
also the size of the particles. Hence, in this chapter, bio-receptors of different 
size i.e. anti-E.coli antibodies and different length i.e. thiolated E.coli-binding 
aptamer are investigated for detection of E.coli bacteria and compared with 
the E.coli-binding aptamer with long linker length (biotinylated aptamer).  
5.2 Background 
It has been demonstrated earlier that the deviation of the 3f signal depends on 
the mechanical characteristics of the linker and also its length.[146-149] In the 
previous chapter, the nonlinear acoustic response of QCR was probed with 
functionalised specific DNA aptamers that are multivalent and bind whole 
bacterial cell for direct detection and quantification of viable E.coli KCTC 2571 
bacteria. This anharmonic acoustic aptasensor could directly detect                       
107 cells/mL target bacteria within 5 mins and had high specificity towards 
E.coli (KCTC 2571) bacteria as compared to same concentration of S.typhi 
bacteria. Aptamers are smaller in size in comparison to antibodies (8–25 kDa 
nucleic acids vs ~150 kDa antibodies). As ADT signal is influenced by the 
linker characteristics, polyclonal antibodies which are larger than aptamers 
were investigated with the same bioassay parameters used for detection of 
E.coli bacteria. Also, for the length of the linker same E.coli binding aptamers 
were employed, but instead of using biotin-streptavidin interface, thiolated 
aptamers were used that would directly bind to the sensor surface.  
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5.3 Comparison of aptasensor with immunosensor 
Polyclonal antibodies (pAb) are very commonly used as bio-receptor in lot of 
immunosensor-based assays for bacterial detection. They are typically raised 
in rabbits, goats or sheep.[235] Polyclonal antibodies raised against specific 
bacterial strains are the most commonly used bio-receptors for whole bacterial 
cell detection, where the binding targets on the cell envelope are usually 
unknown.[120] To increase the specificity and sensitivity of the sensor, isolated 
surface epitopes can be used to produce monoclonal antibodies.[236] However, 
since the aptamers used for E.coli detection are also polyvalent, polyclonal 
anti-E.coli antibodies were selected for comparison purpose. 
5.4 Linking the antibodies to the QCR 
5.4.1 Cleaning the surface of gold electrode  
AT-cut stepped (non-uniform) quartz crystals were used with fundamental 
resonant frequency range of 14.23 -14.25 MHz (Lap-Tech Inc., Bowmansville, 
Ontario, Canada). The surfaces of gold electrodes of quartz crystals were 
cleaned with acetone for 5 mins and then with isopropanol (IPA) by                     
ultra-sonication process for 5 mins. Then after drying with nitrogen gas, they 
were placed in plasma cleaner to remove impurities and contaminants from 
the surface using inert argon gas for 1 min in a Harrick Plasma cleaner. They 
were then stored in a well of clean 24-well tissue culture plate covered with 
plastic film.  
5.4.2 Formation of self-assembled monolayer (SAM) 
The cleaned quartz crystals were then immersed in about 250 µl of 1mM 
ethanolic solution of mixture of thiols [biotin terminal group (10%), and 
methoxy terminal group (90%)] and left overnight for formation of a             
SAM. Thiols with biotin terminal group HS-C11-(EG)6-Biotin (th004-m11.n6-
0.005) and methoxy terminal group HS-C11-(EG)3-OCH3 (th006-n3) were 
obtained from Prochimia Surfaces, Poland. The following day, the gold 
surfaces of quartz crystals were rinsed three times with ultra-pure ethanol 
(Sigma-Aldrich, UK) for removing the non-adsorbed thiols and then both sides 
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of crystal were dried with a stream of nitrogen gas. After making sure that the 
electrode on bottom side was completely dried, the crystal was mounted on 
PCB cartridge and sealed with “O-ring” of microfluidic flow-cell with only one 
face exposed to the solution. The gold surfaces were then rinsed with                
de-ionized (DI) water to remove ethanol followed by phosphate buffer saline 
(PBS) with physiological pH 7.4. 
5.4.3 Deposition of Streptavidin  
PBS buffer solution (100 µL) was then flowed over the substrate at the 
continuous flow rate of 10 µL/min and baseline measurements were taken for 
15 mins at 5 min interval. This was followed by about 150 µl of Streptavidin 
(10 µg/mL) for 15 mins at the flow rate of 10 µL/min; thus forming a strong 
bond with the biotin terminal group of the alkane thiol. Measurements were 
taken under flow for 15 mins at 5 min interval. 
5.4.4 Immobilisation of bio-receptor on the gold electrode of QCR 
After depositing streptavidin, PBS buffer solution (500 µL) was then flowed 
over the substrate at the continuous flow rate of 100 µL/min for 5 mins, to 
remove the unbound streptavidin.  
Then the surface was functionalised with biotinylated polyclonal anti-E.coli 
antibodies, by passing over the surface for 15 mins. The excess antibodies 
were removed by flowing PBS solution and then baseline measurements were 
taken every 5 minutes over 30 minutes under a continuous flow of PBS at flow 
rate of 5 µl/min. Rabbiy polyclonal anti-E.coli antibodies (biotin) Ab68451 
(Abcam, Cambridge, UK), were used. Aliquots of pAbs were prepared and 
stored at -20°C or -80°C to avoid repeated freeze / thaw cycles.  
The steps followed to link the biotinylated polyclonal anti-E.coli antibodies to 
the surface of gold electrodes of QCR, are depicted in Fig. 5.1. 
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Fig. 5.1 - Functionalisation steps: (1) Mixed SAM with 10% biotin thiol and 90% 
methoxy thiol, (2) Streptavidin layer, (3) Biotinylated Anti-E.coli antibody and (4) final step of 
flowing the E.coli (KCTC 2571) bacteria.  
 
 
After functionalising the surface with anti-E.coli antibodies, in order to detect 
E. coli (KCTC 2571) by direct assay, 107 cells/mL of bacteria were spiked into 
the sample (as final concentrations) over the prepared sensor surface at a 
flow rate of 5 µl/min for further 60 mins. A total of 3x106 bacterial cells are 
therefore injected over 60 mins, respectively. Frequency scans were taken at 
0.02 SU and 0.1 SU (0.1s period) and Δf and ΔD were simultaneously 
monitored in real time during E.coli detection steps using a quartz crystal 
nonlinear network analyzer. All the measurements were taken in continuous 
flow mode. 
5.5 Determination of drive amplitude 
To determine the optimal drive amplitude, the surfaces of the QCR were 
functionalised with polyclonal anti-E.coli antibodies, and then rinsed with PBS 
buffer. After taking baseline measurements, 107 E.coli/mL (as final 
concentrations) were spiked into the sample and passed over the prepared 
sensor surface at a flow rate of 5 µl/min for 60 mins.  
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Fig. 5.2 - I3fmax shift (%) measured at different amplitudes – 0.1 to 0.5 SU at 60 
mins, after passing 107 E.coli/mL on the surface functionalised with polyclonal 
antibodies (pAbs). 
Resonant frequency (f0) was determined with frequency sweep and the 
sensor was then driven by a pure sinusoidal oscillation at f0 in frequency 
mode scan, at different amplitudes ranging from 0.1 to 0.5 SU. The complex 
values (in-phase and quadrature) of current and voltage were recorded at 1f 
and 3f simultaneously using the ADT machine. The percentage shift in the 
peak values of the corresponding 3f signal (I3fmax) from baseline, are plotted at 
60 mins (Fig. 5.3). Maximum shift was observed at 0.1 SU which corresponds 
to excitation voltage of 3 Volts and 7.5 nm of oscillation amplitude at 
surface.[233,234] But the value of oscillation amplitude seems to have inverse 
relation with corresponding 3f signal. At 0.2 SU (6 Volts) 3f signal dropped 
despite increase in oscillation amplitude. Thus, 0.1 SU was selected for 
further measurements as it gave maximum 3f signal. 
5.6 Detection of E.coli bacteria with polyclonal antibodies 
After determining the optimal drive amplitude, triplicate sets of experiments 
were carried out with two concentrations of E.coli bacteria. In order to detect 
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E.coli (KCTC 2571) by direct assay, different concentrations of bacteria were 
spiked into the sample (106 – 107 cells/mL as final concentrations) over the 
prepared sensor surface at a flow rate of 5 µl/min for further 60 mins. A total 
of 3x105 & 3x106 bacterial cells are therefore injected over 60 mins, 
respectively. To check specificity of the sensor, S.typhi bacterial samples 
were also used at 10 times the concentration of E.coli bacteria. Thus, 108 
cells/mL as final concentrations of S.typhi bacteria were also spiked into the 
sample over the prepared sensor surface at a flow rate of 5 µl/min for further 
60 mins. Frequency scans were taken at 0.02 SU and 0.1 SU (0.1s period) 
and Δf0, ΔD and ΔI3fmax were simultaneously monitored in real time during 
streptavidin and polyclonal antibody immobilisation and E.coli detection using 
a quartz crystal nonlinear network analyzer. All the measurements were taken 
in continuous flow mode.  
Comparison of sensitivity 
The shifts in the respective values of I3fmax are plotted at 5 mins, 30 mins and 
60 mins (as shown in Fig. 5.5, 5.6 and 5.7, respectively). The signals with                     
106 E.coli/mL and 107 E.coli/mL were much higher at 5 mins, 30 mins and 60 
mins when compared to the signal obtained with 108 S.typhi/mL bacteria. 
Relative decrease in peak values of ΔI3fmax from baseline are plotted over 60 
mins for which the E.coli and S.typhi bacteria were flowed over the sensor 
surface after achieving the baselines, as shown in the Fig. 5.4.  
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Fig. 5.3 - I3fmax shift (%) as a function of time with 10
6, 107 E.coli/mL and              
108 S.typhi/mL over the surface functionalised with polyclonal antibodies. 
 
Fig. 5.4 - I3fmax shift (%) at 5 mins with with 10
6, 107 E.coli/mL and 108 S.typhi/mL 
over the surface functionalised with polyclonal antibodies. 
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Fig. 5.5 - I3fmax shift (%) at 30 mins with 10
6, 107 E.coli/mL and 108 S.typhi/mL 
over the surface functionalised with polyclonal antibodies. 
 
Fig. 5.6 - I3fmax shift (%) at 60 mins with 10
6, 107 E.coli/mL and 108 S.typhi/mL 
over the surface functionalised with polyclonal antibodies. 
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Comparison of specificity 
Mean values of the triplicate sets of experiments conducted with each 
concentration of E.coli bacteria (106- 107 cells/mL) and S.typhi bacteria              
(108 cells/mL) recorded at 30 mins, were calculated and their ratios were 
compared. These ratios for ΔI3fmax measurements are plotted in Fig. 5.7. For 
10 times lower concentration of E.coli than S.typhi bacteria, the ratio values 
was 3.71. This value was found to be lower than that observed with aptamer 
as bio-receptor for same bacterial concentrations (as shown in Fig. 5.17). 
 
Fig. 5.7 - Comparison of specificity: ratio of mean values of I3fmax shift for 
different concentrations of E.coli/mL and 108 S.typhi/mL. 
5.7 Comparison of the length of the linker (long vs short) 
Linkers with different lengths were investigated by Ghosh et al., where the 
ADT signal varied with the linker length.[146-149] It was found that with the 
longer linker the percentage elongation is less and also the inclination is less, 
resulting in lower 3f response compared to a short linker. Based on this, the 
linker length was investigated for detection of E.coli bacteria. Before the E.coli 
binding aptamers were immobilised on the surface of the sensor through 
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biotin-streptavidin assay which comprised of biotin thiol, streptavidin and then 
the biotinylated aptamer. This allowed three-dimensional folding of the 
aptamer providing functional aptamer-immobilised surface. The bacteria were 
then bound to the surface through this chain of molecules acting as bio-
molecular linker. To compare linker with shorter length, to the same aptamer 
sequence a thiol group was added to the 3’ end instead of biotin. Introduction 
of terminal thiol groups allowed for the straight-forward immobilisation of DNA 
aptamers on gold surfaces.  
Chemisorption of thiols to elemental gold is a well-known mechanism resulting 
in stable self-assembled monolayers (SAMs). Immobilisation of thiolated DNA 
to gold is widely used.[237] Aptamer could be immobilised in a highly controlled 
orientation, i.e. via this thiol group. This controlled orientation facilitates high 
binding activity by avoiding a loss of functionality resulting from immobilisation 
in random orientation. However, several factors influencing aptamer folding 
have to be carefully considered during the immobilisation of aptamers on to 
the sensor surfaces. For this, the gold electrode is first incubated with              
thiol-modified aptamer (ssDNA) and then subsequently exposed to                                
6-mercaptohexanol (MCH) solution. This treatment of the gold layer with 
MCH, blocks access of analyte and buffer components to the gold surface 
(causing unspecific adsorption), and on the other hand, supports the vertical 
orientation of the aptamers when conjugated to the surface (by preventing 
interaction of aptamer and gold surface, thereby enhancing functional 
structures).[238]  
Mixed SAMs are commonly formed by the simultaneous co-immobilisation of 
different components. However, MCH is also used only to backfill after DNA 
aptamer immobilisation, to displace non-specific interactions between the 
aptamer and gold and to cause the aptamer to stand up from the surface. The 
inclusion of MCH during thiolated aptamer immobilisation may prevent                       
non-specific adsorption of aptamer during aptamer immobilisation, forcing the 
aptamer to stand up from the surface and allowing a greater aptamer loading 
of the surface than when only thiolated DNA aptamer is immobilised.  
 125 
 
5.8 Linking the thiolated aptamer to the QCR 
5.8.1 Cleaning the surface of gold electrode  
AT-cut stepped (non-uniform) quartz crystals were used with fundamental 
resonant frequency range of 14.23 -14.25 MHz (Lap-Tech Inc., Bowmansville, 
Ontario, Canada). The surfaces of gold electrodes of quartz crystals were 
cleaned with acetone for 5 mins and then with isopropanol (IPA) by                     
ultra-sonication process for 5 mins. Then after drying with nitrogen gas, they 
were placed in plasma cleaner to remove impurities and contaminants from 
the surface using inert argon gas for 1 min in a Harrick Plasma cleaner. They 
were then stored in a well of clean 24-well tissue culture plate covered with 
plastic film.  
5.8.2 Immobilisation of thiolated DNA aptamer  
Thiolated DNA aptamers were purchased from Sigma-Aldrich, UK. 6-
mercaptohexanol (MCH), tris(2-carboxyethyl)phosphine hydrochloride solution 
(TCEP), sodium chloride, and magnesium chloride were all procured from 
Sigma-Aldrich, UK. Ethylenediaminetetraacetic acid disodium salt dehydrate 
(EDTA), tris-EDTA buffer (TE Buffer), and 10 mM phosphate buffer saline 
solution (PBS) were procured from Fisher Scientific, UK, and used for surface 
cleaning and functionalisation. Immobilisation buffer was 1xTE buffer, 1 M 
NaCl, 50 mM MgCl2 and 10 mM EDTA. Thiolated DNA aptamer was reduced 
with 0.5M TCEP in a 1:1 (v/v) ratio for 1-2 hours at room temperature. After 
reduction, the DNA was diluted to 1 µM with immobilisation buffer. 
1 µM reduced thiolated DNA aptamer solution was immobilised on the gold 
electrode. After immobilisation, the gold electrodes were sequentially rinsed in 
immobilisation buffer and then washed three times in PBS to remove any 
remaining Mg2+. To ensure complete thiol coverage of the gold surface, the 
electrodes were backfilled with MCH using immersion in 1mM in DI water for 
30 mins. The gold electrodes were then washed three times with PBS.  
Immobilisation of the thiolated DNA aptamer on the surface was confirmed by 
simultaneously measuring the frequency shift. After achieving baseline, 
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introduction of 1 µM reduced thiolated DNA aptamer caused frequency shift 
(Δf0) of ~ 300 Hz. A positive frequency shift (Δf0) of ~ 100 Hz was observed 
due to introduction of an aqueous solution of MCH (as shown in Fig. 5.9).  
 
Fig. 5.8 - Functionalisation steps: (1) Thiolated aptamer (ThiC6), (2) backfilling with      
6-mercaptohexanol (MCH), (3) final step of flowing the E.coli (KCTC 2571) bacteria.  
 
 
Fig. 5.9 - Frequency shift measured after immobilising: (a) thiolated DNA aptamer 
(b) aqueous solution of spacer thiol MCH. 
 127 
 
5.9 Determination of drive amplitude 
The surfaces of the QCR were functionalised with thiolated E.coli binding DNA 
aptamer, and then rinsed with PBS buffer. After taking baseline 
measurements, 107 E.coli/mL (as final concentrations) were spiked into the 
sample and passed over the prepared sensor surface at a flow rate of 5 µl/min 
for 60 mins. Resonant frequency (f0) was determined with frequency sweep 
and the sensor was then driven by a pure sinusoidal oscillation at f0 in 
frequency mode scan, at different amplitudes ranging from 0.1 to 0.5 SU. The 
complex values (in-phase and quadrature) of current and voltage were 
recorded at 1f and 3f simultaneously using the ADT machine. The percentage 
shift in the peak values of the corresponding 3f signal (I3fmax) from baseline, 
are plotted at 60 mins (Fig. 5.10).  
 
Fig. 5.10 - I3fmax shift (%) measured at different amplitudes: 0.1 to 0.5 SU at 60 
mins, after passing 107 E.coli/mL on the surface functionalised with thiolated 
DNA aptamers. 
Maximum shift was observed at 0.1 SU which corresponds to excitation 
voltage of 3 Volts and 7.5 nm of oscillation amplitude at surface.[233,234] But the 
value of oscillation amplitude seems to have inverse relation with 
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corresponding 3f signal. At 0.2 SU (6 Volts) 3f signal dropped despite 
increase in oscillation amplitude. Thus, 0.1 SU was selected for further 
measurements as it gave maximum 3f signal.   
5.10 Detection of E.coli bacteria with thiolated aptamer 
After determining the optimal drive amplitude, triplicate sets of experiments 
were carried out with a range of E.coli bacterial concentration. In order to 
detect E.coli (KCTC 2571) by direct assay, bacteria were spiked into the 
sample (107 cells/mL as final concentrations) over the prepared sensor 
surface at a flow rate of 5 µl/min for further 60 mins. A total of 3x106 bacterial 
cells are therefore injected over 60 mins, respectively. To check specificity of 
the sensor, S.typhi bacterial samples were also used at 10 times the 
concentration of E.coli bacteria. Thus, 108 cells/mL as final concentrations of 
S.typhi bacteria were also spiked into the sample over the prepared sensor 
surface at a flow rate of 5 µl/min for further 60 mins. Frequency scans were 
taken at 0.02 SU and 0.1 SU (0.1s period) and Δf0, ΔD and ΔI3fmax were 
simultaneously monitored in real time during streptavidin and thiolated 
aptamer immobilisation and E.coli detection using a quartz crystal nonlinear 
network analyzer. All the measurements were taken in continuous flow mode. 
Relative decrease in peak values of ΔI3fmax from baseline are plotted over 60 
mins for which the E.coli and S.typhi bacteria were flowed over the sensor 
surface after achieving the baselines, as shown in the Fig. 5.11.  
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Fig. 5.11 - I3fmax shift (%) as a function of time with bacterial suspension of 
different concentrations (cells/mL) over the surface functionalised with 
thiolated aptamers. 
Comparison of sensitivity 
The shifts in the respective values of I3fmax are plotted at 5 mins, 30 mins and 
60 mins (please see Fig. 5.12, 5.13 and 5.14, respectively). The signal with 
107 E.coli/mL was much higher at 5 mins, 30 mins and 60 mins when 
compared to the signal obtained with 10 times the concentration of S.typhi 
bacteria. 
 
 
Fig. 5.12 - I3fmax shift (%) at 5 mins with 10
7 E.coli/mL and 108 S.typhi/ over the 
surface functionalised with thiolated aptamer (shorter linker length). 
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Fig. 5.13 - I3fmax shift (%) at 30 mins with 10
7 E.coli/mL and 108 S.typhi/ over the 
surface functionalised with thiolated aptamer (shorter linker length). 
 
 
Fig. 5.14 - I3fmax shift (%) at 60 mins with 10
7 E.coli/mL and 108 S.typhi/ over the 
surface functionalised with thiolated aptamer (shorter linker length). 
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Comparison of specificity 
Mean values of the triplicate sets of experiments conducted with each 
concentration of E.coli bacteria (107 cells/mL) and S.typhi bacteria (108 
cells/mL) recorded at 30 mins, were calculated and their ratios were 
compared. These ratios for ΔI3fmax measurements are plotted in Fig. 5.15. For 
10 times lower concentration of E.coli than S.typhi bacteria, the ratio values 
was 6.28. This value was found to be lower than that observed with longer 
linker (biotinylated aptamer) for same bacterial concentrations (please see                          
Fig. 5.17). 
 
Fig. 5.15 - Comparison of specificity with short linker (thiolated aptamer): ratio 
of mean values of I3fmax shift for 10
7 E.coli/mL and 108 S.typhi/mL.  
5.11 Comparison of 3f signals with different bio-receptors  
Comparison of sensitivity 
Mean values of the triplicate sets of experiments conducted with each type of 
bio-molecular linker for concentration of E.coli bacteria (107 cells/mL) was 
recorded at 30 mins, were calculated and they are presented in Fig. 5.16. 
I3fmax values were found to be highest for longer linker (biotinylated aptamer-
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streptavidin-biotin thiol) about 2.06 units which was almost 1.6 times than that 
found for shorter linker (thiolated aptamer) and 5.8 times for pAbs (biotinylated 
antibody-streptavidin-biotin thiol). Thus, the assay with longer bio-molecular 
linker (biotinylated aptamer) had better sensitivity than with shorter linker and 
immunoassay. 
 
Fig. 5.16 - Comparison of sensitivity –I3fmax shift for 10
7 E.coli/mL with different 
bio-receptors: long linker (biotinylated aptamer), short linker (thiolated 
aptamer) and polyclonal antibody. 
Comparison of specificity 
Mean values of the triplicate sets of experiments conducted with each type of 
bio-molecular linker for concentration of E.coli bacteria (107 cells/mL) and 
S.typhi bacteria (108 cells/mL) recorded at 30 mins, were calculated and their 
ratios were compared. These ratios for ΔI3fmax measurements are plotted in 
Fig. 5.17. I3fmax values were found to be highest for longer linker (biotinylated 
aptamer-streptavidin-biotin thiol) about 12.6 which was almost 2 times than 
that found for shorter linker (thiolated aptamer) and 3.4 times for pAbs 
(biotinylated antibody-streptavidin-biotin thiol). Thus, the assay with longer 
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bio-molecular linker (biotinylated aptamer) had better specificity than with 
shorter linker and immunoassay. 
 
Fig. 5.17 - Comparison of specificity – ratio of mean values of I3fmax shift for 
different concentrations of E.coli/mL and 108 S.typhi/mL with different bio-
receptors – long linker (biotinylated aptamer), short linker (thiolated aptamer) 
and polyclonal antibody. 
5.12 Summary 
In the ADT technique, for a given drive frequency (f), the 3f signal is 
dependent on the force-extension characteristic of the molecular tether, its 
length, and also the size of the particles. Hence, to meet the objectives O.2.1 
and O.2.2, in this chapter bio-receptor of different size i.e. anti-E.coli 
antibodies and different length i.e. thiolated E.coli-binding aptamer were 
investigated for detection of E.coli bacteria. It was found that the sensitivity 
and specificity of the assay with longer linker (biotinylated aptamer-
streptavidin-biotin thiol) was highest for detection of E.coli bacteria as 
compared with shorter linker (thiolated aptamer) and biotinylated antibody 
assay.  Bio-receptors with different linker lengths have been previously 
investigated, and it was found that with the longer linker the percentage 
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elongation is less and also the inclination is less, resulting in lower 3f 
response compared to a shorter linker. However, in this chapter, the response 
with shorter linker (thiolated linker) was found to be lower than longer linker in 
terms of both sensitivity and specificity. This could be due to saturation of the 
surface with 100% thiolated aptamers which might have affected its 
functionality by steric hindrance because of overcrowding. This can be 
potentially improved by co-immobilisation of the thiolated aptamer with MCH 
in a fixed combination rather than backfilling with MCH.  
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Chapter 6 Investigating novel mechanical designs of aptamer 
receptor for detection of bacteria using nonlinear acoustic 
biosensor 
6.1 Introduction 
Rapid point-of-care diagnostic tests need to be both sensitive and specific to 
play a significant role in stopping the spread of AMR. Sensitivity and 
specificity of a test is very crucial as a false-positive result can lead to 
unneeded interventions and treatment. In chapters 4 and 5, bio-receptors with 
different sizes and lengths were explored for detection of E.coli bacteria. 
Anharmonic acoustic aptasensor comprising of ADT as transducer and long 
bio-molecular linker with E.coli-binding aptamer as bio-receptor, demonstrated 
highest sensitivity and specificity. To further enhance the sensitivity and 
specificity of this system, novel mechanical structures were designed using 
the same E.coli-binding aptamer sequence such that the newly configured 
aptamer sequence along with the innovative structure would not only 
quantitatively detect bacteria, but also give a characteristic signal, highly 
specific for that interaction. Quartz crystal resonator (QCR) used to obtain this 
unique signal was operated in two modes: the first one measured the change 
in 3f signal (I3fmax) caused by binding of E.coli bacteria to the immobilised 
modified aptamers, and the second one measured the characteristic signal as 
a results of introduction of the mechanical structure with designed nonlinearity 
into the stem of the E.coli-binding aptamer sequence. 
 6.2 Background 
Aptamers are promising alternative bio-receptors that can substitute 
antibodies in various applications, as they offer several advantages, namely 
high binding affinity, high specificity and stability. Of all, the most important 
advantage is that aptamers can be chemically synthesised, whereas 
antibodies have to be obtained using less efficient biochemical or biological 
methods. In fact much of the success of nucleic acid aptamers is due to 
SELEX, a well-designed process by which aptamers can be generated for a 
given target (e.g., proteins, cells, etc.). Once aptamers are selected by this 
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SELEX process and their sequences are revealed, they can be chemically 
synthesised, thus, maintaining stable product quality. This also facilitates post-
SELEX modifications, which can be made by precise introduction of labels or 
other modifications at defined positions in the aptamer sequence.[239] The 
nucleic acid aptamers have also been previously modified for several reasons: 
to increase chemical diversity; to convey stability to enzymatic (endonuclease) 
degradation; to improve cellular uptake; to increase flexibility/rigidity and also 
to provide a means of measurement (e.g., incorporation of a 
fluorophore).[240,241]  Thus, as the aptamers are so versatile and adaptable, the 
E.coli-binding aptamers were also modified and applied in the bioassay. 
The sensitivity and specificity of the bioassay depends on the affinity and 
strength of the ligand-receptor interaction. Intermolecular forces holding 
together ligand-receptor pairs are very important in biosensing, as these not 
only play important role in binding but they also provide stability to the intrinsic 
molecular structures. But, if the molecular structure of the receptor between 
the surface and the ligand is modified such that, it transiently becomes 
unsteady with the applied force, it can introduce potential non-linearity into the 
system and can give rise to unique signal, specific for that interaction. 
Therefore, the ‘stem’ of the E.coli-binding aptamer was modified to obtain a 
characteristic signal. A hairpin structure (comprising of DNA duplex) was 
added into the bio-molecular linker, such that depending on the positions of 
the receptor and biotin molecule on the arms of the hairpin structure, it would 
open up or stretch briefly due to the forces exerted by the oscillating resonator 
vibrating in thickness shear mode and opposing forces due to the inertia of the 
bound bacteria and the viscous forces of the liquid medium (as shown in 
figure 6.1). It was hypothesised that this transient unwinding can introduce 
momentary non-linearity in the dynamics and therefore the transduced 
characteristic electrical signal would enhance the specificity of the bioassay. 
DNA duplex is a good candidate as it can be smartly incorporated into the 
aptamer sequence without affecting its function as a bio-receptor. Two force 
application geometries of dsDNA viz. unzipping and shearing have been 
exploited earlier.[242-245] These were incorporated into the E.coli-binding 
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aptamer to give two configurations: unzip (weak) and shear (strong) (as 
depicted in Fig. 6.2). If the voltage is applied for very less impact time, in the 
weak configuration, the position of the biotin molecule (which then binds to 
streptavidin immobilised on the surface) on one arm of the hairpin structure is 
such that, it opens up under the pulling force, which does not happen for the 
strong configuration. Accordingly, two configurations are designed to establish 
that the distinct signal is due to the opening up of the hairpin structure and not 
just due to its presence. A numerical differentiation method is employed to a 
full complex 3f signal using Wolfram Mathematica software, to measure the 
resulting transient response due to the opening up of the designed hairpin 
structure. As square of the differentiated signal was taken, this method is 
named as ADT-D2 i.e. ADT differentiated power. Energy of this signal was 
also calculated by integration and named as ADT-DI i.e. ADT differentiated 
energy.  
 
Fig. 6.1 – Two different force application geometries of DNA duplex:                           
(a) Unzipping, and (b) Shearing mode. Adapted and modified from [241]. 
 6.3 Modified aptamer sequences – novel mechanical designs 
The fluorescein-labelled ssDNA E.coli-binding aptamers consisting of 88 
bases were flanked with random sequence (named as, aptamer handle) of 21 
bases to its 3’ end, to make a longer sequence of total 109 bases (please see 
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table 6.1). This aptamer handle constituted one arm of the hairpin structure. 
Using Mfold software, binding was checked and it was found that ssDNA 
aptamer (88-mer) does not bind to aptamer handle (21-mer) or the total 
sequence consisting of 109 bases do not fold on itself. Complementary 
sequences to these 21 bases (added to 88 bases at 3' end) were procured 
with Biotin-TEG (triethylene glycol) attached to 5' end in aptamer configuration  
that would open in unzipping mode under the pulling force and to 3' end in 
aptamer configuration that would stretch in shear mode. The resultant two 
aptamer designs (configurations) are depicted in Fig. 6.2. Aptamer handles 
which constituted one arm of the hairpin structures of both the aptamer 
configurations (unzip and shear) were joined by hybridisation process to other 
arm of hairpin structure comprised of complementary 21 bases with Biotin-
TEG at either end (5' or 3') and then introduced on the QCR surface coated 
with streptavidin (surface – 10% Biotin thiol / 90% methoxy thiol)  (as shown in 
Fig. 6.3). Hybridisation was confirmed by measuring the frequency shift. 
Fig. 6.2 - Modified aptamer configurations – unzip and shear mode 
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6.4 Hybridisation of aptamer sequences 
Hybridisation is a phenomenon in which single-stranded DNA or RNA 
molecules anneal to complementary DNA or RNA. Heating followed by 
cooling facilitates hybridisation. Heat ‘breaks’ all hydrogen bonds, thereby 
disrupting any secondary structure within each oligonucleotide. Slow cooling 
then facilitates hybridisation as new hydrogen bonds form between the 
complementary sequences. 
 
Table 6.1: Aptamer configurations 
Fluorescein-labelled 
ssDNA aptamer 
sequence: (88-mer) 
FITC-
5'GCAATGGTACGGTACTTCCACTTAGGTCGAGGTTAGT
TTGTCTTGCTGGCGCATCCACTGAGCGCAAAAGTGCAC
GCTACTTTGCTAA3' 
Random sequence 
of aptamer handle 
(one arm of hairpin 
structure): 21-mer 
5'TATATTACGTATATATTATAT3' 
Biotinylated 
sequence with 
complementary 
bases to aptamer 
handle (other arm of 
hairpin structure): 
21-mer 
Unzipping mode: Biotin TEG 
at 5' end 
Biotin-TEG 
5'ATATAATGCATATATA
ATATA3' 
Shear mode:             Biotin 
TEG at 3' end 
5'ATATAATGCATATATA
ATATA3'-TEG-Biotin 
Aptamer 
configuration unzip  
Fluorescein-labelled ssDNA aptamer sequence (88-mer) 
with aptamer handle (21-mer) hybridised to complementary 
sequence (21-mer) with Biotin TEG at its 5' end 
Aptamer 
configuration shear  
Fluorescein-labelled ssDNA aptamer sequence (88-mer) 
with aptamer handle (21-mer) hybridised to complementary 
sequence (21-mer) with Biotin TEG at its 3' end 
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E.coli-binding aptamers (88-mer) along with aptamer handles of both the 
aptamer configurations (unzip and shear) were annealed and joined by 
hybridisation process to complementary 21 bases with Biotin-TEG at either 
end (5' or 3') and then introduced on the QCR surface coated with streptavidin 
(surface – 10% Biotin thiol / 90% methoxy thiol)  (as shown in Fig. 6.3).  
Both the sequences i.e. fluorescein-labelled ssDNA E.coli-binding aptamer 
sequence plus aptamer handle (109-mer) and biotinylated complementary 
sequences (21-mer) to aptamer handle [with Biotin-TEG at either (5' or 3')] 
were re-suspended to the same molar concentration, using TE buffer.  
Annealing was performed by mixing equal volumes of both the sequences (at 
equimolar concentration) in a 1.5 ml microfuge tube along with an appropriate 
volume of 10× annealing buffer and water to make the final concentration of 
each sequence to equal 50 µmol and 1× annealing buffer.  
Then the tubes were placed in a standard heat block at 90–95°C for 3–5 
minutes. Later, the heat block was removed from the apparatus and allowed 
to cool to room temperature (or at least below 30°C) on the workbench. Slow 
cooling to room temperature was done for 45–60 minutes. Thereafter, it was 
stored at 4°C until ready to use. 
 
Fig. 6.3 – Modified aptamer designs (configurations): (1) Unzip mode, (2) Shear 
mode. 
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To confirm whether hybridisation occurred or not, frequency shifts were 
measured. Post-hybridisation, the gold surfaces of quartz crystals were rinsed 
with ultra-pure ethanol for removing the non-adsorbed thiol. After placing the 
crystal on cartridge and sealing with “O-ring” of flow-cell, about 6-8 mL of DI 
water was passed through for 10 mins; thus removing the ethanol. The gold 
surfaces were then rinsed with PBS solution. For functionalization, a solution 
of ~7 µg/ml of streptavidin was flown over the surface. The excess 
streptavidin was removed by flowing PBS solution and then baseline 
measurements were taken. Thereafter, fluorescein-labelled ssDNA aptamer 
sequence plus aptamer handle (109-mer) with and without hybridised 
biotinylated complementary sequences (21-mer) to aptamer handle [with 
Biotin-TEG at either (5' or 3')] were flowed over the surface and resonance 
frequency shift was measured.  
 
Fig. 6.4 – Frequency shift measured after immobilising: (a) biotinylated 21b              
(pre-hybridisation), and (b) biotinylated 21b+109b (post-hybridisation). 
The frequency shift is reported in Hz as shown in the Fig. 6.4. When 
streptavidin is injected into the flow-cell, frequency shift of Δf (~ 150 Hz) was 
observed for both the experiments. Smaller shift Δf (~ 50 Hz) was observed 
during the immobilisation step of biotinylated 21-mer sequences and larger 
shift Δf (~ 210 Hz) due to the more mass going on the surface because of the 
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hybridised sequence. Following the binding of both the sequences, any 
unbound sequence was removed from the flow-cell by rinsing with PBS. Thus, 
for this experiment, it can be concluded that the hybridisation step was 
successful which resulted in larger frequency shift, as the biotin was attached 
only to the 21base sequence and not to the ssDNA E.coli-binding aptamer 
sequence with aptamer handle (109-mer). 
X-ray photoelectron spectroscopy (XPS) measurements 
XPS measurements were carried out with a Thermo Scientific K-Alpha 
spectrometer using a monochromatic Al Kα X-ray source (Ion Gun Operating 
range: 100 eV - 4 keV) with a spot size of 400 μm. The survey spectra were 
collected over a range of −10 to 1350 eV with pass energy of 200 eV. The 
high resolution spectra over the Au 4f, C1s, O1s, S2p, and N1s regions were 
acquired with pass energy of 50 eV.  
Survey spectra especially over N1s and P2p (Fig. 6.5) demonstrated that the 
peaks were higher for substrates with biotinylated 21b+109b, indicating 
hybridisation of the complementary sequences. 
 
Fig. 6.5 – XPS spectra showing comparison of surveys for different substrates: 
(a) Biotinylated 21b (pre-hybridisation) and (b) Biotinylated 21b+109b (post hybridisation) 
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6.5 Binding of the two modified aptamer configurations to E.coli bacteria 
Post-hybridisation, binding of the fluorescein-labelled hybridised sequences 
(FITC-109b+21b-biotin) to E.coli bacteria strain (KCTC 2571) was validated 
through fluorescence assay. 
Fluorescence assay 
Microplate wells were first washed with 150 µL of 5% BSA in PBS overnight at 
4°C and next day washed with washing buffer (1× PBS and 0.05% [v/v] 
Tween 20). E.coli bacteria strain (KCTC 2571) was cultured in nutrient broth 
to middle growth phase (OD600 of 0.45) and centrifuged at 3,000 rpm for 10 
mins to remove the media. This washing step was repeated 3 times. 
Subsequently, E.coli bacteria (107/mL) were incubated with                       
fluorescein-labelled hybridised sequences (FITC-109b+21b-biotin) (nM as 
final concentrations) in microplate wells for 45 mins at 25°C with mild shaking. 
Cells were then washed three times to remove unbound sequences from cells 
by centrifugation for 10 mins and were re-suspended in 150 µL of washing 
buffer . Finally, the fluorescence intensity of each sample was measured with 
BMG FLUOstar Omega microplate reader (at excitation 485 nm and emission 
520 nm wavelengths). The fluorescence intensity was compensated by 
subtraction with the fluorescence intensity of blank and then by division with 
respective gains.  
Here, both the configurations as depicted in Fig. 6.1 (aptamer config. unzip 
and shear) exhibited a high affinity for the target E.coli strain. Fig. 6.6 & 6.7 
show representative binding saturation curves obtained by fluorescence 
analysis for both the aptamer configurations, respectively. The dissociation 
constants (Kd) of both the aptamer configurations unzip and shear 
against E.coli (KCTC 2571) were estimated to be 22.8 and 25.9 nM, 
respectively, by nonlinear regression analysis. Thus, this confirmed the 
binding of the target E.coli strain to both the aptamer configurations                 
post-hybridisation. Also, the values were close to the Kd value reported for the 
original aptamer sequence (88b) after binding to E.coli (KCTC 2571) 
bacteria.[230] 
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Fig. 6.6 – Binding saturation curves of aptamer configuration unzip to the 
target E.coli strain and estimation of their dissociation constants (Kd) value of 
22.8 nM obtained by nonlinear regression analysis. 
 
Fig. 6.7 – Binding saturation curves of aptamer configuration shear to the 
target E.coli strain and estimation of their dissociation constants (Kd) value of 
25.9 nM obtained by nonlinear regression analysis. 
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6.6 Linking the modified aptamers to the QCR 
6.6.1 Cleaning the surface of gold electrode  
AT-cut stepped (non-uniform) quartz crystals were used with fundamental 
resonant frequency range of 14.23 -14.25 MHz (Lap-Tech Inc., Bowmansville, 
Ontario, Canada). The surfaces of gold electrodes of quartz crystals were 
cleaned with acetone for 5 mins and then with isopropanol (IPA) by                     
ultra-sonication process for 5 mins. Then after drying with nitrogen gas, they 
were placed in plasma cleaner to remove impurities and contaminants from 
the surface using inert argon gas for 1 min in a Harrick Plasma cleaner. They 
were then stored in a well of clean 24-well tissue culture plate covered with 
plastic film.  
6.6.2 Formation of self-assembled monolayer (SAM) 
The cleaned quartz crystals were then immersed in about 250 µl of 1mM 
ethanolic solution of mixture of thiols [biotin terminal group (10%), and 
methoxy terminal group (90%)] and left overnight for formation of a             
SAM. Thiols with biotin terminal group HS-C11-(EG)6-Biotin (th004-m11.n6-
0.005) and methoxy terminal group HS-C11-(EG)3-OCH3 (th006-n3) were 
obtained from Prochimia Surfaces, Poland. The following day, the gold 
surfaces of quartz crystals were rinsed three times with ultra-pure ethanol 
(Sigma-Aldrich, UK) for removing the non-adsorbed thiols and then both sides 
of crystal were dried with a stream of nitrogen gas. After making sure that the 
electrode on bottom side was completely dried, the crystal was mounted on 
PCB cartridge and sealed with “O-ring” of microfluidic flow-cell with only one 
face exposed to the solution. The gold surfaces were then rinsed with                
de-ionized (DI) water to remove ethanol followed by Phosphate buffer saline 
(PBS) with physiological pH 7.4. 
6.6.3 Deposition of Streptavidin  
PBS buffer solution (100 µL) was then flowed over the substrate at the 
continuous flow rate of 10 µL/min and baseline measurements were taken for 
15 mins at 5 min interval. This was followed by about 150 µl of Streptavidin           
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(10 µg/mL) for 15 mins at the flow rate of 10 µL/min; thus forming a strong 
bond with the biotin terminal group of the alkane thiol. Measurements were 
taken under flow for 15 mins at 5 min interval. 
6.6.4 Immobilisation of bio-receptor on the gold electrode of QCR 
After depositing streptavidin, PBS buffer solution (500 µL) was then flowed 
over the substrate at the continuous flow rate of 100 µL/min for 5 mins, to 
remove the unbound streptavidin. Then the surface was functionalised with 
aptamer configurations unzip and shear post-hybridisation (annealed to 
biotinylated-ssDNA sequence consisting of 21 bases), by passing over the 
surface for 15 mins. The excess of bio-receptors were removed by flowing 
PBS solution and then baseline measurements were taken every 5 minutes 
over 30 minutes under a continuous flow of PBS at flow rate of 5 µl/min.  
After this, in order to detect E. coli (KCTC 2571) by direct assay, 107 cells/mL 
of bacteria were spiked into the sample (as final concentrations) over the 
prepared sensor surface at a flow rate of 5 µl/min for further 60 mins. A total 
of 3x106 bacterial cells are therefore injected over 60 mins.  
Frequency scans were taken at 0.02 and 0.1 SU (0.1s period) to measure 3f 
signal and at 0.1 to 0.7 SU (1s period) to measure ADT-D2 and ADT-DI signal. 
Δf and ΔD were simultaneously monitored in real time during streptavidin and 
aptamer immobilisation and E.coli detection using a quartz crystal nonlinear 
network analyser. All the measurements were taken in continuous flow mode. 
6.7 Determination of drive amplitude 
The surfaces of the QCR were functionalised with aptamer configurations 
unzip and shear, separately post-hybridisation step, and then rinsed with PBS 
buffer.  
After taking baseline measurements, 107 E.coli/mL (as final concentrations) 
were spiked into the sample and passed over the both the prepared sensor 
surfaces at a flow rate of 5 µl/min for 60 mins.  
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Resonant frequency (f0) was determined with frequency sweep and the 
sensor was then driven by a pure sinusoidal oscillation at f0 in frequency 
mode scan, at different amplitudes ranging from 0.1 to 0.5 SU.  
The complex values (in-phase and quadrature) of current and voltage were 
recorded at 1f and 3f simultaneously using the ADT machine. The percentage 
shift in the peak values of the corresponding 3f signal (I3fmax) from baseline, 
are plotted at 60 mins (Fig. 6.8). Maximum shift was observed at 0.1 SU. The 
results were found consistent with the ones obtained with E.coli binding 
aptamers (unmodified), where the maximum shift in 3f signal was also 
observed at 0.1 SU. 
 
Fig. 6.8 - I3fmax shift (%) measured at different amplitudes – 0.1 to 0.5 SU at 60 
mins, after passing 107 E.coli/mL on the surface functionalised with: (a) 
Aptamer (unmodified); (b) Aptamer configuration unzip (modified), and (c) Aptamer 
configuration shear (modified) 
6.9 Selection of aptamer configuration for E.coli detection 
After functionalising the surfaces of the QCR with two different aptamer 
configurations (unzip and shear), baseline measurements were taken. To 
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obtain ADT-D2 and ADT-DI signal, different amplitudes ranging from 0.1 to 0.7 
SU were applied for 1s in frequency mode scan. Thereafter, 107 E.coli/mL (as 
final concentrations) were spiked into the sample and passed over the both 
the prepared sensor surfaces at a flow rate of 5 µl/min for 60 mins. At the end 
of the experiment, again different amplitudes were applied for 1s. Signals 
measured at 3rd harmonic (3fADT-D2) and 3fADT-DI both were analysed. ADT-D
2 
and ADT-DI analysis showed characteristic signals observed at 0.6 and               
0.7 SU with aptamer configuration unzip but none with aptamer configuration 
shear mode) as shown in Fig. 6.9 and 6.11, respectively. As hypothesised, 
characteristic response was observed in unzipping mode due to transient 
unwinding of the DNA helix (aptamer hairpin structure) after E.coli binding. 
This could be due to opposing forces acting on the helix due to viscous drag 
after bacterial binding. In the shearing mode, unique signals were not 
observed, as the bond might have got only stretched but not unwound after 
E.coli binding (as shown in Fig. 6.10 and 6.12). Thus, aptamer configuration 
unzip was selected for further investigations. 
 
Fig. 6.9 - ADT-D2 signal measured at 3rd harmonic (3fADT-D
2) after flowing                     
107 E.coli/mL over surface functionalised with aptamer configuration unzip. 
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Fig. 6.10 - ADT-D2 signal measured at 3rd harmonic (3fADT-D2) after flowing                     
107 E.coli/mL over surface functionalised with aptamer configuration shear. 
 
Fig. 6.11 – ADT-DI signal measured at 3rd harmonic (3fADT-DI) after flowing                     
107 E.coli/mL over surface functionalised with aptamer configuration unzip. 
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Fig. 6.12 - ADT-DI signal measured at 3rd harmonic (3fADT-DI) after flowing                     
107 E.coli/mL over surface functionalised with aptamer configuration shear. 
6.10 Detection of E.coli bacteria using aptamer configuration unzip 
Aptamer configuration unzip was selected for detection of E.coli bacteria as it 
not only gave characteristic signal due to transient DNA helix unwinding at 0.6 
and 0.7 SU, but also the shift in I3fmax was observed maximum with this 
configuration. 
In order to detect E.coli (KCTC 2571) by direct assay, bacteria were spiked 
into the sample (107 cells/mL as final concentrations) over the prepared 
sensor surface at a flow rate of 5 µl/min for further 60 mins.  
A total of 3x106 bacterial cells are therefore injected over 60 mins, 
respectively. The changes in resonant frequency and dissipation units were 
measured and also the shift in 3f signal (I3fmax). The results were comparable 
to the ones obtained with E.coli binding aptamer (unmodified).  
Relative decrease in peak values of ΔI3fmax from baseline are plotted at 60 
mins for which the E.coli bacteria were flowed over the sensor surface after 
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achieving the baselines, as shown in the Fig. 6.15. This relative decrease in 
ΔI3fmax was compared with the increase in resonant frequency (Δf0) and the 
relative increase in dissipation values ΔD. Fig. 6.13 and Fig. 6.14 depict the 
frequency shift and dissipation shift at 60 mins after introducing the E.coli 
bacteria over the surface functionalised with E.coli-binding aptamers.  
 
Fig. 6.13 - Frequency shift (Hz) at 60 mins with different bacterial suspensions 
flowed over the surface functionalised with aptamer configuration unzip. 
 
Fig. 6.14 - Dissipation shift (%) at 60 mins with different bacterial suspensions 
flowed over the surface functionalised with aptamer configuration unzip. 
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Fig. 6.15 – I3fmax shift (%) at 60 mins with different bacterial suspensions flowed 
over the surface functionalised with aptamer configuration unzip. 
 
6.11 Specificity analysis 
For specificity analysis, ADT-D2 and ADT-DI signals at 3rd harmonic were 
measured at 0.6 SU before and after flowing E.coli bacteria functionalised with 
aptamer configuration unzip. Three set of scans were taken each time to 
ensure reproducibility. Characteristic signals were obtained for 107 E.coli/mL 
but none for 108 S.typhi/mL. ADT-D2 signal at 0.6 SU before and after E.coli 
bacteria are shown in Fig. 6.16 and 6.17. ADT-D2 signal at 0.6 SU before and 
after S.typhi bacteria are shown in Fig. 6.18 and 6.19. Also, ADT-DI signal at 
0.6 SU before and after E.coli bacteria are shown in Fig. 6.20 and 6.21 and for 
S.typhi bacteria in Fig. 6.22 and 6.23. 
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Fig. 6.16 – ADT-D2 signal measured at 3rd harmonic (3fADT-D2) before flowing            
107 E.coli/mL over surface functionalised with aptamer config. unzip at 0.6 SU 
(ADT-D2max: Mean = 0.0016, SD = 0.0002). 
 
Fig. 6.17 - ADT-D2 signal measured at 3rd harmonic (3fADT-D2) after flowing                 
107 E.coli/mL over surface functionalised with aptamer config. unzip at 0.6 SU 
(ADT-D2max: Mean = 66.8415, SD = 67.8378). 
 154 
 
 
Fig. 6.18 - ADT-D2 signal measured at 3rd harmonic (3fADT-D2) before flowing            
107 S.typhi/mL over surface functionalised with aptamer config. unzip at 0.6 SU 
(ADT-D2max: Mean = 0.0007, SD = 0.00004). 
 
Fig. 6.19 - ADT-D2 signal measured at 3rd harmonic (3fADT-D
2) after flowing            
107 S.typhi/mL over surface functionalised with aptamer config. unzip at 0.6 SU 
(ADT-D2max: Mean = 0.0008, SD = 0.0001). 
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Fig. 6.20 - ADT-DI signal measured at 3rd harmonic (3fADT-DI) before flowing            
107 E.coli/mL over surface functionalised with aptamer config. unzip at 0.6 SU 
(ADT-DImax: Mean = 0.8460, SD = 0.1141). 
 
Fig. 6.21 - ADT-DI signal measured at 3rd harmonic (3fADT-DI) after flowing            
107 E.coli/mL over surface functionalised with aptamer config. unzip at 0.6 SU 
(ADT-DImax: Mean = 497.7650, SD = 327.8621). 
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Fig. 6.22 - ADT-DI signal measured at 3rd harmonic (3fADT-DI) before flowing            
107 S.typhi/mL over surface functionalised with aptamer config. unzip at 0.6 SU 
(ADT-DImax: Mean = 0.3719, SD = 0.0058). 
 
Fig. 6.23 - ADT-DI signal measured at 3rd harmonic (3fADT-DI) before flowing            
107 S.typhi/mL over surface functionalised with aptamer config. unzip at 0.6 SU 
(ADT-DImax: Mean = 0.3800, SD = 0.0073). 
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Comparison of specificity 
Mean values of the triplicate set of scans conducted with each concentration 
of E.coli bacteria (107 cells/mL) and S.typhi bacteria (108 cells/mL) recorded at 
60 mins, were calculated and their ratios were compared. These ratios for 
I3fmax,  ADT-D
2
max and ADT-DImax measurements are plotted in Fig. 6.24. For 
10 times lower concentration of E.coli (107 cells/mL) than S.typhi (108 
cells/mL) bacteria, the ratio values were 8.59 for I3fmax and 575.84 for ADT-
DImax. The ratio of means value for ADT-D
2
max was found to be highest and 
about 4394.30 times that of I3fmax and 65.55 times that of ADT-DImax. Thus, this 
showed that addition of hairpin structure into the E.coli-binding aptamers 
introduced non-linearity into the system and the resultant unique unzipping 
signal dramatically increased the specificity of the sensor which could be 
determined by ADT-D2 method of analysis. 
 
Fig. 6.24 - Comparison of specificity: ratio of mean values of I3fmax shift,         
ADT-DImax shift and ADT-D
2
max shift (10
7 E.coli/mL : 108 S.typhi/mL). 
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6.10 Summary 
The focus of this chapter is to investigate the influence of structurally modified 
aptamers with designed nonlinearity in enhancing specificity of the 
anharmonic acoustic detection of E.coli bacteria. Two configurations were 
designed by introducing smart chemical moieties into the structure of the 
E.coli-binding aptamers operating in two different modes: (1) unzip, and (2) 
shear mode. Out of these two, unzip configuration gave characteristic signals 
when the sensor was driven at higher amplitudes (0.6 and 0.7 SU) due to 
transient unzipping response, while for the shear configuration no 
characteristic signal was observed, implying there was no unzipping of the 
hairpin structure. Unzipping is dependent not only on the amplitude of the 
drive but also on its duration. Unzipping signal was observed at higher 
amplitude as the scans of shorter duration were employed. However, for 
scans of longer duration, lower amplitude would be enough due to greater 
thermal assistance. This unzip configuration was further investigated to 
determine specificity of the anharmonic acoustic sensor. S.typhi bacteria were 
used as control sample. 
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Chapter 7 Summary of conclusions and Future work 
7.1 Introduction 
This chapter presents the summary, contributions and conclusions of this 
thesis and closes with a discussion of the limitations of the present research, 
and the proposal of a number of areas of further research to build upon the 
findings of this thesis. 
7.2 Summary of contributions and conclusions of the work 
This doctoral thesis was motivated by the global need for rapid diagnostic 
tests to control growing problem of infectious diseases especially, due to 
antimicrobial resistance (AMR). If rapid diagnostic tests are made available for 
pathogen identification and also determination of their susceptibility to 
antimicrobials; this will facilitate appropriate prescription and reduce the 
chances of development of drug-resistant or multidrug-resistant infectious 
diseases.  
AMR is endangering the global health and needs to be tackled collectively on 
global scale. Therefore, the responses of various professional groups like 
Infectious Diseases Society of America (IDSA, US), Jim O’Neill’s AMR review 
group (UK) and Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria (PACCARB, US) were reviewed to identify the current key 
unmet needs regarding diagnostic testing.[2] The review made it clear that an 
ideal rapid diagnostic test should be cheap and reliably deliver sensitive, 
specific and quantitative measurements and be suitable for integration onto a 
POC platform. The key features of POCTs that distinguish them from 
conventional laboratory tests are: they do not require specialised laboratory 
infrastructure or trained personnel to use them; they deliver a rapid (i.e. within 
1 hour) diagnosis and they are more cost-effective than conventional tests.[69] 
Presently, bacterial identification (ID) and antibiotic susceptibility testing (AST) 
are the well-established diagnostic methodologies. Culture-dependent 
pathogen identification methods are very time-consuming and generally 
require 18 to 48 hours with further 8 to 48 hours to perform AST and report 
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the results. As it is unlikely to shorten the time required to conduct phenotypic 
AST, the initial pathogen detection and identification step needs to be 
reduced, to reduce the length of the diagnostic cycle. This will help clinicians 
to initiate appropriate treatments quickly. Thus, the initial literature survey 
explored all the currently available culture-independent rapid diagnostic 
methods viz. nucleic-acid based methods, immunological methods,                
mass-spectrometry-based methods and biosensor-based methods. 
Detection of whole-cell bacteria is important so that they can be further utilised 
for subsequent AST. However, nucleic acid-based methods are genotypic 
tests and do not permit isolating pathogens for further use. Immunological 
tests can detect whole-cell bacteria but in these methods also, bacteria cannot 
be recovered for AST. Moreover, both these methods are also label-based 
and require laborious labelling processes, making them costly. Also, methods 
like PCR, ELISA or MALDI-TOF-MS are laborious and require specialised 
equipment and trained personnel to operate the system. Biosensor-based 
methods allow label-free detection of whole-cell bacteria, except for optical 
label-based biosensors. However, optical biosensors are bulky in size and the 
set-up method of electrochemical biosensors is very complicated, making 
them both difficult to be translated as POCT. Later flow immunoassays (LFIs) 
are cheap and can be employed at the point-of-care but it is difficult to 
integrate them with electronics and suffer from higher false-positive rates than 
PCR and ELISA. On the other hand, ADT could potentially address this 
problem because of its intrinsic ability to differentiate specific and non-specific 
interactions, making diagnosis more reliable and reproducible. Also, ADT is an 
easy-to-use, integrable, low-cost technology that can be miniaturised and 
applied as POCT. Moreover, it is also possible to maintain suitable 
temperature and grow bacteria within the microfluidic device integrated with 
ADT, to investigate antibiotic action on slow growing pathogens. Therefore, as 
potentially AST can be performed with ADT and it can be applied at the point-
of-care for rapid, label-free, low-cost, detection with high specificity which is 
lacking in most of the other methods, this technology was selected to explore 
its use for whole-cell bacterial detection. 
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In biosensor-based diagnostic methods, it is vital to identify appropriate             
bio-receptor targeting bacteria, which can be then potentially coupled with the 
transducer. The right combination would then expedite diagnosis and thus 
decreasing the time between culture collections to specific antimicrobial 
treatment. Aptamers that are analogous to antibodies in their range of target 
recognition and variety of applications, they possess several key advantages 
over their protein counterparts. Therefore, in this thesis for the first time 
‘aptamer’ as bio-recognition element, was coupled with anharmonic acoustic 
transduction technique for detection of target E.coli bacteria. The main aim of 
this thesis was to investigate the feasibility of this ‘anharmonic acoustic 
aptasensor’ platform for rapid point-of-care detection of whole-cell bacteria, 
which can be applied for rapid identification of the pathogen and subsequent 
determination of antimicrobial susceptibility. Following are the most important 
observations made from this research: 
7.2.1. Addressed the experimental challenges with the integrated 
biosensor assay 
E.coli-binding aptamer as bio-receptor was first time integrated with the ADT 
transduction technique and also the microfluidic flow-cell for detection of 
target E.coli (KCTC 2571) bacteria. To achieve high sensitivity and specificity 
with this integrated bioassay several experimental challenges were addressed 
around the transduction technique, microfluidic flow-cell, and the assay itself 
and the objective O.1.1 was achieved. 
a. Increasing the sensitivity of the sensor through energy trapping 
Energy trapping concept is well-known concept and have been previously 
explored by Efimov et al., where they investigated the variation in sensitivity of 
QCR in response to energy trapping effect. They observed that the energy 
trapping effect not only suppresses the spurious modes but also increases the 
sensitivity of the QCR by confining the oscillations to the region of additional 
loading. Hence, this effect was further explored in terms of anharmonic 
acoustic detection technique and the electrode geometry was modified to 
stepped (non-uniform) crystals, by loading the gold electrodes of QCR with 
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central gold deposits. To demonstrate the energy trapping effect on the ADT 
signal, experiments were performed, where QCRs with the uniform and 
stepped electrodes were used to detect the streptavidin-coupled beads. It was 
observed that the sensitivity of the QCR (3f signal) increased dramatically 
almost 3 times by loading it with central gold deposit (~ 65 nm height) and 
concentrating the oscillations to loaded area through energy trapping effect, in 
comparison to that of the uniform crystals. Thus, energy trapping effect 
increased the sensitivity of the nonlinear acoustic sensor. 
b. Identification of optimal method of measurement of 3f signal 
The two modes of scans used for ADT measurements were explored: 
frequency mode scan (FMS) and amplitude mode scan (AMS). It was found 
that for AMS scans, it is imperative to determine f0 values before each scan to 
get maximum response. Consequently, real-time measurements are difficult to 
obtain with AMS mode scan, as the driving frequency needs to be reset to 
resonant frequency before each scan. Thus, it was concluded that FMS mode 
scan should be used for measuring 3f signal as it gives true shift and also 
allows real-time measurements as there is no need to reset the driving 
frequency to f0 before each step. This was an important finding as it reduced 
the overall assay time, which is one of the important requirements for the 
diagnostic test for controlling AMR. 
c. Selection of suitable bioassay format 
The interface between the transducer and the bio-receptor plays important 
role, influencing the generation of anharmonic acoustic signal.                  
Biotin-streptavidin bioassay format was selected to ensure optimum 
orientation of the bio-receptor, thereby, enhancing the performance of the 
biosensor assay. 
d. Resolved the problem of bubble formation with the microfluidic flow-
cell 
Previous experiments with ADT machine done by Ghosh et al. [151, 152] were 
done using simple batch method, wherein a droplet of sample was placed on 
the sensor surface. However, in all the experiments for this PhD project, a 
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microfluidic flow-cell was used for sample delivery. The performance of this 
flow-cell was frequently challenged with the problem of bubble formation, 
which apparently affected the signal acquired. The problem was identified to 
be at the entry point of tubes into the flow-cell. This issue was resolved by 
increasing the diameter of both inlet and outlet and inserting small piece of 
softer tube having internal diameter same as the outer diameter of the harder 
tubes connected to sample reservoir (as shown in Fig. 3.21 (B) and (C). Thus, 
this was a key solution as it ensured the reliability of the signal and also 
efficient exposure of the sample to the surface without any interference due to 
bubbles.  
e. Achievement of baseline stability 
For the comparability purposes, it is important that baseline is measured 
under the same conditions as that after passing analyte. Baseline values 
essentially represent the noise in the system. Therefore, baseline stability is 
important to get better signal-to-noise ratio (SNR) after introduction of the 
target analyte. Several ways were tried before a stable baseline could be 
achieved like, warming up the QCR half an hour before the experiments, 
ensuring proper clamping, removing bubbles (if any) from the system, etc. Of 
all the steps, the most critical and useful step was found to be acoustically 
clean the surface intermittently with constant amplitude scans. Given that ADT 
is very sensitive transduction technique, baseline stability was a very 
important achievement, as it reduced the noise and improved the SNR of the 
measurements. 
7.2.2. Anharmonic acoustic aptasensor enables detection of E.coli 
bacteria 
ADT transduction technique has been previously employed for detection of 
Bacillus subtilis spores in liquid, but not for live whole-cell bacteria. For the 
first time, the nonlinear acoustic response of QCR was probed with 
functionalised specific DNA aptamers that are multivalent and bind whole 
bacterial cell for direct detection and quantification of viable E. coli KCTC 
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2571 bacteria. This aptamer-based assay coupled with nonlinear acoustic 
sensor constituted the anharmonic acoustic aptasensor. 
With this aptasensor, it is possible to detect the presence of viable surface-
bound E.coli bacteria by measuring the maximum value of magnitude of the 
transduced 3f current (I3fmax), which is referred to as the 3f or ADT signal. The 
fabricated ‘anharmonic acoustic aptasensor’ on gold surface of QCR 
electrodes was successful in rapid, sensitive, specific and quantitative 
detection of E.coli bacteria and met the objective O.1.  
Enabling rapid and sensitive detection of viable whole-cell E.coli 
bacteria:  
The response of this aptasensor was observed for the bacterial suspensions 
ranging from 105-108 cells/mL. The results show that the 3f signals (I3fmax) 
allow rapid, sensitive and quantitative detection of 2.5 x 104 viable E.coli 
bacteria in 5 mins, as compared to standard frequency shift (Δf0) and 
dissipation shift (ΔD) measurements.  
Enabling quantitative detection of viable whole-cell E.coli bacteria: 
Linear quantitative correlation could be reliably achieved with 3f signal (I3fmax) 
(R2 = 0.984) for four concentrations of E.coli bacteria (105-108 cells/mL), than 
with Δf0 and ΔD. For the highest concentration of E.coli of 10
8 cells/mL, 
negative frequency and dissipation shifts were observed. This could be due to 
increase in mass going on the surface, highlighting the need for washing step 
with these methods. On the other hand, linear quantitative correlation could be 
achieved for E.coli concentrations with ΔI3fmax without the washing step, as the 
3f signal is additive since the motion of the flexibly bound bacteria is 
synchronous and their interaction with the surface is independent of each 
other. 
Enabling specific detection of viable whole-cell E.coli bacteria: 
This aptasensor also allowed detection of E.coli bacteria with high specificity. 
To determine specificity, S.typhi bacteria were used as control sample. For 
the same concentrations of E.coli and S.typhi bacteria (108 cells/mL), the ratio 
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values were, 1.01 for Δf0, 8.42 for ΔD and highest 19.02 for ΔI3fmax. Thus, the 
increase in resonant frequency and the relative increase in dissipation were 
found to be lower by 18.83 and 2.26 times than the relative decrease in 3f 
signal (I3fmax).  
Enabling reproducible detection of viable whole-cell E.coli bacteria: 
Triplicate set of experiments were performed to validate reproducibility after 
achieving stable baseline each time.  
Accordingly, this anharmonic acoustic aptasensor which allows fast, sensitive 
quantitative detection of viable target bacteria with high specificity and 
reproducibility not only saves time but also allows subsequent AST by sparing 
intact bacteria for further characterisation. Thus, this sensor could be applied 
for rapid pathogen identification to reduce the overall length of the diagnostic 
cycle and prevent AMR. 
7.2.3 Comparative performance of different bio-receptors integrated with 
ADT for detection of bacteria 
In the ADT transduction technique, for a given drive frequency (f), the 3f signal 
is dependent on the force-extension characteristic of the molecular tether, its 
length, and also the size of the particles. Hence, to meet the objective O.2.1 
and O.2.2, bio-receptors of different size i.e. anti-E.coli antibodies and 
different length i.e. thiolated E.coli-binding aptamer (shorter) were investigated 
for detection of E.coli bacteria, respectively.  
It was found that the sensitivity and specificity of the assay with longer linker 
(biotinylated aptamer-streptavidin-biotin thiol) was highest for detection of 
E.coli bacteria as compared with shorter linker (thiolated aptamer) and 
biotinylated antibody assay. Bio-receptors with different linker lengths have 
been previously investigated, and it was found that with the longer linker the 
percentage elongation is less and also the inclination is less, resulting in lower 
3f response compared to a shorter linker. However, the response with shorter 
linker (thiolated linker) was found to be lower than longer linker in terms of 
both sensitivity and specificity.  
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This could be due to saturation of the surface with 100% thiolated aptamers 
which might have affected its functionality by steric hindrance because of 
overcrowding. This can be potentially improved by co-immobilisation of the 
thiolated aptamer with MCH in a fixed combination rather than backfilling with 
MCH. 
7.2.4 Novel aptamer configurations enabling highly specific detection of 
bacteria 
The influence of structurally modified aptamers with designed nonlinearity was 
investigated in enhancing the sensitivity and specificity of the anharmonic 
acoustic detection of E.coli bacteria. Two configurations were designed by 
introducing smart chemical moieties into the structure of the E.coli-binding 
aptamers operating in two different modes: (1) unzip, and (2) shear mode. Out 
of these two, unzip configuration gave characteristic signals when the sensor 
was driven at higher amplitudes (0.6 and 0.7 SU) due to transient unzipping 
response, while for the shear configuration no characteristic signal was 
observed, implying there was no unzipping of the hairpin structure.  
Unzipping is dependent not only on the amplitude of the drive but also on its 
duration. Unzipping signal was observed at higher amplitude as the scans of 
shorter duration were employed. However, for scans of longer duration, lower 
amplitude would be enough due to greater thermal assistance.  
This unzip configuration was further investigated to determine specificity of the 
anharmonic acoustic aptasensor. S.typhi bacteria were used as control 
sample. Characteristic signals were obtained for 107 E.coli/mL but none for 
108 S.typhi/mL. 
This is again unique and novel for a biosensor assay. This enables detection 
of bacteria with high specificity by introduction of innovative mechanical 
structures in the stem of the E.coli-binding bacteria. This can be also applied 
for multiplex detection by employing aptamer designs with and without unzip 
configurations on the single sensor and differentiating the characteristic 
signals by varying driving amplitude and duration of scans. This is a novel 
direction for the research in terms of developing aptamer-based bioassay for 
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nonlinear acoustic sensor ADT to be used as POC device for infectious 
disease diagnosis. 
7.3 Potential impact through future research 
7.3.1 Exploring detection of other pathogens 
It was possible to directly detect viable E.coli bacteria with the fabricated 
anharmonic acoustic aptasensor, but it will be interesting to explore direct 
detection of other pathogens of different sizes like, virus (smaller) and fungi 
(larger). Also, the E.coli (KCTC 2571) bacteria detected in this work are             
non-pathogenic. To apply this sensor for pathogen identification in real-world 
samples, a similar feasibility study needs to be carried out with pathogenic 
strains. 
7.3.2 Exploring other diagnostic methods 
The aptamer-based bioassay which constituted the bio-recognition element of 
the biosensor assay can be applied to other diagnostic methods too. It will be 
interesting to test this aptamer-based bioassay with the Lateral Flow Assays 
(LFAs) that are rapid, cheap and simple-to-use which can be applied easily at 
the point-of-care to control AMR. 
7.3.3 Investigating QCRs with lower resonant frequency 
For all the experiments TSM quartz crystal resonators were used with 
fundamental resonant frequency range of 14.275 -14.325 MHz. However, 
QCRs with lower resonant frequencies like 5 MHz could be integrated with 
aptamer-based assay and tested for detection of E.coli bacteria. QCRs with 
lower resonant frequencies will have greater amplitude of oscillations. This 
could cause greater distortion or stretching of the biomolecular linkers for 
given driving amplitude, thus a greater 3f signal. 
7.3.4 Improving microfluidics for in-situ pathogen identification and AST 
The anharmonic acoustic aptasensor allows a label-free direct phenotypic 
detection of live bacteria within a controlled microfluidic environment, which 
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can be maintained at a desired temperature. This means it is possible to 
culture bacteria within the microfluidic cell and measure the growth curve. 
Thus, it is possible to introduce antibiotic and to record any change in signal 
and thereby interpret the antibiotic susceptibility. My work has led to this 
current activity in Dr. Ghosh's lab. A successful outcome of the project will 
allow, “rapid identification of pathogens along with determination of phenotypic 
antibiotic susceptibility and minimum inhibitory concentration”, for the first time 
known. Also, this sensing system can be further applied for detection of 
pathogens in biological samples like blood, urine, food samples, etc. For this 
disposable cartridge with foil-based pressure sensors are being developed 
and investigated, as a part of another Enterprise Project.  
7.3.5 Modification of the aptamers to enable multiplex detection 
By introducing smart chemical structures in the E.coli-binding aptamer 
sequence, a characteristic signal was achieved which significantly enhanced 
the specificity of the biosensor. The novel mechanical hairpin structure 
introduced in the stem of the aptamer comprised of a short dsDNA helix (21b) 
with very low GC content, thus allowing unzipping easily. This can be further 
modified and several sequences can be tried with different AT or GC nucleic 
acid combinations and thus varying the corresponding signal, as the driving 
amplitude will differ depending on the nucleic acid composition. Also, instead 
of all complementary strands, sequences with mismatched based can be 
introduced to cause unzipping at a lower amplitude. Aptamer configurations 
thus modified having specific binding affinity for different bacteria can be 
employed on the same QCR and the different amplitudes could be determined 
for different configurations giving characteristic signals. Thus, this could be 
applied for multiplex detection of bacteria using single sensor platform. 
7.4 Considerations for ‘Anharmonic acoustic aptasensor’ as POCT 
Point-of-care (POC) biosensor systems can potentially improve patient care 
through real-time and remote health monitoring. It is expected that future POC 
diagnostic systems should support artificial intelligent algorithms through the 
use of decision support process, in order to provide accurate and efficient 
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diagnostic results in real-time. Decision support processing is a critical 
component of a POC system since they can assist new clinicians in their 
diagnostic and clinical judgement and thereby, help in controlling AMR. 
Currently, Lateral Flow Assays (LFAs) that are fast, inexpensive and easy-to-
use are applied at the point-of-care. Like LFAs, anharmonic acoustic 
aptasensor also has the potential to be applied at the POC. Anharmonic 
acoustic aptasensor is an analytical device consisting of three important 
elements: ADT along with QCR as transducer, microfluidic flow-cell for sample 
introduction and aptamers as bio-receptor. In order to apply anharmonic 
acoustic aptasensor as POCT, all these three elements need to be further 
improved.  
The small size and simple construction of biosensor used for detection of 
biological agents are ideally suited for POC lab-on-a-chip systems. The 
currently used ADT machine for transduction is portable, but to be applied as 
lab-on-a-chip system, it needs to be further fabricated at micro- or nano-scale. 
Besides, it is also important to use materials having mechanical properties 
that enable improved sensitivity with low electrical losses. 
Previous experiments with ADT machine were done by using simple batch 
method, wherein a droplet of sample was placed on the sensor surface. 
However, in all the experiments for this PhD project, a polycarbonate 
microfluidic flow-cell (Fig. 3.21) was used for sample delivery. The microscale 
features of the microfluidic flow-cell ensured laminar flow and very little 
mixing. But by using cheaper materials like Polydimethylsiloxane (PDMS) for 
fabrication, the cost of this microfluidic flow-cell can be further reduced. 
Currently, a lot of researchers use PDMS and soft lithography due to their 
easiness of use and fast process. This permits to build prototypes very quickly 
and test its applications, instead of wasting time in laborious fabrication 
protocols. Also, the soft lithography technique requires only a little bench 
space under a lab fume hood to place rapid PDMS prototyping instruments 
and to quickly assess microfluidic concepts. In the past, research efforts have 
been made to realise the rapid multiplexed detections using lab-on-a-chip 
devices with integrated microfluidic system. Therefore, in addition to the points 
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mentioned in the section 7.3.4, the microfluidic flow-cell should be further 
improved to address the issue of multiplexed detection at the POC. The 
microfluidic flow-cell with multiple channels can be designed to achieve 
multiplex detection. But this warrants use of syringe pump with multiple 
channels and with most precise flow rate and pressure control.  
The E.coli-binding aptamers can be easily procured, as they can be replicated 
by simple chemical synthesis with very high fidelity once a useful DNA 
sequence of the aptamer is known. Aptamers are thus easily quantifiable and 
do not require re-evaluation before a new batch of aptamers comes into use. 
The regeneration of the crystals used is a key factor to be considered in the 
development of a real-world biosensor. Aptamer receptors can allow repeated 
affine layer regeneration after ligand binding and recycling of the biosensor 
with little loss of sensitivity. Aptamers can be denatured and renatured to their 
original conformations by changing the temperature and pH, thus can be 
reused for the subsequent capture assay. Another elution strategy is based on 
the usage of the chelating agent like ethylenediamine tetra-acetic acid 
(EDTA), which chelates the divalent ions that are important for the binding 
affinity of the aptamer against the target. Thus, aptamers have excellent 
reusability property and are suitable bio-receptors for bacterial detection.[246-
248] 
Also, biosensors with wireless link capabilities are desirable because wireless 
sensing systems can monitor health conditions in real-time and also promote 
novel healthcare services, like real-time drug delivery.  
In summary, by further improving all the three elements of the ‘anharmonic 
acoustic aptasensor’ with the help of advanced techniques, it is possible to 
apply it at the POC and thereby, control AMR. 
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